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Abstract
Allergen proteases from a number sources including the filamentous fungus A. fumiga-
tus, are thought to be important in the development of severe asthma through protease
dependent interactions with the respiratory epithelium. The first aim of the thesis was
to determine the effect of a variety of growth substrates on the secretion of proteases
from different strains of A. fumigatus. The second aim was to investigate the effects of
recombinant allergen proteases Asp f 5 and Asp f 13 expressed in the P. pastoris pro-
tein expression system and crude A. fumigatus culture supernatants on airway epithelial
cells and determine whether protease induced interleukin 8 (IL-8) release from airway
epithelial cells was dependent on the activation of protease activated receptor 2 (PAR-2).
Results demonstrated that the AF293 strain of A. fumigatus secreted serine proteases
during growth on pig lung homogenate medium and metalloproteases during growth on
a casein based medium but suppressed protease secretion in Vogel’s minimal medium.
Analysis of the secretion and RNA levels of proteases in A. fumigatus showed that the
matrix metalloprotease, Asp f 5 and the serine protease, Asp f 13 were up-regulated and
secreted during growth in pig lung medium and that the matrix metalloprotease, Lap1 was
up-regulated and secreted along with Asp f 5 and Asp f 13 in casein medium. This finding
was confirmed using protease inhibitors and by using strains of A. fumigatus in which Asp
f 5 and Asp f 13 genes were disrupted. These results suggest that A. fumigatus was able to
detect different complex proteins available as substrates in it’s environment and regulate
protease secretion accordingly. Furthermore, in several strains of A. fumigatus, protease
activity was not suppressed by growth in Vogel’s medium, suggesting differences in the
regulation of protease secretion between strains. Both A. fumigatus culture supernatants
and recombinant Asp f 5 and Asp f 13 produced in P. pastoris caused epithelial airway cell
desquamination, and IL-8 release in a protease and dose-dependent manner. In addition,
both recombinant Asp f 5 and Asp f 13 were both shown to cleave PAR-2 at a site that
resulted in receptor activation.
In conclusion, differences in the secretion of proteases between A. fumigatus strains
and during growth of A. fumigatus on different media suggests a requirement for the
standardisation of the preparation of A. fumigatus allergen extracts used both in clinical
diagnosis of A. fumigatus allergy and in vitro and in vivo research studies. Furthermore, it
is proposed that allergen proteases secreted by A. fumigatus may interact with a variety of
host proteins including, matrix molecules, enzymes and receptors which may exacerbate
allergic airway diseases.
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Chapter 1
Introduction
1.1 The role of fungi in allergic airway disease
1.1.1 Allergic airway disease
Asthma can generally be described as a disease of the airways characterised by inflam-
mation, airway obstruction, airway remodelling and hyper-responsiveness, resulting in
decreased pulmonary function. Exacerbations of asthma may occur in response to a wide
variety of stimuli including mechanical stress, cold air, cigarette smoke, and most com-
monly allergenic material. Asthma is the result of many different interactions between
the immune system, genetic factors and the environment. However, many of the pre-
cise mechanisms behind these interactions remain unknown and asthma remains a highly
complex disorder affecting a large number of people, with highly variable symptoms.
Allergy is known to play a role in several asthma phenotypes (Table 1.1). Individuals
that are known to have allergic reactions to certain stimuli are said to be atopic. Atopic in-
dividuals have a tendency to inappropriately produce immunoglobulin E (IgE) in response
to substances in the environment. Studies by Pearce et al. suggested that around 50-60%
of adults and children with asthma were skin prick text positive to one or more common
allergens [135]. The substances in the environment that elicit this response, are known
as allergens and come from a variety of sources such as house dust mite faeces, fungi,
pet allergens, grass and tree pollen [144]. In allergic asthma, symptoms are triggered
in response to an allergen, resulting in inflammation. Allergic asthma my take several
forms depending on the cytokine environment present in the lung. It has been suggested
by Douwes et al. that around 50% of asthmatics demonstrate Th2 driven eosinophilic
allergic asthma, whilst the remaining 50% of asthmatics are characterised by steroid re-
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sistant, non-atopic, non-IgE-dependent, and non-eosinophilic inflammation, defined as
neutrophilic allergic asthma [5,47]. However, it has also been suggested that neutrophilia
and eosinophilia may occur concurrently, complicating the classification of asthma into
pure neutrophilic and eosinophilic forms [47].
In eosinophilic asthma, challenge of the immune system by an allergen results in a
two stage response, leading to discrete acute and late phase reactions, separated by several
hours [18, 55, 126]. Allergen challenge results in the development of an inappropriate in-
flammatory response, driven by type 2 CD4+ T helper (Th) memory cells (CD4+ Th2M).
This response is known as a type I hypersensitivity reaction. Antigen presenting cells
(APCs) and dendritic cells (DCs) are resident at the site of allergen entry, and take up the
allergen by phagocytosis. They then move through the lymphatic system to a lymph node,
where presentation of the allergen to the appropriate immature CD4+ Th2 cell, resulting
in the production IL-4 and IL-13, which skew the immune response towards Th2 driven
inflammation. The production of IL-10 by APCs and DCs, down-regulates Th1 cytokines,
and up-regulates B Cell proliferation. Activated B cells then produce IgE that specifically
binds the allergen. Mast cells are recruited to the area and activated by IL-3. Cross-linking
of receptors on the surface of mast cells results in the release of a number of substances
including cytokines and chemokines. Histamine released by mast cells causes smooth
muscle contraction and the broncho-constriction associated with the early phase of an
asthma exacerbation. The cytokines and chemokines released by mast cells and CD4+
Th2 cells including, IL-3, IL-5 and GM-CSF, allow the recruitment of eosinophils into
local tissues. Eosinophils produce an array of chemicals and enzymes including major
basic protein, eosinophil cationic protein, eosinophil peroxidase (EPO), reactive nitrogen
species (RNS) and reduced oxygen species (ROS) [110]. The release of these substances
results in the chronic inflammation seen in the late phase reaction (Figure 1.1). Once
sensitisation has occurred, IgE levels may remain high leading to a rapid response every
time the allergen is encountered. In many cases of allergy related asthma, the condition
is rarely resolved and the CD4+ Th2 mediated reaction persists. In a normal CD4+ im-
mune reaction, the Th2 response should abate as regulatory functions eliminate effector
CD4+ Th2 cells after activation. However, in asthmatic airways Th2 CD4+ cells persist
via one or a combination of the following mechanisms; increased generation from Th0
CD4+ precursors, increased recruitment and/or proliferation of effector/memory CD4+ T
cells, or reduced elimination of CD4 + T cells [40].
Alternatively in neutrophilic asthma, it has been suggested that presentation of al-
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Table 1.1: Clinical subtypes of asthma, information obtained from [21]
Subtype Key Features and Diagnosis
Childhood Asthma
Transient infant wheezing Characterised by impaired lung function at birth. Unlikely to
continue wheezing past the age of 3. No family history of asthma.
No markers of an atopic predisposition.
Non-atopic wheezing of
toddlers and early school
years
Characterised by wheezing beyond age 3. Around 40% are
non-atopic with a history of viral lower respiratory disease early in
life.
Persistent IgE mediated
asthma
Characterised by continued wheezing leading to persistent chronic
asthma. Associated with high levels of atopy, bronchial
responsiveness and impaired lung function (lowered FEV1).
Genetic factors and early allergic sensitisation are key risk factors.
Airway obstruction is reversible.
Late onset childhood asthma Asthma occurring during or after puberty mainly affecting women
with a low remission rate. Atopy is the major determinant for
bronchial hyperresponsiveness (BHR).
Adult Onset Asthma
Aspirin induced asthma
(AIA)
Characterised by asthma attacks, chronic hyperplastic
rhinosinusitis and nasal polyps following ingestion of aspirin or
other NSAIDs (Non-steroidal anti-inflammatories)
Asthma related to chronic
persistent respiratory
infection
Characterised by onset of asthmatic symptoms subsequent to a
severe respiratory infection.
Asthma related to
immunologic or
non-immunologic exposure
in the workplace
Immunologic asthma can be IgE or non-IgE mediated.
Non-immunologic is also know as irritant induced asthma or
reactive airway syndrome and has no immunological basis,
damage to the airway epithelium by smoke or inhaled chlorine
may induce asthma.
Severe Asthma
Asthma with fixed airflow
obstruction
Chronic asthma with irreversible airway obstruction related to
chronic airway inflammation and remodelling.
Near fatal asthma Main risk factors are recurrent severe exacerbations with
hospitalisation and a history of emergency visits. Lack of action in
response to progressive deterioration by the patient also increases
chances of a near fatal attack.
Steroid resistant asthma Characterised by continued inflammation in the presence of high
doses of glucocorticoids.
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lergens by DCs to Th0 CD4+ precursors, in the presence of IL-6, TGF-β and IL-1β,
results in the development of Th17 CD4+ T cells. These cells then produce IL-17A, IL-
17F and IL-22, which in turn signals through the IL-17RA receptor, on both epithelial
cells and fibroblasts. This results in the production of the Chemokine (C-X-C Motif)
Ligands, CXCL1, CXCL2, CXCL5, and IL-8, which act as neutrophil chemoattractants.
Additionally, the Chemokine (CC Motif) Ligands, CCL2, and CCL20 are also produced
resulting in macrophage chemotaxis. The release of ROS and matrix metalloproteases
by neutrophils and macrophages as well as the release of neutrophil elastase by neu-
trophils, is thought to drive airway inflammation, remodelling and the development of
the severe asthma phenotype (Figure 1.2). It is unknown if the maintenance of this phe-
notype and the persistence of inflammation is due to continual stimulation by signalling
through chemokines, such as IL-6, or the lack of repression by terminating signals such
as IL-27 [5].
Persistence of the inflammatory reaction results in the development of a chronic in-
flammatory response and a cycle of injury followed by impaired repair, which has been
implicated as a factor in the development of chronic severe asthma. In severe asthma, the
airway wall is infiltrated with CD4+ T cells, eosinophils, mast cells, macrophages, plasma
cells and neutrophils. The airway lumen contains mucus mixed with macrophages, lym-
phocytes, eosinophils and sloughed epithelia cells, which results in significant thickening
of the mucus within the lumen [40]. Modifications to the structure of the airway, known
collectively as airway remodelling, are also found. The airway wall is thickened compared
to normal, resulting in reduction of the diameter of the airway lumen [74]. Epithelial cells
are shed creating a denuded epithelium and the remaining columnar epithelial cells may
undergo metaplasia into goblet cells. In addition, increased mucus or abnormal mucus
composition is also observed [130]. Thickening occurs in the sub-epithelial layer due to
the deposition of collagen (Types I, III and V), fibronectin and tenascin in the lamina retic-
ularis [17, 145]. Smooth muscle mass also increases up to three times the normal level,
due to smooth muscle cell hyperplasia, hypertrophy and myofibroblast migration [17].
There is also increased vascularisation, including angiogenesis and increased vascular di-
lation and permeability, resulting in airway wall odema [74]. Thickening of the airway
walls, is proposed to be the primary cause of the irreversible airway obstruction observed
in individuals with severe asthma.
Allergy has been shown previously to be strongly associated with severe asthma. Al-
though, the mechanisms resulting in the development of allergic inflammation leading
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Figure 1.1: Major cell types implicated in the pathogenesis of acute and chronic allergic
eosinophilic asthma. APC = Antigen Presenting Cell, Th2= CD4+ T helper cell 2, ThP=
T helper Cell Precursor, IL= Interleukin, GM-CSF= Granulocyte Macrophage Colony
Stimulating Factor. Modified from [73].
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Figure 1.2: Major cell types implicated in the pathogenesis of acute and chronic allergic
neutrophilic asthma. APC = Antigen Presenting Cell, Th17= CD4+ T helper cell 17, ThP=
T helper Cell Precursor, IL= Interleukin, GM-CSF= Granulocyte Macrophage Colony
Stimulating Factor. Modified from [5].
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to severe asthma are not clear [32, 116, 129]. There is substantial evidence that in some
cases, fungal allergens may be involved, which will discussed in the next section.
1.1.2 Fungal involvement in allergic airway disease
Clinically, the involvement of fungi in asthma is well reported, however a definite asso-
ciation is difficult to establish possibly because exposure, in both time and intensity, is
highly variable [45]. In the previous section, the relationship between allergy and severity
of asthma was discussed, and allergy to fungal antigens in particular has been shown to be
associated with severe asthma [24, 33, 67, 129, 136, 182]. Several studies have indicated,
that in individuals with persistent asthma, around 20-25 % have positive skin test reactiv-
ity to Aspergillus or other fungi [28, 111, 152]. Other studies have also reported a strong
link between severe asthma and sensitivity to both Alternaria alternata and Cladosporium
herbarum allergens [182]. Furthermore individuals with severe asthma were found to be
more likely to be sensitive to allergens from one of more of the following fungi, A. fumi-
gatus, Penicillium notatum, C. herbarum or A. alternata or the yeast Candida albicans,
compared with individuals with mild asthma [127].
Exposure to fungi is ubiquitous although the precise allergens that individuals are
exposed to may be different depending on the source of the allergic material. Exposure
to different fungal allergens or different life cycle stages of the same fungi may result in
different responses with regards to allergy. It has been suggested that, unlike exposure
to allergens from other sources, such as house dust mites, chronic exposure to fungal
allergens may occur during colonisation of the host lung by fungi and that the products
of germinating conidia and hyphae within the lung may be responsible for allergy and
the development of asthma [45]. Such theories have been supported in a study by Porter
et al., which demonstrated that colonisation of the lung by A. niger, in a murine model,
resulted in the development of asthma and atopy [140]. Alternatively, it is possible that
exposure to fungal allergens may occur due to inhalation of allergens secreted into the
environment. Several studies have demonstrated differences in allergen production in A.
fumigatus when grown on a different media substrates or during germination in the lung,
suggesting that different allergen profiles may be present from A. fumigatus growing in
different environments [52,53,94,115,143,163]. These results were confirmed clinically
as different preparations of fungal allergens from the same species of fungi, provided by
different manufacturers were found elicit different skin test results in the same patient
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[3]. It is therefore suggested that, the conditions under which fungi grow are critical in
influencing the allergens secreted by the fungi and the ability of the fungi to elicit an
allergic reaction.
A. fumigatus is associated with several airway diseases, including allergic airway dis-
ease, and has been studied in greater detail than other fungi. Therefore A. fumigatus is
suggested to be an excellent candidate for investigations into the role of fungi in asthma,
and will be discussed further in the next section.
1.1.3 A. fumigatus associated allergic airway diseases
The Aspergillus genus represents a large group of around 180 types of highly faculta-
tive saprophytic filamentous fungi that are found worldwide but most commonly in the
northern hemisphere during autumn and winter [65]. A. fumigatus is ubiquitous in the
environment and important in the recycling of carbon and nitrogen within the soil. As
they are near obligate aerobes, Aspergillus spp. growth generally occurs in an oxygen
rich environment. A. fumigatus is a thermophilic species that will grow at temperatures as
high as 55°C and survive up to temperatures as high as 70°C [102]. Whilst there are many
differences between strains of Aspergillus, they all share a similar life cycle (Figure 1.3).
Reproduction is generally asexual, however it has been suggested that sexual reproduc-
tion may be possible [48]. In the vegetative filamentous growth phase of the asexual cycle,
Aspergillus form colonies of mycelium, comprised of multi-nucleated branching hyphae.
These hyphae develop uninucleate asexual spores, known as conidia, on branches called
conidiophores. The process of conidia production and sporulation occurs in response to
physiochemical changes in the environment [162].
In the clinical setting A. fumigatus can be seen as an opportunistic pathogen that causes
a range of diseases known collectively as aspergillosis. The pathology of aspergillosis
varies depending on the site of infection, virulence of the strain and status of the infected
individual. For an Aspergillus infection to become successfully established, the fungus
must overcome physiological barriers and the host immune response. The lung epithelium
provides the first line of defence with conidia being physically removed from the lung by
the ciliary action of the epithelial cells. Furthermore, lung epithelial cells also express
a range of pattern recognition receptors (PRRs), such as toll like receptors (TLR) 2 and
4, which recognise unknown pathogen associated molecular patterns (PAMPs) on A. fu-
migatus resulting in the secretion of the chemokines TNF-α and IL-8 (a potent netrophil
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Figure 1.3: Life cycle of Aspergillus spp.. Germination of conidia occurs in response to
physiochemical changes in the environment and is followed by the formation of colonies
of mycelium, comprised of multinucleated branching hyphae in the plateau phase. Hy-
phae develop uninucleate asexual spores, known as conidia, on branches called conid-
iophores which are released into the surrounding environment. (Images taken from The
Aspergillus Website [1]).
chemoattractant) [13, 14, 120]. Any conidia that are not removed by the mucocilliary es-
calator are cleared by alveolar macrophages. Studies by Steele et al. have suggested that
PRRs such as Dectin-1, which interact with β-1,3-glucans on the surface of spore and
hyphae, are crucial for the recognition of A. fumigatus by macrophages and neutrophils
and are required for phagocytosis [164]. Further studies by Sturtevant et al. demonstrated
that binding of the complement protein C3 to the surface of conidia is be involved in the
activation of the alternative complement pathway, leading to opsonisation, phagocytosis,
and ingestion by macrophages [166]. Studies have also suggested that both conidia and
hyphae are capable of binding and degrading components of the complement pathway
including Factor H, C3, C4 and C5, resulting in the down-regulation or termination of
the complement cascade [20]. Phagocytosis of conidia by macrophages and the forma-
tion of a phagosome has been shown to be dependant on actin polymerisation and phos-
phatidylinositol 3-kinase activity [79]. Conidia are destroyed by the fusion of the phago-
some with compartments of the endocytic pathway and the killing of conidia depends
on phagolysosome acidification, mediated by vacuolar ATPases [79]. Neutrophils have
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also been shown to be able to directly phagocytose conidia directly, however, the main
role of neutrophils is in the destruction of fungal hyphae [31, 165]. The destruction of
fungal hyphae is mediated by polymorphonuclear neutrophils (PMNs). Contact between
unknown components of PMNs and fungal hyphae, instigates a respiratory burst and de-
granulation of PMNs, which leads to the rapid destruction of hyphae [12]. Incubation
of PMN granules with hyphae shows the rapid release of hyphal cell-wall glycoproteins,
suggesting cell wall destruction as the mechanism of hyphal killing [103]. Recently, neu-
trophils have been shown to produce neutrophil extracellular traps (NETs), consisting of
DNA coated in fungicidal proteins, which have been suggested to have a fungistatic effect
in vivo [31].
Components of the adaptive immune system also have a role in the clearance of A. fu-
migatus. Immunocompetent mice infected with a virulent strain of A. fumigatus produce
an array of CD4+ Th1 type cytokines, including IL-12, IL-18, TNF-α, and IFN-γ that are
important in reducing fungal load [138]. It has been demonstrated that progression of in-
vasive aspergillosis is dependent on the initiation of a CD4+ Th2 type response shown by
an increase in IL-4/10 levels and a concomitant fall in IFN-γ. Taken together these results
suggested that a CD4+ Th1 type immune response from the adaptive immune system is
required for efficient clearance of A. fumigatus infections. Whilst the affects of steroids
on the interactions between A. fumigatus and the immune system is unclear it has been
suggested that the pleiotropic immunosuppressive effects of glucocorticoids may promote
the development of a CD4+ Th2 type response [103]. Additionally, glucocorticoids such
as dexamethasone have been shown to suppress the conidia killing action of peritoneal
macrophages and alveolar macrophages [30]. Any such interaction could potentially be
very important in asthmatic individuals where the use of corticoids is widespread and
CD4+ Th2 type allergic responses dominate.
By considering the hosts mechanisms of defence, virulence factors in A. fumigatus are
either substances produced by the fungus that allow for better colonisation of the lung or
components of the conidia which promote resistance to the host immune response. Stud-
ies investigating virulence in A. fumigatus have classically looked at single gene knock-
outs of putative A. fumigatus virulence genes and have rarely shown conclusively that
virulence is associated with a single gene [103]. For example, knock out of a metallopro-
tease secreted during mycelial growth shows no impact on A. fumigatus virulence in the
mouse model [81]. Additionally DNA fingerprinting of clinical and environmental iso-
lates of A. fumigatus has shown there to be little difference between the two strains [103].
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This indicates that, unlike other pathogens few human specific virulence mechanisms
have evolved in A. fumigatus, and in fact existing mechanisms that promote survival in
the environment allow for growth in the immunocompromised host. Together these ob-
servations suggest that virulence is multifactorial and that investigations into virulence
should examine multiple gene knockouts.
A. fumigatus can infect several sites in the body, including the lungs and sinuses,
and can even cause systemic infections. However, in the context of individuals with
asthma, manifestations that affect the lungs are the most important. There are several ma-
jor types of pulmonary disease caused by Aspergillus; aspergilloma, chronic necrotising
aspergilloma (CNA), invasive pulmonary aspergillosis (IPA), allergic bronchopulmonary
aspergillosis (ABPA) and severe asthma with fungal sensitisation (SAFS). Aspergillus fu-
migatus is known to be a source of allergenic material that causes exacerbations in asthma
and has been implicated in asthma and diseases associated with asthma including ABPA
and SAFS [45].
ABPA is the result of an allergic reaction to allergens produced by Aspergillus and
is predominantly seen in patients with severe asthma or cystic fibrosis. Unlike other
diseases caused by A. fumigatus, such as IPA, immunosuppression is not required for
colonisation [177]. Instead, colonisation occurs due to the inability of the host to clear
the infection from severely damaged lungs, due to ongoing severe asthma or cystic fi-
brosis. In ABPA, the symptoms of severe asthma are further complicated by dilation of
the proximal bronchi along with the presence of thick mucus plugs that block both prox-
imal and distal bronchioles. The plugs are found to comprise of eosinophils, Charcot-
Leydon crystals, Curshmanns spirals and, frequently, fungal hyphae [177]. Diagnosis of
ABPA is not straightforward. The defining features are any severity of asthma with pul-
monary infiltrates, eosinophilia, central bronchiectasis, thick mucus plugs, increased As-
pergillus precipitins, Aspergillus specific IgE, elevated serum IgE, a positive Aspergillus
skin prick test, a positive Aspergillus specific RAST (Radioallergosorbent) test and As-
pergillus colonisation of the airways [45]. It is estimated that between 7% and 14% of
severe asthmatics may be affected by ABPA [19]. Severe asthma with fungal sensitisation
is a relatively new definition for a subset of patients with severe asthma and evidence of
fungal sensitisation, which do not meet the criteria for ABPA [45]. Amongst individu-
als with persistent asthma requiring specialist referral, around 20-25% show positive skin
test reactions to Aspergillus or other fungi [45]. The defining features of SAFS, are severe
asthma and at least one positive skin and RAST test to Aspergillus or other fungi. Unlike
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ABPA there is no evidence of pulmonary infiltrates, eosinophilia, central bronchiectasis,
thick mucus plugs, or elevated serum IgE [45]. By applying these criteria to different stud-
ies it has been estimated that the number of people effected by SAFS is between 730,000
and 2,340,000 in the USA alone [45]. In a trial by Denning et al., the treatment of patients
with SAFS, with oral anti-fungals resulted in improved quality of life in around 60% of
SAFs patients [46].
The pathogenesis of ABPA is similar to that of asthma but with some key differences.
The pathogenesis of asthma is associated with a CD4+ Th2 cytokine profile, however in
ABPA a mixed profile of Th2/Th1 cytokines was observed [173]. This was confirmed by
Hogaboam et al. in a murine model of chronic airway disease where sensitisation to A.
fumigatus allergens caused increased levels of IFN-γ, TGF-β, IL-4 and IL-13, confirming
the presence of a mixed Th1/Th2 type response [70]. Studies by Wark and colleagues,
comparing, sputum samples from individuals with ABPA and matched subjects with sta-
ble asthma, have shown increased airway inflammation with increased IL-8, eosinophil
and neutrophil infiltration and eosinophil degranulation [177]. Other work has also shown
that A. fumigatus secreted proteases, increased both IL-6 and IL-8 production in airway
alveolar cells, suggesting that A. fumigatus, may mediate IL-6 and IL-8 release [88]. IL-6
and TGF-β production is known to drive Th0 cell differentiation to the Th17 phenotype,
and the production of IL-17, resulting the production of IL-8, and increased neutrophil
chemotaxis. This suggests that the inflammation observed in ABPA may also have a
neutrophilic component. Reduced levels of the anti-eosinophil regulatory cytokine IL-10
have also been suggested to exacerbate ABPA. Borish et al. found that asthmatics had
lower levels of IL-10 compared with matched controls [27], whilst Grunig et al. demon-
strated that IL-10 knockout mice suffered increased airway inflammation [64]. Taken
together these results suggest that both eosinophilic and neutrophilic inflammation is ob-
served in ABPA as part of a mixed Th1/Th2/Th17 type response, which leads to airway
obstruction, bronchiectasis and airway remodelling as seen in severe asthma. The patho-
physiology of SAFS has not yet been fully described.
The precise mechanisms by which A. fumigatus induces allergic inflammation seen
as in SAFS and ABPA are not entirely clear, however, results from several studies have
suggested that allergen proteases may be key in causing the development of severe asthma
and associated diseases through interactions with the respiratory epithelium [45, 77, 144,
146]. Allergen proteases and the role of the airway epithelium in the development of
airway inflammation will be discussed in greater detail in the next section.
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1.2 The interaction of allergen proteases with the respi-
ratory epithelium
1.2.1 The role of the respiratory epithelium in asthma
The respiratory epithelium is a impermeable barrier that lines the airways and represents
the primary point of cellular contact between exogenous material and the lung. As such,
the airway epithelium is important in the detection of antigens and the response of the
airway to exogenous stimuli, and is capable of signalling to other structural and inflam-
matory cells in the airway wall. The basic structure of a normal conducting airway com-
prises of a surface epithelium composed of ciliated and secretory cells that overlay a
sub-epithelial layer consisting of connective tissues and glands (Figure 1.4) [68].
In the epithelial layer, ciliated columnar epithelial cells are the predominant cell type,
whilst goblet cells are the major secretary cell type, producing mucus, which along with
ciliated epithelial cells, forms the mucociliary escalator [92]. Coordinated beating of the
cilia acts to clear inhaled foreign materials, such as fungal spores and aero-allergens [68].
In the proximal airways, mucus producing goblet cells and ciliated columnar cells are
layered above basal epithelial cells that act as a reserve to replenish cells from the epithe-
lium [68]. The final layer of the epithelium is the basement membrane (BM) [104]. The
uppermost part of the BM, the lamina densa, consists predominantly of type IV collagen
and laminin, which are secreted by epithelial cells [134]. The lower layer of the BM, the
lamina reticularis, consists of types III and V collagen and fibronectin and is primarily
synthesised by underlying fibroblasts [68, 134].
Epithelial cell monolayer integrity is dependent on cell-cell and cell-matrix interac-
tions involving junctional proteins anchored in the cell wall and attached to the cytoskele-
ton. Epithelial cells are attached laterally to one another by desmosomes and zonula
occludens (tight junctions), and to the basement membrane by hemidesmosomes. Ad-
herens junctions are cell-cell interactions that are critical for the maintenance of a stable
epithelium [66]. Desmosomes are button-like cell junctions that are linked to the cytok-
eratin element of the cytoskeleton allowing for the formation of a contiguous network
across the epithelium providing high tensile strength in the tissue [66]. The subepithelial
layer may be subdivided into the lamina propria and the submocusa. The lamina propria
contains elements, which support the epithelial layer including capillaries, nerve fibres,
elastic tissue and fibroblasts, which contribute to the lamina reticularis by the production
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Figure 1.4: A diagrammatic view of airway wall structure.
of fibronectin [50]. In the proximal airways, the submucosa is composed of spirally ar-
ranged smooth muscle and cartilage. Submucosal glands produce mucin and an array of
substances important in local airway defence, including lysozyme, lactoferrin, transferrin
and a protease inhibitor [68].
It is suggested that the airway epithelium plays a pivotal role in modulating the in-
flammation and remodelling observed in severe asthma, and may represent an alternative
or complementary model to the immune responses suggested to mediate inflammation in
allergic asthma [72]. It is suggested that inflammation and remodelling may be modulated
by the epithelium via the secretion of cytokines and growth factors in response to the ac-
tivation of cellular receptors, such as Toll-like receptors and protease activated receptors.
It is also suggested that the integrity of the epithelium is important in severe asthma and
airway remodelling, and it is likely that disruption of the epithelium is an important factor
in the pathology of asthma and related diseases.
Protease activated receptors (PARs), are 7 transmembrane domain G protein coupled
receptors, which are expressed in a wide variety of tissues including airway epithelial
cells, eosinophils, neutrophils, mast cells, fibroblasts and airway smooth muscle [141].
Activation of PARs involves cleavage of the receptor by a protease at a specific site, which
results in the release of the N-terminal region of the protein and exposure of the activate
portion of the tethered ligand . The tethered ligand then binds back to the receptor, causing
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the G-protein mediated activation of a number of pathways which may effect cell shape,
transcription, secretion, metabolic responses, and cell motility [141] (Figure 1.5). There
are currently thought to be four protease activated receptors, and PAR-1, PAR-2 and PAR-
4 are known to be expressed on airway epithelial cells [10]. Activation of these receptors
has been suggested to cause the release of IL-6, IL-8, GM-CSF, eoxtaxin, PGD2, PGE2,
PDGF and MMP-9 [10]. Activation of PARs either directly by allergen proteases, or by
trypsin, mast cell tryptase, or metalloproteases, released by airway cells in the allergic
response, is suggested to cause increased inflammation in the context of severe asthma.
Figure 1.5: General mechanism of activation of PARs by proteases. [141]
Toll like receptors (TLR), are a family of ten pathogen recognition receptors that are
activated by common molecules associated with groups of pathogens, known as pathogen
associated molecular patterns (PAMPS). These include lipopolysaccharide, flagellin, dou-
ble stranded RNA and unmethylated CpG motifs. Airway epithelial cells have been shown
to express TLRs 1-10, however TLR3, TLR2, TLR4, and TLR5 were found to be the most
strongly expressed [153]. Sha et al demonstrated that activation of TLRs by a range of
PAMPs caused the up-regulation of a number of cytokines, including IL-8, MIP-3α, and
GM-CSF, which act as macrophage and neutrophil chemoattractants [153].
In severe asthma, the airway epithelium has been shown to be severely compromised,
with widespread damage and a failure of cells to form functional tight junctions [71].
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Holgate et al. proposed that in chronic asthma, repair of the epithelial cell barrier was
impaired and a chronic wound scenario develops [71] (Figure 1.6). It was suggested
that damage to the epithelium, results in over expression of the epithelial growth fac-
tor receptor (EGFR). Trans-activation of EGFR by oxidative stress responses results in
the release of cytokines such as IL-8, which further augment inflammation by the re-
cruitment of neutrophils, leading to increased activation of EGFR by neutrophil derived
ROS [72]. It was also suggested that impaired epithelial proliferation causes the bronchial
epithelium to spend longer in the repair phenotype, resulting in prolonged secretion of
pro-fibrogenic growth factors, such as TGF-β, from both damaged epithelium and inflam-
matory cells, causing continued augmentation of a remodelling response [71]. Holgate
et al. also suggest that in the asthmatic lung, the interactions between the epithelium
and underlying fibroblasts are similar to those seen in the epithelial-mesenchymal trophic
unit (EMTU) during development, which controls physiological remodelling of the air-
way during branching morphogenesis in the foetus [71, 176]. It was therefore suggested
that the EMTU is reactivated in chronic asthma driving pathological remodelling, and that
disordered EMTU signalling is a key feature in the origins of human asthma [71]. The
damage to the epithelium that initiates airway wall remodelling is suggested to be caused
by environmental triggers, indicating a role for allergen protease mediated cell damage
and tight junction disassembly.
Dysregulation of the activity of matrix metalloproteases (MMPs) has been associated
with asthma [15, 35, 62, 106, 178]. MMPs are a large super-family of zinc dependent en-
dopeptidases, with a wide variety of substrates, including ECM components [62]. MMPs
may be secreted in a pro-form that may be activated by proteolysis after secretion. They
may also be inhibited by one of the tissue inhibitors of metalloproteases (TIMPs). Ex-
periments have demonstrated higher levels of pro-MMP-2, pro-MMP-9 and TIMP-1 in
asthmatics than in controls [35, 106]. In immunohistochemical studies, patients with se-
vere asthma demonstrated staining of MMP-9 in the basement membrane and increased
levels of TGF-β compared to normal controls [178]. As the regulation of MMPs is tightly
controlled by cleavage of pro-domains, it is suggested that the presence of exogenous pro-
teases in the lung, such as allergen proteases, may result in activation of these proteases
and the dysregulation of MMP activity observed in asthma.
These studies suggest a number of pathways by which the airway epithelium might be
involved in the pathogenesis of asthma. Further more they suggest mechanisms by which
allergen proteases might interact with the airway epithelium in such a way as to increase
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Figure 1.6: Summary of current concepts in the pathogenesis of airway remodelling in
allergen-induced asthma.
the severity of inflammation in the airways and contribute to severe asthma. These include
the degradation of the epithelial cell monolayer, activation of cellular receptors such as
PARs and TLRs, and the release of pro inflammatory cytokines including IL-6 and IL-8.
1.2.2 Allergen protease interactions with the airway epithelium
The ability of a given antigen to act as an allergen depends on its interaction with IgE. The
binding of antibodies to a given epitope within a allergen may be based on the primary
or tertiary structure of the allergen. Allergens from a number of sources, including house
dust mites faeces, plant pollen, cockroaches, and various fungi, have been shown to have
protease activity, as well as IgE binding capability. [45,77,144,146]. The house dust mite
(Dermatophagoides pteronyssinus) is known to produce a cysteine protease Der p 1, and
three serine proteases, Der p 3, Der p 6 and Der p 9, all of which are found in house
dust mite faecal pellets [2, 36]. Several plant allergens have been described as proteases
including, the aspartic protease CPA63, from japanese cedar pollen (Cryptomeria japon-
ica) and the cysteine protease Phl p 1, from Timothy grass (Phleum pratense) [63, 78].
Cockroach allergens have also been described as proteases including an inactive aspartic
protease, Bla g 2, from Blattella germanica and a serine protease, Per a 10, from Periplan-
eta americana. As with the house dust mite, cockroach allergens were found primarily in
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faecal remnants (frass). Several fungi have also been shown to produce allergen proteases
including A. fumigatus, A. niger, A. flavus, A. oryzae, P. brevicompactum, P. citrinum,
P. chrysogenum, P. oxalicum, T. rubrum, and T. tonsurans [45]. Allergen protease from
fungi represent three of the major families of proteases, including metalloproteases, ser-
ine proteases and aspartic proteases, and in many instances there is significant homology
between individual fungal proteases (Table 1.2).
Table 1.2: Classification of allergen proteases derived from fungi (data obtained from
[45]).
Protease classification Named allergen
Metalloproteases Asp f 5
Aspartic proteases Asp f 10
Serine proteases Asp f 13, Asp fl 13, Pen b 13, Pen c 13, Tri r 2, Asp fl 1, Asp o 13,
Cur l 1, Epi p 1, Pen c 1,Tri r 4, Tri t 4
Vacuolar serine proteases Asp f 18, Asp fl 18, Asp n 18, Pen c 2, Pen c 18, Pen ch 18, Pen o
18, Rho m 2
As well as acting as allergens that elicit Th2 driven allergic inflammation, the protease
components of allergen proteases have been suggested to perform other functions, which
may contribute to airway inflammation and remodelling. These include damage to the
airway epithelium cells including tight junctions, and direct activation of cellular receptors
leading to the modulation of immune responses [80]. Airway wall remodelling and the
modulation of inflammation by allergen proteases is thought to occur via a number of
common mechanisms.
Disruption of the respiratory epithelial cell monolayer and epithelial cell tight junc-
tions, is suggested to cause increased inflammation due to epithelial cell damage and an
increase in allergen delivery across the epithelial cell monolayer. Wan et al. suggested
that Der p 1 may be involved in the disruption of epithelial tight junctions, allowing the
penetration of allergens through the epithelial cell layer, resulting in increased allergy and
inflammation [175]. Further studies by Wan et al. demonstrated that the disruption of tight
junctions in MDCK and airway epithelial cells by Der p 1 occurred in a time dependent
manner, which correlated with an increase in cell permeability [174]. It was suggested
that whilst Der p 1 may directly cleave the extracellular protein, occludin, the intracel-
lular protein, ZO-1, may be indirectly cleaved by activation of a cell surface associated
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zymogen, or by activation of a protease activated signalling cascade [174]. Work from
the same group has recently shown that plant allergens known to cause exacerbations of
asthma also exhibit similar protease activity, which affects the integrity of cell-cell junc-
tions [146]. Runswick et al. demonstrated that pollen diffusates from Ragweed, White
Birch and Kentucky Blue Grass, and Easter Lily were capable of causing the loss of tight
junction integrity from confluent monolayers of airway epithelial cells, allowing for in-
creased delivery of allergens across the epithelial cell barrier [146]. Fungal proteases
have also been shown to degrade tight junctions. Tai et al. demonstrated that the serine
protease Pen ch 13 was able to degrade the tight junction protein occuldin [167].
The activation of protease activated receptors (PARs) by allergen proteases on a va-
riety of cells has been shown to mediate the release of a number of cytokines that are
involved in the modulation of inflammation and airway wall remodelling [141]. The
effect of house dust mite proteases on protease activated receptors (PARs) has been in-
vestigated by several groups [4, 11, 87]. Kauffman and colleagues showed that Der p 1
causes the release of the pro-inflammatory cytokines, IL-6 and IL-8, by a PAR indepen-
dent mechanism in the airway epithelial A549 cell line [87]. Conversely, Asokananthan
et al. demonstrated that PAR-2 may be activated by Der p 1 in A549 cells and HeLa cells.
However, it is unknown if the response was due to protease action of the allergen, as a
control using inhibitor deactivated Der p 1 was not included [11]. Studies by Adam and
colleagues showed that Der p 3 and not Der p 1, caused IL-8 release by a PAR-2 dependent
mechanism [4]. Cockroach allergens have also been shown to interact with PARs. Page
et al. showed that proteolytically active extracts from B. germanica frass, increased IL-8
secretion by the activation of PAR-2 [132]. The same group also demonstrated that serine
proteases from Blattella germanica increased TNF-α mediated MMP-9 upregulation, by
the activation of PAR-2, whilst Hughes et al. showed that similar allergen preparations
could cause the activation of pro-MMP-9 [77, 131].
Allergen proteases from several fungi have also been shown to activate PARs. Mat-
suwaki et al. demonstrated that an aspartic protease from A. alternata was capable of
activating the PAR-2 receptor causing the release of pro-inflammatory cytokines from
eosinophils, whilst Boitano et al. demonstrated the activation of PAR-2 and the release of
calcium in response to activation of PAR-2 by serine porteases from A. alternata [25,113].
Similarly, serine proteases, Pen c 13 and Pen ch 13, were shown by Chiu et al. and
Tai et al. respectively to cause the release of pro-inflammatory cytokines by a protease-
dependent mechanism [38, 167]. Chui et al. further demonstrated that Pen c 13 activated
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both PAR-1 and PAR-2 resulting in activation of the ERK-1/2 pathway. A. fumigatus also
secretes a number of proteases, some of which are allergen proteases. It has been sug-
gested that A. fumigatus proteases may act in the same way as other allergen protease from
fungi, when mediating inflammation, including disruption of the epithelial cell monolayer
and the activation of PARs [26].
1.2.3 A. fumigatus allergen proteases
To date there are 20 A. fumigatus antigens that have been confirmed to act as aller-
gens [29]. A. fumigatus allergens can be found in culture supernatants, cell cytoplasm and
as components of the cell wall (Figure 1.3). The primary route of exposure to A. fumiga-
tus allergens in asthma, SAFS and ABPA is through the airway and alveolar epithelium
by inhalation of spores and hyphal fragments. Pepys et al. have also shown that A. fu-
migatus was cultured from sputum in 145 out of 2080 (7%) patients with various chest
disorders [137]. Within this subset it was found that A. fumigatus was cultured at a sig-
nificantly greater frequency in the sputum of asthmatics over other chest disorders [137].
Green et al. have shown that around 25% of hyphal fragments contain detectable al-
lergen [61]. However the true level of exposure to allergens in uncolonised individuals
remains unknown. Furthermore, as previously discussed, exposure to A. fumigatus aller-
gen protease may be continuous due to colonisation of the host rather than intermittent
as with other inhaled aero-allergens, leading to chronic inflammation and airway wall
remodelling [45, 140].
Four A. fumigatus allergens have been shown to be proteases including, a metallpro-
tease, Asp f 5, an aspartic protease, Asp f 10, and two serine proteases, Asp f 13 and Asp
f 18. Of these proteases, Asp f 5, Asp f 10 and Asp f 13 are secreted, whilst Asp f 18
was found to be vacuolar [105, 117, 119, 142]. These proteases have been both purified
from A. fumigatus cultures, expressed in E. coli as recombinant proteins, and extensively
characterised for both enzymatic activity and allergenicity. These studies suggested that
Asp f 5 and Asp f 13 were the major allergen protease secreted by A. fumigatus during
growth on protein containing media.
Asp f 5 (Mep) was first identified by Monod et al. in culture supernatants of A. fumi-
gatus grown in liquid medium containing collagen as the sole carbon and nitrogen source
at neutral pH [117]. After extensive purification, Asp f 5, was shown to be a 42 kDa met-
alloprotease, with optimal protease activity between pH 6.5 and pH 9.0 [117]. IgE bind-
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Table 1.3: International Union of Immunological Society (IUIS) approved allergens for
A. fumigatus and their characteristics. E= Recombinant allergen expressed E. coli, P=
Allergen purified from extract, T= Recombinant allergen expressed in P. pastoris, Pf=
Pfam predicted, * Molecular Weight predicted from mRNA sequence (unprocessed pre-
cursors)/Molecular Weight from purification or expression as a recombinant in E. coli [2].
Allergen CADRE Gene
Accession No.
M.W. (*) Function IgE binding from A.
fumigatus sensitised
patient sera
Asp f 1 AFUA 5G02330 19.6/18(E) [9] Mitogillin/Ribotoxin [9] 83% IgE to Asp f 1(E) [98]
Asp f 2 AFUA 4G09580 32.8/37(E) [98] Fibrinogen Binding
Mannoprotein [179]
90% IgE to Asp f 2(E) [98]
Asp f 3 AFUA 6G02280 18.5/19(E) [98] Peroxiredoxin [105] [69] 94% IgE to Asp f 3(E) [98]
Asp f 4 AFUA 2G03830 34.0/30(E) [98] Unknown 78% IgE to Asp f 4(E) [98]
Asp f 5 AFUA 8G07080 68.7/43(E/P)
[117, 160]
Metalloproteinase
(Pf) [117]
93% IgE to Asp f 5(E) [41]
Asp f 6 AFUA 1G14550 23.3/26.7(E)
[42]
Mn Superoxide
Dismutase [42]
56% IgE to Asp f 6(E) [98]
Asp f 7 AFUA 4G06670 27.5/12(E) [41] Adhesin similar C. als
[Obs. P. Bowyer]
46% IgE to Asp f 7(E) [41]
Asp f 8 AFUA 2G10100 11.1/11(E)
[114]
Ribsomal Protein P2 [114] Asp f 8(E) binds IgE [114]
Asp f 9 AFUA 1G16190 40.3/33.7(E)
[41]
Adhesin similar C. als
(Obs. P. Bowyer)
89% IgE to Asp f 9 (E) [41]
Asp f
10
AFUA 5G13300 41.6/39(E/P)
[105]
Aspartic protease [105] 28% IgE to Asp f 10
(E) [41]
Asp f
11
AFUA 2G03720 19.5/21(E) [51] Cyclophilin [51] 90% IgE to Asp f 1 (E) [51]
Asp f
12
AFUA 5G04170 80.6/65(E) [97] Hsp90 [97] Asp f 12(E) binds
IgE/IgG [97]
Asp f
13
AFUA 4G11800 42.2/33(E/P)
[53, 101, 119,
122]
Serine Protease (Subtilisin
Family) [82]
Asp f 13(E) weakly binds
IgE [121]
Asp f
15
AFUA 2G12630 15.9/17-25(T)
[Obs E. Farnell]
Cerato-platanin (Pf) Binds [Obs E. Farnell]
Asp f
17
AFUA 4G03240 19.4/- Adhesin similar C. als
[Obs. P. Bowyer]
-
Asp f
18
AFUA 5G09210 52.6/34(P)
[142, 156]
Vacuolar Serine
Protease [156]
79% IgE to Asp f 18
(P) [156]
Asp f
22
AFUA 6G06770 47.3/47(E)
[100]
Enolase [100] 26% IgE to Asp f 22
(E) [100]
Asp f
23
AFUA 2G11850 44.4/44(E)
[150]
Ribosomal Protein
L3 [150]
27% IgE to Asp f 23
(E) [150]
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ing was confirmed by probing with pooled sera from patients with aspergilloma [117].
Further characterisation showed that the protease had collagenase, but not elastinolytic
activity [117]. Markaryan et al. demonstrated using Immunogold staining that Asp f 5 is
produced by invading A. fumigatus in neutropenic mice [112]. Asp f 5 was cloned and
expressed in E. coli by Sirakova et al. and was shown to have similar protease activity to
the native protease, however expression was inefficient and the majority of the protease
was trapped in inclusion bodies [160].
Asp f 10 (Pep1) was identified by Lee et al. in culture supernatants of A. fumigatus
grown in liquid medium containing elastin as the sole carbon and nitrogen source at acid
pH [105]. Characterisation of culture supernatants containing Asp f 10 demonstrated that
Asp f 10 had optimum protease activity at pH 5, was an aspartic protease, and was capable
of degrading elastin, collagen and laminin. Cloning and expression of Asp f 10 in E. coli,
demonstrated that Asp f 10 had a molecular weight of 39 kDa and revealed homology to
other fungal aspartic proteases such as PepO (A. oryzae and PepI (A. saitoi). Immunogold
staining revealed that Asp f 10 was produced and secreted during the growth invasion of
A. fumigatus in the murine lung [105].
Asp f 13 (Alp1) was demonstrated, by Monod et al., to be secreted in culture su-
pernatants of A. fumigatus grown in liquid medium containing collagen as the sole car-
bon and nitrogen source at neutral pH [119]. Asp f 13 has been purified and exten-
sively characterised by Monod et al., Larcher et al., Frosco et al. and Moutaouakil et
al. [53, 101, 119, 122]. These studies demonstrated that Asp f 13 was a 33 kDa serine
protease, with optimal activity at pH 9.0 and was capable of cleaving both elastin and
collagen. Immunogold staining revealed that Asp f 13 was present during A. fumigatus
invasion of the murine lung [122]. Recombinant proteins produced by the cloning and
expression of Asp f 13 in E. coli demonstrated similar properties to the native protease
isolated previously from culture supernatants [121].
Asp f 18 (Alp2) was shown to be a vacuolar serine protease that was not detected
in A. fumigatus culture supernatants. Characterisation of the protease revealed it to be
a 52 kDa serine protease with a functional pH range from pH 4.5 to pH 11 that was
present in cell wall fractions of A. fumigatus [142]. Molecular cloning in E. coli showed
homology with PEPC, a serine proteases described in A. niger. Shen et al. described the
IgE binding properties of Asp f 18 along with several other homologous vacuolar serine
proteases [157].
As well as allergen proteases, A. fumigatus is known to secrete a number of other
46
proteases including, leucine aminopeptidases (Lap1 and Lap2) and a X-prolylpeptidase
(DppIV), Tripeptidyl-peptidase, Carboxypeptidase S1, Carboxypeptidase 5, Carboxypep-
tidase 4, Tripeptidyl peptidase A, and Carboxypeptidase S1. Control of the secretion of
proteases by A. fumigatus is known to be regulated depending on the pH of the surround-
ing environment and the availability of nitrogen. In many previous studies, A. fumigatus
was found to secrete proteases when grown in liquid medium containing complex protein
such as collagen or elastin as the sole carbon and nitrogen source [105, 117, 119, 142].
Further studies by Gifford et al. and Bergmann et al. showed that protease secretion
was suppressed by growth of A. fumigatus in the presence of a primary nitrogen source
such as ammonium, even when complex nitrogen sources such as BSA or serum were
present [23, 58]. Studies by Bergmann et al. also showed that several proteases, includ-
ing Asp f 5, Asp f 10, Asp f13, TppA, DppIV and DppV were regulated by the common
transcription factor prtT [23]. Other studies have investigated the transcriptional regu-
lation of A. fumigatus allergens and proteases during growth under different conditions.
McDonagh et al. investigated the expression of A. fumigatus genes during invasion in the
murine model and showed that several allergens, including some proteases, are up regu-
lated during invasion of the murine lung, including Asp f 5 and the alkaline serine protease
AorO [115]. Fraczek et al. demonstrated increased production of Asp f 5, Asp f 10 and
Asp f 13 in response to oxidative stress induced by hydrogen peroxide [52]. Finally, Sri-
ranganadane et al. showed that A. fumigatus secretes different sets proteases depending on
the pH of a common growth medium containing collagen [163]. At neutral pH, A. fumiga-
tus was found to secrete alkaline serine protease (Alp1), a metalloprotease (Mep), leucine
aminopeptidases (Lap1 and Lap2) and a X-prolylpeptidase (DppIV), whilst at acid pH,
A. fumigatus was found to secrete Tripeptidyl-peptidase, Aspartic endopeptidase (Pep1),
Carboxypeptidase S1, Carboxypeptidase 5, Carboxypeptidase 4, Tripeptidyl peptidase A,
and Carboxypeptidase S1. Control of protease secretion in response to growth on different
sources of protein has not been investigated but is important when determining exposure
to aero-allergens derived from A. fumigatus growing in the environment.
Several studies have investigated the effects of gene disruption of the A. fumigatus
proteases, with respect to protease secretion in A. fumigatus, virulence and growth. In
studies by Monod et al and Jaton-Ogay et al., targeted gene disruption of Asp f 5 and Asp
f 13, both individually and together, demonstrated that the disruption of protease activity
did not result in decreased morbidity in vivo compared with controls in which genes had
not been disrupted [81,118]. Studies by Bergmann et al. also demonstrated that disruption
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of the prtT transcription factor, inhibiting secretion of Asp f 5, Asp f 10, Asp f13, TppA,
DppIV and DppV did not affect virulence in vivo compared with a controls but did inhibit
growth on media containing complex protein in vitro [23]. Finally disruption of the Asp
f 18 gene by Reichard et al., showed reduced growth and sporulation of A. fumigatus,
however virulence was not investigated in vivo [142].
Taken together, these findings suggest that A. fumigatus secretes allergen proteases
during growth on lung extra cellular matrix like substrates and in vivo in the murine lung.
Studies have also shown that these proteases, may not be important in virulence of the
fungi in vivo. However, evidence does suggest that these proteases may have a role in
the development of allergy and inflammation due to interactions with components of the
respiratory epithelium and airway wall.
1.2.4 The interaction of A. fumigatus proteases with the airway ep-
ithelium
It has been suggested that A. fumigatus allergen proteases act in a similar way to other
aero allergens during exposure to the airway epithelium. They may contribute to airway
inflammation and remodelling by damage to the airway epithelium cells and tight junc-
tions, and the direct activation of cellular receptors leading to the modulation of immune
responses.
Goblet cell hyperplasia and increased mucus production are both features of the air-
ways in severe asthmatics [130] . In vivo studies, in a mouse model of intranasal exposure
allergens demonstrated that exposure to house dust mite, rag weed and A. fumigatus ex-
tracts abolished tolerance to allergens, resulting in increased mucus secretion as well as
airway hyper-responsiveness, eosinophilic inflammation, mast cell and smooth muscle
hyperplasia, and airway remodelling [60]. In a rat model of chronic asthma, intranasal
exposure to A. fumigatus spores, resulted in goblet cell hyperplasia and hyper-secretion
of mucus [56]. Other features of severe asthma were also observed including, elevated
Th2 cytokines, increased airway eosinophilia, total IgE and sub-epithelial collagen de-
position [56]. A further study, using a mouse model, demonstrated that IL-6 is up regu-
lated during exposure to A. fumigatus extract in both bronchial lavage fluid and peripheral
blood. Furthermore it was shown that IL-6 was essential for mucus hyper secretion, with
a deficiency in IL-6 production resulting in lowered levels of IL-13 expression and lower
levels mucus secretion [124]. Whilst these studies show a strong link between A. fu-
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migatus exposure and increased mucus secretion it is unknown if protease action of A.
fumigatus allergens was required for increased mucus production.
A. fumigatus proteases have been suggested to interact with epithelial cell tight junc-
tions in the airway wall. In separate studies by Daly et al. and Kogan et al. it has
been demonstrated that A. fumigatus spores and culture supernatants can cause cultured
A549 cells to detach from confluent monolayers and that this detachment was due to a
breakdown of focal adhesions and the actin cytoskeleton [43, 93]. Whilst these studies
confirmed A. fumigatus allergens were able to breakdown cell junctions, they used A549
cells (derived from type II pneumocytes) that are known to display poor tight junction
formation. Studies by Riazanskaia (PhD thesis, unpublished) demonstrated that A. fumi-
gatus culture supernatants containing Asp f 5, Asp f 13 and Lap1, degraded epithelial cell
tight junctions in MDCK cells by a mechanism that was dependent on metalloprotease
activity [143]. However, the precise A. fumigatus allergen proteases involved in epithelial
cell tight junction cleavage remain unknown.
In the context of asthma cell death is also important as it may contribute to the devel-
opment of a chronic wound in the lung resulting in activation of the EMTU. Co-culture
of live A. fumigatus alongside A549 cells has been shown to cause cell detachment and
death by necrosis [43]. A. fumigatus allergen preparations have also been shown to in-
duce protease-dependent cell death. Kogan et al. have shown that culture filtrate from
A. fumigatus can induce cell detachment and death, which is attenuated in the presence
of the serine and cysteine protease inhibitor antipain [93]. However the precise proteases
involved in A. fumigatus mediated airway epithelial cell death are not know.
The interaction between A. fumigatus proteases and physiological proteases in the
context of asthma and remodelling may also be of interest. Studies by Simonen-Jokinen
et al. showed by gelatin zymography, that components of an A. fumigatus extract were
able to cause activation of pro-MMP-9 (92 kDa), by cleavage into its active form MMP-9
(82 kDa) [159]. This would suggest that a protease produced by A. fumigatus is capa-
ble of MMP activation and thus may be an important regulator of MMP-9 activity. In a
second study Sadaat et al. used A. fumigatus extracts, however, in this instance extracts
were treated with a cocktail of protease inhibitors [147]. Cell line cultures treated with
A. fumigatus extracts showed no cell cytotoxicity, and no MMP-9 activity in gelatin zy-
mography when compared to controls. This confirms the requirement of protease activity
in A. fumigatus extracts to cause cell cytotoxicity and activate pro-MMP-9 [147]. These
studies demonstrate that components of A. fumigatus culture supernatants can activate
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pro-MMP-9, however the precise protease that causes this activation remains unknown.
As well as directly interacting with the airway wall allergen proteases may also in-
teract with the immune system. These interactions might lead to increased inflammation,
increased tissue damage in the airway wall and the development of a remodelled airway
wall. Kiss et al. have shown that a protease from Aspergillus oryzae is able to induce
eosinophillic inflammation and the production of IL-4 in the absence of adaptive immune
cells that is dependent on protease activity. They demonstrated that in mice with a vari-
ety of signalling models knocked out, including STAT-6 and MyD88, inflammation was
induced by a novel pathway [91]. Other studies by Kheradmand et al., using an A. fu-
migatus derived serine protease in combination with OVA or whole A. fumigatus culture
supernatants, have shown that proteolytic activity is essential for inducing allergy in mice
that are resistant to Th2 type responses [90]. In this role it is suggested that the pro-
tease acts as an adjuvant, resulting in an increased inflammatory immune response to a
bystander allergen that may be A. fumigatus derived or otherwise [90]. Kurup et al. have
also demonstrated a similar responses in mice sensitised with Asp f 13 and Asp f 2. When
administered in combination, it was shown that the serine protease Asp f 13 has syner-
gistic effects on the inflammatory action of Asp f 2 [99]. These studies are of particular
interest as they suggest that a protease-activated pathway results in an increase in the re-
sponse to both the allergen protease and other by-stander allergens. The mechanism by
which allergen proteases may enhance the immune response is still unclear.
The role of A. fumigatus in the activation of airway epithelial cell PARs, has also been
investigated. An in vitro study using the A549 cell line, demonstrated that transcription
of IL-8, TNF-α and GM-CSF was up-regulated after 8 hours in response to germinating
conidia. Heat inactivated conidia did not yield the same result [22]. It has also been shown
that A. fumigatus derived serine proteases in A. fumigatus extracts are able to induce IL-
6 and IL-8 production in airway epithelium and cause epithelial cell desquamination in
A549 cells [88]. This is known to occur in response to the activation of PAR-1 and PAR-2
in airway epithelial cells [141]. Studies by Borger et al., investigating the transcriptional
regulation of IL-6 and IL-8 in response to A. fumigatus serine proteases demonstrated that
IL-6 and IL-8 release was associated with increased NF-κB DNA binding [26]. In another
in vitro study by Balloy et al., using the BEAS-2B cell line, IL-8 was also shown to be up-
regulated in response to germinating A. fumigatus conidia with IL-8 transcription linked
to signalling in the PI3K, p38 MAPK, ERK1/2 and NF-κB pathways [13]. Activation
of these pathways has been shown to be consistent with with PAR-2 activation in lung
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epithelial cell lines [39, 89]. This evidence would suggest a role for A. fumigatuss serine
proteases in the secretion of IL-6 and IL-8 through the PAR receptor pathway, however
this remains unconfirmed.
A. fumigatus has also been show to interact with Toll-like receptors in a manner that
is dependent on PARs. Studies by both Moretti et al. and Balloy et al. have explored
the mechanisms causing IL-8 release from PMNs and airway epithelial cells, respec-
tively, during exposure to both A. fumigatus conidia and culture supernatants [13, 120].
Both studies described a complex series of interactions between pathways associated with
PAR-2 and Toll-Like Receptor 4 (TLR-4), including A. fumigatus driven activation and
inhibition of p38 MAPK, ERK1/2, MyD88 and NF-κB. Moretti et al. suggested that PAR-
2 activation during stimulation of TLR 4 by A. fumigatus conidia, caused reduced NF-κB
activation and therefore reduced IL-6/IL-8 secretion and inflammation [120]. This might
have suggested that A. fumigatus proteases would have reduced IL-8 release, however,
Moretti et al. also showed that a serine protease from A. fumigatus was capable of cleav-
ing PAR-2, but that cleavage results in deactivation of the receptor and loss of sensitivity
to the PAR-2 agonist trypsin. Balloy et al. investigated the effects of TLR-4 and PAR-2
activation on IL-8 secretion specifically, and found that activation of the TLR-4 pathway
in response to A. fumigatus conidia resulted in NF-κB activation but not IL-8 secretion,
whilst activation of phosphatidylinositol 3-kinase, p38 MAPK, and ERK1/2 was required
for IL-8 secretion, pointing towards a PAR-2 dependent mechanism [13]. They also sug-
gest that activation of these pathways may also cause the release of IL-8 via transcription
factors not dependent on NF-κB [13]. Taken together these findings would suggest that
the activation of PARs and interaction with TLRs in airway wall cells causes the produc-
tion of IL-6 and IL-8, which, as discussed earlier, may be involved in the development of
inflammation in severe asthma.
There may also be the potential for interaction with fibroblasts and airway smooth
muscle cells through activation of PAR receptors by allergen proteases. Currently the
effect of A. fumigatus allergen proteases on normal and asthmatic fibroblast PARs is not
known. Activation of these receptors may be interesting in the context of airway remod-
elling as it has been shown that activation of PAR-1 and PAR-2 in fibroblasts causes in-
creased collagen production, mitogenesis, and vascularisation by PDGF and VEGF [141].
Similarly the effect of A. fumigatus allergen proteases on PARs expressed in airway
smooth muscle is not known. In airway smooth muscle, PAR-1 activation has been shown
to induce contraction of smooth muscle, whilst PAR-2 activation is known to increase re-
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sponse to histamine in human subjects [107]. These changes are similar to some of the
features seen in airway remodelling in severe asthma. In both cases the activaton of PARs
would be dependent on penetration of allergen proteases through the epithelium and dif-
fusion into the submucosa. The extent of allergen penetration into the submucosa remains
unclear.
Evidence from a number of studies, suggested several systems by which A. fumiga-
tus allergen proteases may modulate inflammation and airway wall remodelling, how-
ever, in many instances the precise proteases involved and the pathways through which
they act have not been adequately identified. The mechanisms surrounding the A. fu-
migatus protease-dependent release of cytokines, such as IL-6 and IL-8, by airway ep-
ithelial cells are of particular interest as they suggest a role for A. fumigatus mediating
neutrophil driven inflammation and increased mucus production, during diseases such as
severe asthma, SAFS and ABPA. The precise interactions of A. fumigatus proteases with
the PAR-2 receptor requires further investigation.
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1.3 Hypothesis and Aims
1.3.1 Hypothesis
This thesis addresses the hypothesis that the allergen proteases, Asp f 5 and Asp f 13, se-
creted by A. fumigatus during growth cause the protease-dependent degradation of epithe-
lial cell monolayers and the release of cytokines from lung epithelial cells by activation
of protease activated receptor 2.
1.3.2 Aims
The first aim of this project was to determine the environmental conditions which result
in the production of allergen proteases by A. fumigatus and to produce well characterised
A. fumigatus allergen preparations containing active allergen proteases for exposure to
airway epithelial cells in vitro. A clinically derived strain of A. fumigatus (AF293) was
grown in media containing a variety of different nitrogen sources including a control
medium, Vogel’s minimal medium, a non physiological substrate, insoluble casein, and
the physiological substrate, insoluble pig lung. Cultures were characterised for changes in
A. fumigatus growth morphology, growth rate, and culture pH, as well as protease expres-
sion, secretion and activity in culture supernatants during growth on different substrates.
The second aim of this study was to assess the effects of Asp f 5 and Asp f 13 gene
deletion in A. fumigatus on protease activity in A. fumigatus culture supernatants, and to
produce well characterised A. fumigatus culture supernatants that did not contain Asp f
5 or Asp f 13 for exposure to airway epithelial cells in vitro. Strains of A. fumigatus in
which Asp f 5 (A1160pyrg+ Af5∆) and Asp f 13 (A1160pyrg+ Af13∆) genes had been
deleted were grown in media containing a variety of different nitrogen sources including
control medium, Vogel’s minimal medium (ammonium nitrate), casein medium, pig lung
medium. Cultures were characterised for changes in A. fumigatus growth morphology
and growth rate, as well as protease secretion and activity in culture supernatants during
growth on different substrates.
The third aim of this project was to produce recombinant Asp f 5 and Asp f 13 allergen
proteases for the investigation of the activities of Asp f 5 and Asp f 13 on airway epithelial
cells in vivo. Recombinant Asp f 5 and Asp f 13 were produced in the eukaryotic Pichia
pastoris yeast protein expression system and their activity characterised with respect to
previously purified native Asp f 5 and Asp f 13, including, protease activity, substrate
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specificity, and IgE binding.
The fourth and final aim of this study was to investigate the mechanisms involved
in the protease-dependent degradation of epithelial cell monolayers and the release of
IL-8 from epithelial cells caused by both proteolytically active A. fumigatus culture su-
pernatants and by recombinant Asp f 5 and Asp f 13. The airway epithelial A549 cell
line was treated with various doses of A. fumigatus supernatants and recombinant Asp f 5
or Asp f 13, both with and without the inhibition of protease activity, and the effects on
epithelial cell monolayer integrity and IL-8 secretion measured. Activation of the PAR-2
receptor was assessed using peptide homologs of the PAR-2 cleavage site, and a function
blocking antibody.
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Chapter 2
Materials and Methods
Unless otherwise stated all chemicals and reagents were obtained from Sigma-Aldrich
(Poole, UK). All primers were obtained from Eurofins Genetic Services (Wolverhampton,
UK).
2.1 Aspergillus fumigatus culture
2.1.1 Aspergillus fumigatus strains
For the study of protease secretion in A. fumigatus and as a source of mRNA for cloning,
the AF293 of A. fumigatus was used. AF293 was a clinical isolate from a patient with
invasive aspergillosis, and provided as a kind gift by the Mycology Reference Centre
Manchester. Gene disruption of Asp f 5 (AFUA 8G07080) and Asp f 13 (AFUA 4G1180)
was performed in A. fumigatus strain A1160pyrg+ and was a kind gift from Mike Bromley
and Marcin Fraczek (University of Manchester, Manchester, UK). The strain in which
Asp f 5 had been disrupted was referred to as Af5∆, whilst the strain in which Asp f 13
had been disrupted was referred to as Af13∆. The unmodified A1160pyrg+ strain was
used as a control in studies involving gene disruption of Asp f 5 and Asp f 13. For the
investigation of variations in protease secretion by different strains of A. fumigatus, 8
strains of A. fumigatus, including AF10, AF65, AF71, AF72, AF90, AF210, AF294 and
CEA10 were acquired as a kind gift from Peter Warn (University of Manchester).
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2.1.2 Spore preparation and storage
For the general passaging of A. fumigatus and the preparation of spores for experiments,
spores were prepared as follows. Spores from a glycerol stock stored at -80 °C were used
to inoculate a T25 tissue culture flasks containing sabouraud dextrose agar prepared as de-
scribed below. A. fumigatus was grown at 37 °C for 48-72 hours in an incubator, or until
sporulation occurred. Spores were harvested by gentle agitation in 3 mL of PBS-Tween
20 (0.05 % v/v). Harvested spores were filtered through 3 layers of sterile Whatman
105 lens cloth (Thermofisher Scientific, Baisingstoke, UK) to remove hyphae and hyphal
fragments. Spores were quantified using a Neubauer hemocytometer (Thermofisher Sci-
entific). For long term storage, spores were harvested as detailed previously and mixed
with 50 % sterile Glycerol to a final concentration of 15 % and stored in Nunc cryo-vials
(Thermofisher Scientific) at -80 °C.
2.1.3 Media preparation
Media for growth of A. fumigatus were based on Vogel’s salts [172]. The composition
of 50x Vogel’s salts without ammonium nitrate and liquid media are shown below. Am-
monium nitrate was prepared as a separate 50x stock solution (Table 2.1). Solid medium
for the growth of A. fumigatus was produced by adding 1.5 % agar (Cat No. GM1002,
Melford, Ipswich, UK) to the media prior to autoclaving. Following sterilisation, the me-
dia were allowed to cool to 60 °C before the addition of 50x Vogel’s Salts. Approximately
25 mL of media was then added to 100 mm petri dishes and allowed to set in a class II
safety cabinet. The preparation of liquid media is described in the following sections.
Vogel’s minimal medium
To prepare 1x Vogel’s minimal medium, 430 mL of dH2O were added to a 2 L Erlenmeyer
flask. Flasks were sealed with sponge stopper and covered with tin foil then sterilised by
autoclaving at 121 °C for 15 minutes. Flasks were cooled to below 60 °C then 10 mL of
50x Vogel’s salts without ammonium nitrate, 10 mL of 50x ammonium nitrate solution
and 50 mL of 10x dextrose solution were added. For experiments in which growth was
measured by culture turbidity, 0.8 g L-1 of Junlon was added to dH2O prior to autoclaving,
and the rest of the medium prepared as described above.
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Table 2.1: Stock solutions for media containing Vogel’s salts [172]. Ingredients must be
added sequentially in the order presented below. Final concentrations are listed as the
concentration in the 1x solution. All solutions are filter sterilised and stored in the dark at
4 °C.
Stock/Component Quantity Concentration in
1x solution
50x Vogel’s salts without ammonium nitrate (1L)
Trisodium citrate dihydrate (Na3C6H6O7.2H2O) 125 g 9.68 mM
Potassium dihydrogen othophosphate (KH2PO4) 250 g 36.8 mM
Magnesium sulphate heptahydrate (MgSO4.7H2O) 10 g 0.81 mM
Calcium chloride dihydrate (CaCl2. 2H2O) 5 g 0.68 mM
Biotin Solution (0.1 mg/mL) 2.5 mL 50 ng L-1
Hutners Trace Elements 5 mL See below
Distilled water (dH2O) Q.S. to 1 L
Hutners trace elements (100 mL)
Citric acid monohydrate (C6H8O7.1H2O) 0.5 g 2.37 µM
Zinc sulphate heptahydrate (ZnSO4.7H2O) 0.5 g 1.73 µM
Iron (III) chloride (FeCl3.6H2O) 0.1 g 370 nM
Copper sulphate pentahydrate (CuSO4.5H2O) 0.025 g 100 nM
Manganese chloride tetrahydrate (MnCl2.4H2O) 0.05 g 252 nM
Boric Acid (H3BO3.1H2O) 0.005 g 62.6 nM
Sodium molybdate ((NH4)Mo7O24) 0.005 g 24.3 nM
dH2O Q.S. to 100 mL
50x Ammonium nitrate solution (1L)
Ammonium Nitrate (NH4NO3) 100 g 25 mM
Distilled Water (dH2O) Q.S. to1L
10x Dextrose Solution (1L)
Dextrose 100 g 55.5 mM
Distilled Water (dH2O) Q.S. to1L
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Casein with Vogel’s salts medium
To prepare casein with Vogel’s salts medium, 490 mL of dH2O were added to a 2 L
Erlenmeyer flask with 5 g of insoluble casein from bovine milk (Cat No. C3400, Sigma-
Aldrich). Flasks were sealed with sponge stopper and covered with tin foil then sterilised
by autoclaving at 121 °C for 15 minutes. Flasks were cooled to below 60 °C then 10 mL
of 50x Vogel’s salts without ammonium nitrate were added.
Pig lung with Vogel’s salts medium
To prepare pig lung with Vogel’s salts medium, 490 mL of dH2O were added to a 2L
Erlenmeyer flask with 2 g lyophilised ground pig lung (Arndale Market Butcher, Manch-
ester, UK). Flasks were sealed with sponge stopper and covered with tin foil then sterilised
by autoclaving at 121 °C for 15 minutes. Flasks were cooled to below 60 °C then 10 mL
of 50x Vogel’s salts without ammonium nitrate were added.
Sabouraud Dextrose Broth
Sabouraud Dextrose Broth was prepared by adding 30g of dehydrated medium (Cat No.
CM0147, Oxoid, Baisingstoke, UK) to 1L of dH2O. The solution was autoclaved at 121
°C for 15 minutes to sterilise.
Sabouraud Dextrose Agar
Sabouraud Dextrose Agar was prepared by adding 65g of dehydrated medium (Cat No.
CM0041, Oxoid) to 1L of dH2O, The solution was autoclaved at 121 °C for 15 minutes
to sterilise.
2.1.4 Preparation of Aspergillus fumigatus culture supernatants
For the preparation of A. fumigatus culture supernatants, 2 L Erlenmeyer flasks contain-
ing 500 mL of culture media were inoculated with 1x106 cfu mL-1 and incubated at 37
°C on an orbital shaker at 320 rpm. After 48 hours, fungal biomass was removed from
the culture by filtration through a sterile J cloth, retaining the supernatant. The remain-
ing supernatant was sterilised by filtration using a 0.22 µm Corning CA Vacuum filter
system (Cat No. BC515, Thermofisher Scientific). The supernatant was then dialysed
overnight at 4 °C against filter sterilised dH2O to remove low weight mycotoxins and Vo-
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gel’s salts using 10 kDa molecular weight cut off snakeskin pleated dialysis tubing (Cat
No. PN68100, Thermofisher Scientific). Dialysed supernatants were freeze dried in 10
mL aliquots and stored at -80 °C. For use, freeze dried stocks were resuspended in an
appropriate vehicle.
2.1.5 Measurement of A. fumigatus growth
Several methods were used to measure growth of A. fumigatus. Measurement of growth
by total DNA and dry biomass were used to measured growth in liquid culture, whilst
radial growth was used to measure growth on agar plates.
2.1.6 Measurement of growth by culture turbidity
A. fumigatus was grown in 2 L Erlenmeyer flasks containing 500 mL of Vogel’s minimal
medium supplemented with 0.8 g L-1. Flasks were inoculated with 1x106 cfu mL-1 and
incubated at 37 °C on an orbital shaker at 320 rpm. At set time points 1 mL of represen-
tative A. fumigatus culture was removed from the flask and culture turbidity measured by
optical density at 600 nm using a spectrophotometer.
Measurement of total DNA
A. fumigatus growth was measured by total DNA. At set time points, 1 mL samples of
A. fumigatus culture was snap frozen in liquid nitrogen and stored at -80 °C prior to ex-
traction. A. fumigatus DNA was directly extracted from 350 µL of culture supernatant as
detailed in Section 2.2.1. Total DNA in each extraction was measured using a NanoDrop
(Thermo Scientific, Wilmington, USA).
Measurement of dry biomass
A. fumigatus growth was measured by dry biomass. Discs of 55 mm Whatman No.1 filter
paper (Cat No. FDH-240-070X, Thermofisher Scientific) were dried to constant weight
for 96 hours at 125 °C and weighed on a microbalance. At set time points biomass was
harvested by filtering 10 mL of A. fumigatus culture through a pre dried filter papaer. After
harvesting, the papers were again dried to constant weight for 96 hours and weighed on a
microbalance. Dry biomass was calculated by subtracting the pre harvesting filter weight
from the post harvesting filter weight.
59
Measurement of radial growth
Radial growth of A. fumigatus on agar media was measured over a period of 96 hours
at 37 °C. Perpendicular lines were drawn through the centre of the base of 100 mm agar
plates. A. fumigatus spores were harvested as detailed in section 2.1.2 and added to the
centre of plate at the point where the lines intersected in 1 µL PBS-Tween 20 (0.05% v/v)
at a concentration of 1x106 cfu mL-1. Every 24 hours the growth of A. fumigatus on each
of the four lines was marked, measured and an average was derived for radial growth at
each time point for each plate. Three plates were used for each A. fumigatus strain being
assayed on each type of media. Plates were photographed at 96 hours post inoculation.
2.2 Molecular Biology
2.2.1 DNA and RNA extraction
A. fumigatus
Genomic DNA was extracted using a FastDNA SPIN Kit (MP Biomedicals, Cambridge,
UK). Approximately 100 mg of cells were lysed using the CLS-Y buffer for 2 x 40 sec-
onds in a FastPrep-24 (MP Biomedicals) instrument for 2 x 40 seconds at 4 m s-1. The
rest of the protocol was performed according to the manufacturer’s instructions. DNA
was eluted in DNase free water and stored at -20 °C until use. RNA was extracted using
a FastRNA ProRed SPIN Kit (MP Biomedicals). Approximately 100 mg of tissue was
lysed using RNA Pro solution in Lysing Matrix C for 2 x 40 seconds in a FastPrep-24
instrument for 2 x 40 seconds at 4 m s-1. The rest of the protocol was performed accord-
ing to the manufacturer’s instructions. The eluted RNA was then purified further using
on column DNase digestion as part of the RNeasy RNA extraction kit (Qiagen, Crawley,
UK) carried out according to the manufacturer’s instructions. RNA was eluted in RNase
free water and stored at -80 °C until further use.
E. coli
For small scale preparations, plasmid DNA was extracted from 12-16 hour cultures using
a QIAprep Spin Miniprep Kit (Qiagen). For larger preparations a Plasmid Midi Kit (Qia-
gen) was used. In instances were insufficient yield was obtained using these kits, alkaline
lysis by the method of Sambrook et al. was used followed by treatment with RNase A
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(Cat No. 10109142001, Roche Applied Science, Burgess Hill, UK) [148]. RNase A was
removed using high salt/ethanol precipitation by the method of Sambrook et al. [148].
P. pastoris
Genomic DNA was extracted using a FastDNA SPIN Kit (MP Biomedicals). Approx-
imately 100 mg of tissue was lysed using the CLS-Y buffer for 2 x 40 seconds in a
FastPrep-24 instrument for 2 x 40 seconds at 4 m s-1. The rest of the protocol was per-
formed according to the manufacturer’s instructions and as described previously.
2.2.2 Polymerase chain reaction
Amplification of specific DNA products from DNA template was carried out using Phu-
sion High-Fidelity PCR Master Mix (New England Biolabs, Hitchen, UK). The reaction
contained the following components; 1x Phusion HF buffer mix (1.5 mM MgCl2), 0.01
U µL-1 Phusion DNA Polymerase, 200 µM dNTPs, 5 ng µL-1 DNA template and 0.5 µM
primers. Parameters for the Phusion PCR reaction are shown in Table 2.2. The annealing
temperature was adjusted depending on the primers used. Thermal cycling was performed
using an MJ Research PTC-200 Peltier Thermo Cycler (Global Medical Instrumentation,
Minneapolis, USA).
Table 2.2: Cycling parameters for PCR using the Phusion Taq system. Annealing tem-
peratures (X) were modified depending on the primers used.
Stage Conditions
Heated Lid All cycles 110 °C, constant
Denaturation 1 cycle 98 °C, 30 seconds
Amplification 40 cycles 98 °C, 15 seconds (Denaturation)
X °C, 30 seconds (Annealing)
72 °C, 75 seconds (Elongation)
Final extension 1 cycle 72 °C, for 5 minutes
Storage 1 cycle 4 °C, Hold
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2.2.3 Quantitative polymerase chain reaction
For the analysis of allergen protease gene transcription, biomass was harvested from 48
hour liquid cultures of A. fumigatus by filtering 5 mL of culture through a sterile J-Cloth.
Excess medium was removed from the biomass by drying with filter paper. The biomass
was then mixed with 1 mL of RNApro red solution (MP Biomedicals) and snap frozen in
liquid N2 (LN2). RNA was extracted as described previously.
RNA amount was quantified using a NanoDrop. QRT-PCR using the Brilliant II
SYBR Green QRT-PCR Master Mix, 1-Step Kit (Agilent Technologies, Wokingham, UK)
was used to quantify the expression of Asp f 5 and Asp f 13 relative to the housekeeping
gene β-tubulin. The final reaction mixture was composed of 1x Brilliant II SYBR Green
QRT-PCR Mix (2.5 mM MgCl2, SureStart Taq DNA polymerase, nucleotides, SYBR
Green), 1 µM of each forward and reverse primer, RT/RNase block enzyme mixture and
25 ng of total RNA. For every sample run a no RT control was used to check for the
presence of contaminating DNA in the sample RNA. A no primer control was also in-
cluded. A no template control was used to check for both contaminating RNA and DNA
in the reagents and consumables. Reactions were carried out on an DNA Engine Opticon
thermocycler (BioRad, Hemel Hempstead, UK) using the reaction conditions outlined in
Table 2.3. The primers used were designed and validated by Paul Bowyer (University of
Manchester) and are shown in Table 2.4. In order to reduce background from potential
DNA contamination primers were designed so that at least one of the primer sequences
spanned an exon/exon boundary. Melting curves were performed for each reaction and
demonstrated that only one PCR product was present in each reaction.
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Table 2.3: Cycling parameters for quantitative PCR using the Brilliant II SYBR Green
qPCR system.
Stage Conditions
Heated Lid All cycles 110 °C, constant
Elongation 1 cycle 50 °C, 60 minutes
Denaturation 1 cycle 95 °C, 1 minute
Amplification 40 cycles 94 °C, 15 seconds (Denaturation)
52 °C, 30 seconds (Annealing)
Fluorescence measurement
72 °C, 75 seconds (Elongation)
Storage 1 cycle 4 °C, Hold
Table 2.4: Primers used for quantitative PCR of Asp f 5 (AFUA 8G07080), Asp
f 13 (AFUA 4G11800), Aminiopeptidase Y/Lap1 (AFUA 3G00650) and β-Tubulin
(AFUA 1G1091). Exon/Exon boundaries are indicated by *.
Primer Sequence Tm
(°C)
Intron
Spanned
Asp-f5-Q-F 5‘-TACTCACGGTC*TTTCCAACCGAC-3‘ 53 3rd
Asp-f5-Q-R 5‘-GCTTCAGACGGATGGCCGTC-3‘ 52
Asp-f13-Q-F 5‘-GAGCGCAGAC*GTTGCCCATG-3‘ 58 1st
Asp-f13-Q-R 5‘-CCTTGTGGGAAATGCTGCCCAG-3‘ 59
Lap1-Q-F 5‘-AGCCCCGAGTTCATCCGA*AAGTC-3‘ 58 1st
Lap1-Q-R 5‘-GGCGTTTACGCTGGGGCTGT-3‘ 59
β-Tubulin-Q-F 5‘-CGACAACGAG*GCTCTGTACG-3‘ 56 6th
β-Tubulin-Q-R 5‘-CAACTTGCGCAGATCAGAGTTGAG-3‘ 57
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2.2.4 Agarose gel electrophoresis
Agarose gel electrophoresis was performed using either a Tris/Acetate/EDTA (TAE) or
Tris/Borate/EDTA (TBE) buffering system. 1x TAE was made fresh from a 50x stock
solution and had the following final composition, 40 mM Tris acetate and 1 mM EDTA.
1 x TBE was made fresh from a 5 x stock solution and contained 45 mM Tris-borate
and 1 mM EDTA. Gels were made using TAE or TBE respectively with Agarose (Lonza,
Tewkesbury, UK). The amount of agarose used was dependent on the matrix density re-
quired for specific DNA molecules. DNA was visualised using Gel Red (Cambridge
Bioscience, Cambridge, UK) at a final concentration of 0.075µl/ml of gel. DNA ladders
were used to quantify the size and amount of DNA molecules. Several different DNA lad-
ders were used, including HyperLadder I, HyperLadder IV (Bioline, London, UK), 1kb
DNA ladder (Appleton Woods, Birmingham, UK) and 1kb DNA ladder (New England
Biolabs).
2.3 Molecular cloning and protein expression
The EasySelect Pichia pastoris system (Invitrogen, Life Technologies, Paisley, UK) was
used to produce recobinant A. fumigatus allergen proteases, Asp f 5 (AFUA 8G07080)
and Asp f 13 (AFUA 4G11800). In this system the Asp f 5 and Asp f 13 cDNAs were
inserted into the pPICZαA vector. The pPICZαA contains several important functional
sequences that are used in the cloning, expression and purification of the Asp f 5 inserted
into the vector. The vector contains a multiple cloning site with restriction enzyme cleav-
age sites for the insertion of sequences into the vector. To aid cloning, an E. coli origin
of replication was included in the vector, allowing for amplification of the vector and
any inserted sequences in E. coli. A gene for resistance to the antibiotic, Zeocin, was
also included to allow for the selection of successfully transformed E. coli and P. pastoris
cells. For secretion of the protein generated from the vector-gene construct, the P. pastoris
secretion signal was included in the vector and added to the inserted gene during expres-
sion. For selective expression of sequences inserted into the vector, the 5’ promoter region
from the AOX gene was included. In P. pastoris, the AOX gene product was expressed
during growth on methanol. Therefore, when P. pastoris successfully transformed with
the vector is grown in methanol medium, the sequence cloned into the vector is also pro-
duced. To aid purification of the protein produced by the expression of the vector, c-myc
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and poly-histidine tag regions were included in the vector after the multiple cloning site.
This added c-myc and poly-histidine tags to proteins expressed from this vector. Poly-
histidine and c-myc tags allow for purification of the protein by affinity chromatography.
The pPICZαA vector is shown in Figure 2.1.
Figure 2.1: The pPICZαA vector and multiple cloning site. Several functional sequences
are shown in the vector. (Taken from the EasySelect Pichia Expression Kit manual)
The P. pastoris genome contains two copies of the AOX1 alcohol oxidase gene. Fol-
lowing transformation, the pPICZα gene construct may be inserted into the genome at one
or both of the AOX1 loci. This resulted in two possible phenotypes, Mut+ where insertion
occurs at one loci and Muts where insertion occurs at both loci. Mut+ was preferable as
the presence of a native AOX1 gene allowed for better growth on methanol during in-
duction of recombinant protein secretion and expression by growth in media containing
methanol. Transformants were screened for Muts and Mut+ phenotypes by PCR.
Asp f 5 and Asp f 13 were inserted into the pPICZαA vector and transformed into
E. coli for vector construct amplification and P. pastoris for protein expression (Figure
2.2). Asp f 5 was cloned entirely by the author. In the first instance, Asp f 13 cDNA
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was provided by Marcin Fraczek (University of Manchester) and subsequently inserted
in pPICZαA and transformed into E. coli and P. pastoris by the author. In subsequent
experiments Asp f 13, was also cloned entirely by the author.
Figure 2.2: A summary of the process of cloning Asp f 5 into P. pastoris using the
EasySelect Pichia Expression Kit (Invitrogen, Life Technologies).
2.3.1 Reverse transcriptase polymerase chain reaction
Asp f 5 and Asp f 13 cDNA was generated using the reverse transcriptase polymerase
chain reaction (RT-PCR). The primers used for RT-PCR are shown in Table 2.5 and were
designed by Marcin Fraczek and the author. Total A. fumigatus RNA used in the reac-
tion was extracted using the FastRNA Pro Red Kit (MP Biomedicals, Cambridge, UK) as
described in Section 2.2.1 from 24 hour cultures of A. fumigatus grown in Sabouraud’s
dextrose broth at 37 °C with shaking at 320rpm. The SuperScript III One-Step RT-PCR
system with platinum Taq (Invitrogen, Life Technologies) was used to perform the re-
action. The reaction mixture was composed of 1x reaction mix (0.2 µM dNTPs, 3 mM
MgSO4), 2 µM forward and reverse primers, 4 ng µL-1 RNA, and 0.04 U µL-1 Super-
script III Taq. The reaction was performed in a QB-96 thermocycler (Quanta Biotech Ltd
Catcombe, UK) using the cycling parameters shown in the Appendix in Table 2.6.
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Table 2.5: Primers used for Asp f 5 (AFUA 8G07080) and Asp f 13 (AFUA 4G11800)
RT-PCR using the SuperScript III One-Step system. Asp f 5 F and R primers were de-
signed by Marcin Fraczek. The Asp f 13 F1 and R1 primers were also designed by Marcin
Fraczek. The Asp f 13 R2 primer was designed by the author.
Primer Sequence Tm
(°C)
Asp-f5-F 5‘-TACAATTGCCCGCTCACCAGTCTTACGGACTC-3‘ 66.2
Asp-f5-R 5‘-TATCTAGAGGACAGACACCACTGGGGACCTCAGTAC-3‘ 66.2
Asp-f13-F1 5‘-TAGAATTCGCGCCTGTCCAGGAAACTCGTCGTGCTGCTC-3‘ 70.8
Asp-f13-R1 5‘-TATCTAGAGGAGCATTGCCATTGTAGGCAGCTTGTGGGGC-3‘ 69.5
Asp-f13-R2 5‘-TATCTAGAGGAGCATTGCCATTGTAGGCAAGCTTGTTGGGGC-3‘ 69.2
Table 2.6: Cycling parameters for RT-PCR using the SuperScript III One-Step system
Stage Conditions
Heated Lid All cycles 110 °C, constant
cDNA synthesis 1 cycle 55 °C, 30 minutes
Denaturation 1 cycle 94 °C, 2 minutes
Amplification 40 cycles 94 °C, 15 seconds (Denaturation)
66 °C, 30 seconds (Annealing)
68 °C, 75 seconds (Elongation)
Final extension 1 cycle 68 °C, for 5 minutes
Storage 1 cycle 4 °C, Hold
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2.3.2 Plasmid and cDNA digestion with restriction enzymes
Asp f 5 cDNA products were double digest using MfeI and XbaI (Roche Applied Sci-
ence). The reaction was composed of 10 ng µL-1 cDNA, 0.1 U µL-1 MfeI, 0.1 U µL-1
XbaI, 1x Buffer 4 and 20 µg µL-1 BSA and performed according to the manufacturer’s in-
structions. Asp f 13 cDNA was digested with EcoRI and XbaI, (Roche Applied Science).
The reaction was composed of 10 ng µL-1 cDNA, 0.1 U µL-1 EcoRI, 0.1 U µL-1 XbaI,
and 1x Buffer H and was carried out according to the manufacturer’s instructions. The
pPICZαA vector was double digested using EcoRI and XbaI (Roche Applied Science)
under the same reaction conditions as Asp f 13 cDNA. The reactions were incubated at
37 °C for 2 hours before heating to 65 °C for 10 minutes to inactivate the restriction en-
zymes. The Asp f 5 or Asp f 13 cDNA and vector DNA were ligated using T4 ligase
(Roche Applied Science). The reaction was composed of 1x T4 ligase buffer, 0.1 U µL-1
T4 ligase, 30 ng µL-1 cDNA, 10 ng µL-1 plasmid DNA. For maximum ligation efficiency
the product and vector were mixed 3:1 and incubated overnight at 4 °C.
2.3.3 Transformation of E. coli with plasmid DNA
All growth of E. coli was performed in Lennox Low Salt LB medium (1 % w/v Tryptone,
0.5% w/v Yeast Extract, 0.5% w/v NaCl, pH 7.0) due to the salt sensitive nature of Zeocin,
the antibiotic used for selection of transformants. For low salt LB Agar, 15 g L-1 of agar
(Melford) was added to medium prior to autoclaving.
E. coli strains were transformed with vector-cDNA constructs using the heat shock
method. Competent DH5α E. coli and cDNA vector constructs were mixed and left on
ice for 30 minutes, mixing gently every 5 minutes, before heat shock for 45 seconds at 42
°C. LB medium was then added to the cells and they were incubated at 37 °C for 1 hour
with shaking, to allow antibiotic resistance gene expression from the vector. Transformed
cells were selected for by growth for 16 hours on LB agar containing 25 µg mL-1 Zeocin
(Invitrogen, Life Technologies). Colonies containing successfully transformed cells were
grown overnight in 2 mL of liquid LB medium with 25 µg mL-1 Zeocin at 37 °C with
shaking at 500 rpm. E.coli strains were stored in 10 % Glycerol-LB broth at -80 °C; 800
µL of a 12 hour culture of E. coli in LB broth was mixed with 200 µL of sterile 50 %
Glycerol and snap frozen in LN2.
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2.3.4 Sequencing of plasmid DNA
Sequencing of the Asp f 5 and Asp f 13 vector constructs was carried out by The Uni-
versity of Manchester DNA Sequencing Facility. The sequencing facility utilised a Prism
3100 Genetic Analyser (Applied Biosystems, Life Technologies) with BigDye Termina-
tor cycle sequencing chemistries (Applied Biosystems, Life Technologies). The primers
used are shown in Table 2.7. Analysis of the sequenced genes was carried out using
ContigExpress software from the VectorNTI Suite for Mac, Version 7 (Invitrogen, Life
Technologies) or the CAP3, Contig Assembly Program, available online as part of the
Mobyle bioinformatics suite (http://mobyle.pasteur.fr/). Translated protein se-
quence alignments were carried out using ClustalW software available as an online tool
from EBI (http://www.ebi.ac.uk/clustalw/).
2.3.5 Transformation of P. pastoris with plasmid DNA
Growth of P. pastoris during transformation was performed in yeast peptone dextrose
(YPD, 1% w/v yeast extract, 2% w/v peptone 2% w/v dextrose) medium and yeast pep-
tone dextrose sorbitol (YPDS, 1 % w/v yeast extract, 2 % w/v peptone 2 % w/v dextrose,
1 M sorbitol) medium. For agar plates, media were supplemented with 20 g L-1 agar
(Melford) prior to autoclaving.
For transformation into P. pastoris, vector constructs were digested with PmeI (New
England Biolabs). The reaction was composed of 10 µg cDNA, 0.1 U µL-1 PmeI, and
1x Buffer 4 in a 50 µL reaction and was carried out according to the manufacturer’s
instructions. Linearised vectors were purified and concentrated by phenol chloroform
extraction followed by high salt/ethanol precipitation by the method of Sambrook et al.
[148]. The vector construct was transformed into competent P. pastoris GS115 using the
protocol from the EasySelect Pichia Expression Kit. Successfully transformed cells were
selected for by growth on YPDS agar plates with 100µg/ml Zeocin at 30°C for 3-4 days.
From these plates, 2-3 colonies were selected and grown overnight in 20 mL liquid YPD
with 100 µg mL-1 Zeocin in a shaking incubator at 28 °C with 200 rpm shaking. P. pastoris
strains were stored in 15 % Glycerol-YPD at -80°C. Cells were cultured overnight at 28
°C with 200 rpm shaking, and resuspended at OD600 of 50-100 in 15 % Glycerol-YPD
and snap frozen in LN2.
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Table 2.7: Sequencing primers used for the sequencing of Asp f 5 (AFUA 8G07080) and
Asp f 13 (AFUA 4G11800) RT-PCR products inserted between the AOX1 regions of the
vector pPICZαA.
Primer Strand Sequence
Asp f 5
5’ AOX Primer Sense 5’-GACTGGTTCCAATTGACAAGC-3’
Asp f 5 SPF 1 Sense 5’-ATGTGGAGGTGGCGACGCAA-3’
Asp f 5 SPF 2 Sense 5’-CACTGTGGATAGCGCGTCGT-3’
Asp f 5 SPF 3 Sense 5’-TACATCGATGCCAAGAGCGG-3’
Asp f 5 SPF 4 Sense 5’-ATCCTACATCGACGCATCGA-3’
Asp f 5 SPR 1 Anti-Sense 5’-CGGCTTCAGCAACATAGTCC-3
Asp f 5 SPR 2 Anti-Sense 5’-GCTTGGTCAATGCAGCCGAG-3’
Asp f 5 SPR 3 Anti-Sense 5’-ACTCGGTCCAGACGTACATG-3’
3’ AOX Primer Anti-Sense 5’-GCAAATGGCATTCTGACATCC-3’
Asp f 13
5’ AOX Primer Sense 5’-GACTGGTTCCAATTGACAAGC-3’
Asp f 13 SPF 1 Sense 5’-ATACCACTAGCGGCGAACCT-3’
Asp f 13 SPF 2 Sense 5’-GAACGCACGTTGCTGGTA-3’
Asp f 13 SPF 3 Sense 5’-TGTTGAGAACGCTTTCGATG-3’
Asp f 13 SPR 1 Anti-Sense 5’-CCAGATTTGGTCCTCCTCAA-3’
Asp f 13 SPR 2 Anti-Sense 5’-CCAATGGTACCAGCAACGTG-3’
Asp f 13 SPR 3 Anti-Sense 5’-AAGATGTCGACAACGGAACC-3’
3’ AOX Primer Anti-Sense 5’-GCAAATGGCATTCTGACATCC-3’
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2.3.6 Expression of recombinant proteins from P. pastoris
A single colony of transformed P. pastoris was grown for 72 hours in 30 mL liquid
Yeast Peptone Dextrose (YPD) medium at 30 °C in a shaking incubator (250 rpm). The
cells were pelleted by centrifugation (5 min, 1000 x g) and washed twice with Buffered
Methanol-complex Medium (BMMY, 1 % w/v yeast extract, 2 % w/v peptone, 100 mM
potassium phosphate pH 6.0, 1.34 % w/v yeast nitrogen base, 4 x 10-5 % biotin, 0.5 %
v/v methanol) to remove traces of YPD. Cells were then pelleted again by centrifuga-
tion (5 min, 1000 x g) and resuspended in buffered minimal methanol medium to induce
expression (BMMM, see EasySelect Pichia Expression Kit protocol). Every 24 hours
following inoculation 100 % methanol was added to a final concentration of 0.5 % v/v.
After 120 hours, cells were pelleted and the supernatant frozen and stored at -80°C or
used immediately in zymography, SDS-PAGE, western blotting or purification.
As the expressed proteins were expected to be allergens, following expression all
recombinant protein preparations were handled in Class II safety cabinets only. This was
done to prevent contamination of the proteins by other agents and also to reduce exposure
of lab staff to potentially allergenic proteins.
2.3.7 Recombinant protein purification
The poly-histidine tag added to the protein during expression was used to purify recom-
binant proteins by affinity chromatography against Nickel coated agarose using 1 mL
HisTrap Columns (GE Health Care, Little Chalfont, UK). Following protein expression,
culture supernatants were clarified by centrifugation twice at 1000 x g for 5 minutes, filter
sterilised 0.22 µm Corning CA Vacuum filter system, dialysed twice for 12 hours against
10 x volume of dH2O at 4 °C, concentrated by freeze drying, and then resuspended in
dH2O such that supernatants were concentrated by 100x.
During purification using HisTrap columns, all steps were performed at a flow rate of 1
mL min-1. Columns were washed with 5 mL of dH2O followed by 5 mL of either denatur-
ing (20 mM sodium phosphate, 0.5 M NaCl, 8 M Urea, pH 7.4) or non-denaturing binding
buffer (20 mM sodium phosphate, 0.5 M NaCl, pH 7.4). Concentrated supernatants were
mixed with denaturing or non-denaturing binding buffer and applied to HisTrap columns
under denaturing or non-denaturing conditions, respectively. Columns were washed with
5 mL of the relevant binding buffer, then proteins were dissociated from the nickel resin,
across a gradient of 0-100% elution buffer (0.5 M imidazole in appropriate binding buffer)
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at a rate of 10 % mL-1. The UV absorbance at 280 nm (A280) of the column flow through
was measured to identify fractions containing eluted proteins.
Recombinant proteins without a poly-histidine tag were purified using a combination
of ammonium sulfate fractionation followed by size exclusion chromatography. In order
to determine the broad fractions in which proteins precipitated, small aliquots of recom-
binant proteins were precipitated at 20 %, 40 %, 60 %, 80 % and 100 % (w/v) ammonium
sulphate. Under constant shaking, finely powdered ammonium sulfate was added to 10
mL aliquots of recombinant proteins at 4 °C and incubated for 1 hour. Precipitated pro-
teins were pellet by centrifugation at ≥ 10,000 x g for 1 hour at 4 °C, the supernatant
removed, and the pelleted proteins resuspended in PBS, before analysis by SDS-PAGE.
Proteins were precisely fractionated, by the sequential addition of ammonium sulphate in
5 % increments. A single 40 mL aliquot of P. pastoris culture supernatant was incubated
with the lowest level of ammonium sulphate found not precipitate proteins in the initial
experiment as described above. Proteins were then pelleted as described above and the
ammonium sulfate content of the supernatant, increased by 5 % by the addition of the
appropriate amount of finely powdered ammonium sulphate. The process was repeated
until no more protein was precipitated in the fractions. Following precipitation, fractions
containing recombinant proteins were combined and further purified by size exclusion
chromatography as described in section 2.4.5.
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2.4 Protein Biochemistry
2.4.1 Protein concentration assay
Concentrations of protein were assayed using the Pierce BCA Protein Assay Reagent. All
samples were assayed in duplicate and standards were performed in triplicate. A seven
point standard curve was created using 2-fold serial dilutions of BSA, with a high standard
of 2000 µg mL-1. Samples were assayed using the microplate procedure, 25 µL of each
sample was added to a well followed by 200 µL of working reagent (50 parts solution A
to 1 part solution B). The plate was then incubated for 30 minutes at 37 °C and cooled
to room temperature. The optical density of each well was determined immediately by
measuring absorbance at 562 nm using a micro-plate reader. To analyse the data, aver-
age optical densities were calculated from technical replicates, blanks subtracted from all
values, and a standard curve created using Prism 5.0 software. Mean absorbances for
standards were plotted against standard concentrations using a graph with linear axes.
Concentrations of protein in samples were interpolated from the standards by linear re-
gression. If necessary protein samples were diluted to fit on the standard curve.
2.4.2 Sodium dodecyl sulphate polyacrilamide gel electrophoresis
SDS-PAGE of protein samples was carried out using the Laemmli buffer system under de-
naturing conditions. Compositions of polyacrylamide gels are shown in Table 2.8. Elec-
trophoresis was performed using a Tris-Glycine running buffer system (25 mM Tris, 200
mM Glycine and 0.1 % (w/v) SDS at pH 8.3). Alternatively SDS-PAGE was carried out
with precast 12 % Precise Protein Gels (Thermofisher Scientific) using a HEPES-Glycine
buffer system (100 mM Tris, 100 mM HEPES, 3 mM SDS, at pH 8.0) or 10 % Novex
NuPage Bis-Tris Mini-gels ((Invitrogen, Life Technologies) using a MOPs Buffer system
(50 mM MOPS, 50 mM Tris base, 0.1 % SDS, 1 mM EDTA, pH 7.7).
Electrophoresis was performed using a BioRad Mini-Protean III Cell (Precise and
hand made gels) or a Novex XCell SureLock Cell (Novex Gels). For Precise and hand
made gels, samples were mixed with 2x reducing sample buffer (125 mM Tris-HCl, 20
% (v/v) Glycerol, 4 % (w/v) SDS, 5 % (v/v) 2-mercaptoethanol, and 0.01 % (w/v) Bro-
mophenol Blue, pH 6.8) and boiled at 95 °C in a heat block for 5 minutes. For Novex
gels, samples were mixed with 4x LDS sample buffer (106 mM Tris HCl, 141 mM Tris
base, 2 % LDS, 10 % Glycerol, 0.51 mM EDTA, 0.22 mM SERVA Blue G250, 0.175
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mM Phenol Red, pH 8.5) and 10x Sample Reducing agent (500 mM DTT) and incubated
for 10 minutes at 70 °C. Samples were loaded onto the gels along with molecular weight
markers. Either Precision Prestained Standards (New England Biolabs) or Kaliedoscope
Prestained Protein Standards were used (BioRad). Gels were run with the appropriate
running buffer for 60-90 minutes at 140v for Precise and hand made gels or at 170V for
55 minutes for Novex gels.
Gels were stained using a number of different techniques. For routine staining, gels
were stained for 1 hour with Comassie Blue stain (45 % (v/v) Methanol, 10 % Acetic Acid
(v/v), 0.25 % (w/v) Comassie Blue R250), followed by destaining for 2 hours in destain
solution (45 % (v/v) Methanol, 10 % (v/v) Acetic Acid), and rehydration in dH2O for 1
hour. For rapid detection of protein bands, gels were stained using InstantBlue stain for
1 hour, no destaining step was required, although better images were produced by rehy-
dration in dH2O for 1 hour. For the detection of small amounts of protein gels were silver
stained using the Silver Stain Plus Kit (BioRad) as per the manufactures protocol. Gels
were dried using the DryEase Mini-Gel drying system (Invitrogen, Life Technologies)
and scanned using an Epson Perfection 1670 Scanner.
Table 2.8: Standard gel compositions for a 4 % stacking and 12 % resolving polyacry-
lamide gels, using the discontinuous SDS-PAGE Laemmli buffer system.
Component 12% Running Gel 4% Stacking Gel
1.5 M Tris-HCl pH 8.8 2.5 mL -
0.5 M Tris-HCl pH 6.8 - 2.5mL
30 % Bis/Acrylamide (29:1) 4.0 mL 1.3 mL
10 % (w/v) SDS 100 µL 100 µL
10 % (w/v) Ammonium Persulfate 50 µL 50 µL
TEMED 5 µlL 10 µL
dH2O 3.4 mL 6.1 mL
Total 10 mL 10 mL
2.4.3 Zymography
Gelatin zymography was used to identify gelatinolytic proteases in samples containing
protease activity. Gel composition is shown in Table 2.9. Electrophoresis was performed
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using a Tris-Glycine running buffer system (25 mM Tris-HCl, 200 mM Glycine and 0.1 %
(w/v) SDS at pH 8.3). Samples were mixed with 2x zymography loading buffer (125 mM
Tris-HCl, 20 % (v/v) Glycerol, 10 % (w/v) SDS, and 0.01 % (w/v) Bromophenol Blue,
pH 6.8) and incubated for 30 minutes at 37 °C. Precision Pre-stained Standards (BioRad)
were loaded to the gel along with the samples. Electrophoresis was performed using a
BioRad Mini-Protean III Cell at 125v for 60 minutes or until the dye marker had reached
the bottom of the gel.
Following electrophoresis, proteins were renatured within the gel by incubation with
2.5 % Triton X-100 for 30 minutes with gentle agitation. Gels were then equilibrated in
Zymogram Developing Buffer (50 mM Tris-HCl, 200 mM NaCl, 6.7 mM CaCl2, pH 7.5)
for 30 minutes with gentle agitation. This was followed by incubation in fresh developing
buffer for 4 hours. Gels were stained and imaged as detailed in the previous section
(2.4.2).
Table 2.9: Standard composition of gels for use in gelatin gel zymography. For zymo-
grapgy a 7.5 % polyacrylamide running gel with 0.1 % gelatin was used.
Gel Type/Component 7.5 % Running Gel 4 % Stacking Gel
1.5 M Tris-HCl pH 8.8 2.5 mL -
0.5 M Tris-HCl pH 6.8 - 2.5mL
30 % Bis/Acrylamide (29:1) 2.5 mL 1.3 mL
10 % SDS 100 µL 100 µL
10 % (w/v) Ammonium Persulfate 50 µL 50 µL
TEMED 5 µL 10 µL
1 % Gelatin 1 mL -
dH2O 3.85 mL 6.1 mL
2.4.4 Western blotting
For western blotting, protein samples were prepared under denaturing conditions and run
on SDS-PAGE gels as described in Section 2.4.2. Following electrophoresis gels were
washed 3 times in dH2O for 5 minutes to remove SDS. Proteins were transferred to Immo-
bilon P, PVDF nitrocellulose membrane (Millipore, UK) using the BioRad Mini Transblot
Cell system.The transfer was carried out for 90 minutes, at a constant current of 300 mA,
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in gel transfer buffer (192 mM Glycine, 25 mM Tris-HCl and 20 % (v/v) Methanol at pH
8.3). Ice blocks were placed in the running buffer to prevent over heating.
Different primary and secondary antibodies required different concentrations and con-
ditions to achieve efficient binding (Table 2.10), however the same general staining pro-
tocol was used in all immunoblotting experiments. To prepare for immunostaining, mem-
branes were washed for 5 minutes in Tris-Buffered Saline Tween-20 (TBST, 100 mM
Tris-HCl, 150 mM NaCl, 0.1 % (v/v), Tween 20, pH 7.4), following transfer. To block
non-specific antibody binding, membranes incubated overnight at 4 °C on a rocker in
TBST+ 5 % (v/v) bovine serum albumin. To remove free BSA, membranes were washed
for 5 minutes in Tris-Buffered Saline (TBS, 100 mM Tris-HCl, 150 mM NaCl, 0.1 %
(v/v), pH 7.4) followed by a 5 minute wash in TBST on a rocker. Membranes were then
incubated with the primary antibody, for 2 hours at 4 °C on a rocker. Unbound primary
antibody was removed by washing membranes twice for 5 minutes and three times for
10 minutes in TBST on a rocker. The secondary antibody was added and incubated, for
2 hours at room temperature on a rocker. Unbound secondary antibody was removed by
washing membranes three times for 5 minutes in TBST and three times for 3 minutes
in TBS on a rocker. Antibody binding was visualised using Pierce CN/DAB substrate
solution as described by the manufacturer (Thermofisher Scientific).
Table 2.10: Concentrations of antibodies used in western blotting procedures. Where
required, antibodies were diluted in TBST.
Blotting Target Primary Antibody Secondary Antibody
Allergens from A.
fumigatus
IgE in pooled patient sera
from 10 patients with
ABPA, CPA or SAFS
Goat IgG Anti-Human IgE
(ε-chain specific)-HRP
conjugated, 1:4000,
(A9667, Sigma-Aldrich)
Recombinant allergens
from A. fumigatus c-myc
conjugated
Mouse monoclonal IgG
Anti-Human c-Myc, 1:4000
(M4439, Sigma-Aldrich)
Goat IgG Anti-Mouse IgG
(Fc specific)-HRP
conjugated, 1:4000,
(A2554, Sigma-Aldrich)
2.4.5 Size exclusion chromatography
Proteins were separated by size exclusion chromatography using a 24ml Superdex S200
column (GE Health Care). Columns were stored in 20 % Ethanol, and washed with 60 mL
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of Phosphate Buffered Saline (PBS, 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.76
mM KH2PO4, pH 7.4) at 0.1 mL min-1. Samples were concentrated by freeze drying and
resuspended in 200 µL of PBS. Samples were loaded onto the column from the injection
loop with 3 mL of PBS. The column was run in 30 mL of filter sterilised PBS at 0.5 mL
min-1 and fractions were collected every 1 mL. Filtration and fractionation were carried
out using an AKTAPrime protein purification system (GE Health Care). Results were
stored and viewed using PrimeView software and analysed using PrimeView Evaluate
(GE Health Care).
2.4.6 LC-MS identification of proteins
Protein identification by liquid chromatography(LC)-mass spectrometry(MS) was per-
formed by the Biomolecular Analysis Core Facility at the University of Manchester.
Bands of interest were excised from the gel and dehydrated using acetonitrile followed
by vacuum centrifugation. Dried gel pieces were reduced with 10 mM dithiothreitol and
alkylated with 55 mM iodoacetamide. Gel fragments were then washed twice, alternately
with 25 mM ammonium bicarbonate followed by acetonitrile, and dried by vacuum cen-
trifugation. Samples were digested with trypsin overnight at 37 °C. The samples were
extracted in one wash of 20 mM ammonium bicarbonate, and two of 50 % acetonitrile, 5
% formic acid. The extract was then dried by vacuum centrifuge to 20 µl. Digested sam-
ples were analysed by LC-MS/MS using an Ultimate 3000 (LC-Packings, Dionex, Am-
sterdam, The Netherlands) coupled to a HCT Ultra ion trap mass spectrometer (Bruker
Daltonics, Bremen, Germany). Peptides were concentrated on a pre-column (5 mm x 300
µm i.d, LC-Packings). The peptides were then separated using a gradient from 98 % A
(0.1 % FA in water) and 1 % B (0.1 % FA in acetonitrile) to 50 % B, in 40 min at 200 nL
min-1, using a C18 PepMap column (150 mm x 75 µm i.d, LC-Packings). Data produced
were searched using Mascot (Matrix Science, UK), against the SWISSPROT database
and the UNIPROT database with taxonomy of Fungi selected. Data were validated using
Scaffold (Proteome Software, Portland, OR).
2.4.7 MALDI-MS analysis of PAR-2 cleavage
Matrix-assisted laser desorption ionization (MALDI)mass spectrometry (MS) analysis of
PAR-2 cleavage was performed by the Biomolecular Analysis Core Facility at the Uni-
versity of Manchester. Following cleavage of the PAR-2 peptide with Asp f 5 and Asp f
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13 as described in section 2.4.8, peptide fragments were analysed as described previously
by Jervis et al. [83]. Briefly, samples were prepared for analysis by desalting using Zip-
Tip Micro Cartridge (Millipore, UK) with reverse phase chromatography, and applied to
a MALDI target using 50 mM α-cyano-4-hydroxycinnamic acid (in acetonitrile-H2O at
a dilution of 4:1, v/v) MALDI-MS matrix. MALDI-tandem time of flight (TOF/TOF)-
MS and tandem MS (MS/MS) spectra were acquired by using a Bruker Ultraflex II mass
spectrometer in the positive-ion reflection mode with external calibration. Spectra were
viewed and analysed using FlexAnalysis 3.0 software (Bruker Daltonics).
2.4.8 Protease activity assays
Casein hydrolysis assay
Protease activity of both crude and recombinant protein was measured using a universal
protease substrate, casein coupled to activated resorufin (Roche Applied Science). As-
says were performed in 100 µL reactions composed of 25 µL of substrate solution (0.4
% resorufin-labeled casein in ultra-pure dH2O), 25 µL 4x reaction buffer (200 mM Tris-
HCl, 20 mM CaCl2, pH 7.8), and 50 µL sample. Reactions were carried out at 37 °C then
stopped with 240 µL stop solution (5 % (w/v) trichloroacetic acid) to precipitate undi-
gested casein. Stopped reactions were incubated at 37 °C for 10 minutes then centrifuged
at ≥ 10000 x g to pellet precipitated proteins. The supernatant was removed and 80 µL
was combined with 120 µL assay buffer (500 mM Tris-HCl, pH 8.8) and the change in
absorbance at 574 nm read using a micro-plate reader. PBS was used in all the assays
are a blank/control. Reactions were carried out at in triplicate. For inhibition of protease
activity, inhibitors were used at the working concentrations shown in table 2.11 (Sec-
tion 2.4.8). Proteases were pre-incubated with protease inhibitor for 30 minutes at room
temperature prior to mixing with substrate solution and reaction buffer.
For the calculation of protease activity, the change in absorbance was measured after 1
minute, 30 minutes and 60 minutes to obtain the rate of dye release. Protease preparations
were diluted until a straight line could be obtained over the time course. Rate of change of
absorbance was measured using linear regression and the protease activity calculated in
International Units of protease activity per mL of enzyme solution (IU mL-1). One IU is
defined as the amount of time in minutes taken to degrade 1 µmol of substance. Protease
activity in IU mL-1 was calculated using a modified version of the Beer-Lambert equation
shown below (Equation 2.1).
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Protease Activity (IU mL-1)=
C×∆A574
e×p (2.1)
Where ∆A574 = Change in Absorbance at 574 nm (Calculated by linear regression)
C = Volume constant (Adjusts equation to convert between M and µM,
accounts for dilution of dye from reaction to assay volume, and the
volume of Af supernatant, in this assay C= 85,000)
e = Extinction coefficient (For resorufin-labeled casein e=66000 L mol-1
cm-1)
p = Light path (For a 200 µL reaction 96 well plate in a micro-plate reader
p= 0.6 cm)
Elastase assay
Elastase activity was measured using the synthetic elastase substrate N-Succinyl-Ala-Ala-
Ala-p-nitroanilide by the method of Castillo et al. [34]. Assays were performed in 100
µl reactions composed of 10 µl of substrate solution (30 mM N-Succinyl-Ala-Ala-Ala-
p-nitroanilide in 100 % DMSO), 65 µl assay buffer (100 mM HEPES, 500 mM NaCl,
pH 7.4) and 25 µl of appropriately diluted sample solution. Change in absorbance at 405
nm was measured every minute for 2 hours using a micro-plate reader at 37 °C. Protease
activity was calculated as shown below (Equation 2.2). For inhibition of protease activity,
inhibitors were used at the working concentrations shown in table 2.11 (Section 2.4.8).
Protease Activity (IU mL-1)=
∆A405
V× e×p (2.2)
Where ∆A405 = Change in Absorbance at 405 nm (Calculated by linear regression)
V = Volume of Af supernatant in the reaction
e = Extinction coefficient (8800 mol-1 cm-1)
p = Light path (For a 100 µL reaction in a 96 well plate in a micro-plate
reader p= 0.3 cm)
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Collagenase assay
Degradation of collagen by proteases was measured using azo dye conjugated collagen
(Sigma-Aldritch) by the method of Chavira et al. [37]. The substrate solution was a
uniform suspension of 5mg/ml Azocollagen (w/v) in assay buffer (50 mM Tris-HCl, 1
mM CaCl2, 0.01 % (w/v) sodium azide, pH 7.8). Azocollagen was insoluble and constant
stirring was required to maintain a uniform suspension during distribution. Assays were
performed by incubating samples in 3 ml of substrate solution in a 5ml universal tube,
at 37 °C, on a shaker at 240 rpm, for 3 hours. The size of tube and rate of shaking
were critical in ensuring a uniform suspension of azocollagen. Reactions were stopped
by centrifugation at ≥ 8000 x g to remove the insoluble azocollagen. Supernatants were
transferred to a 96 well plate and the change in absorbance against the blanks measured
at 520 nm. Due to the nature of the assay it was not possible to calculate the protease
activity in IU, therefore protease activity was expressed as change in absorbance at 520
nm per hour (∆A520 h-1). For inhibition of protease activity, inhibitors were used at the
working concentrations shown in table 2.11 (Section 2.4.8).
Protease activated receptor-2 cleavage assay
The affinity of proteases for the PAR-2 cleavage site was measured using a PAR-2 flu-
oropeptide, as previously described by Matsuwaki et al. [113]. The cleavage site of
the PAR-2 receptor, Abz-Ser-Lys-Gly-Arg-Ser-Leu-Ile-Gly-Lys(Dnp)-Asp, was synthe-
sised as a peptide (Cambridge Peptides, Cambridge, UK). The peptide contained the fluo-
rophore o-aminobenzoic acid (Abz) and quencher chromophore 2,4-dinitrophenol (Dnp).
The peptide was dissolved in DMSO at a concentration of 1mM. Assays were performed
in 100 µL reactions composed of 50 µL of 100 mM PAR-2 peptide in 2x assay buffer (100
mM Tris-HCl, 10 mM CaCl2, pH 7.8) and 50 µL enzyme solution. Assays were incu-
bated at 37 °C and fluorescence (λexcitation = 360 nm; λemission = 460 nm) measured every
minute, for 30 minutes, using a Synergy 2 Multi-Mode Microplate Reader (Biotek Instru-
ments, Leeds). For inhibition of protease activity, inhibitors were used at the working
concentrations shown in table 2.11 (Section 2.4.8).
Protease inhibition
The activity of proteases in the presence of protease inhibitors was carried out as described
previously using the casein hydrolysis assay. To inhibit protease activity inhibitors were
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added to the sample solution and incubated at room temperature for 30 minutes prior to
the addition of substrate solution. The concentrations of inhibitors used are described in
table 2.11. The working concentrations described were the final concentration of inhibitor
used in the protease assay.
Table 2.11: Protease inhibitors used in protease inhibition assays. Inhibitors were ob-
tained from Sigma Aldrich unless otherwise indicated. * inhibitor obtained from Merck
Chemicals, Nottingham, UK.
Protease Inhibitor Protease Class Inhibited Stock
Concentration
Working
concentration
PMSF Serine proteases 200 mM 2 mM
Antipain Serine proteases 0.5 mg mL-1 10 µg mL-1
EDTA Metalloproteases 500 mM 5 mM
Ilomastat * Matrix metalloproteases 2.5 mM 25 µM
Pepstatin A * Aspartic proteases 5 mM 50 µM
E64 Cysteine proteases 1 mM 10 µM
2.4.9 IL-8 Enzyme linked immunosorbent assay
Levels of the cytokine IL-8, were detected in the culture supernatants from A549 cells us-
ing the human CXCL8/IL-8 DuoSet ELISA Development System (R&D Systems, Abing-
don, UK). Capture antibody (mouse anti-human IL-8), detection antibody (biotinylated
goat anti-human IL-8), IL-8 standard and Streptavidin-HRP solution were all provided in
the kit and prepared according to the manufacturer’s instructions. Plates were prepared by
coating Nunc 96-well MaxiSorb ELISA plates (Thermofisher Scientific) with 100 µL per
well of capture antibody, at a concentration of 4 µg mL-1 diluted in PBS (137 mM NaCl,
2.7 mM KCl, 8.1 mM Na2HPO4, 1.76 mM KH2PO4, pH 7.4, 0.2 µm filtered). Plates were
wrapped in cling film to prevent evaporation, and incubated overnight at room tempera-
ture, then washed three times by repeated immersion of the plate in Wash Buffer (0.05 %
v/v Tween 20 in PBS, pH 7.4) followed by total removal of Wash Buffer. Excess wash
buffer was removed by blotting against clean paper towels. Non-specific protein and anti-
body binding was blocked by the addition of 300 µL per well of blocking buffer (1% BSA
in PBS with 0.05 % NaN3) at room temperature for 1 hour. Finally plates were washed as
described above to remove excess blocking buffer.
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To assay IL-8 levels in cell culture supernatants, 100 µL of sample or standard was
added to each well, the plate wrapped in cling film, and then incubated for 2 hours at
room temperature. All samples were assayed in duplicate and standards were performed
in triplicate. A seven point standard curve was created using 2-fold serial dilutions of
recombinant human IL-8, with a high standard of 2000 pg mL-1. Standards were prepared
in serum free cell culture medium. Following incubation, plates were washed as described
above and 100 µL of detection antibody was added to each well, at a concentration of 20
ng mL-1, diluted in Reagent Diluent (0.1 % w/v BSA (fraction V), 0.05 % v/v Tween
20, 20 mM Tris-HCl, 150 mM NaCl, pH 7.4, 0.2 µm filtered). Plates were wrapped
in cling film and incubated for 2 hours at room temperature. Plates were washed again
as described above, followed by the addition of 100 µL per well of Streptavidin-HRP
prepared as described by the manufacturer, in Reagent Diluent. Plates were incubated
in the dark for 20 minutes followed by a final wash in Wash Buffer as described above.
HRP activity was detected by the additon of 100 µL per well of 1-Step Ultra TMB-ELISA
Substrate (Thermofisher Scientific). Plates were incubated, away from bright lights, for
20 minutes or until the low IL-8 standard was visible, then stopped with 50 µL per well of
2 N H2SO4. The optical density of each well was determined immediately by measuring
absorbance at 450 nm with wavelength correction at 540 nm using a micro-plate reader.
To analyse the data, average optical densities were calculated from technical repli-
cates, blanks subtracted from all values, and a standard curve created using Prism 5.0
software. Mean absorbances for standards were plotted against standard concentrations
on a Log10-Log10 graph. Concentrations of IL-8 in samples were interpolated from the
standards by Log-Log line non linear regression using a least squares fitting method.
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2.5 Airway epithelial cell culture
Cell lines were handled using standard aseptic technique in a Class II safety cabinet. All
biological material was disposed of in bleach or a 2 % solution of Virkon. Equipment and
consumable materials were disposed by incineration or decontaminated in a 2 % solution
of Virkon and autoclaved before cleaning.
2.5.1 Cell line culture
The A549 cell line was obtained as a kind gift from Eleni Tsitsiou (University of Manch-
ester). A549 cells are adenocarcinomic human alveolar basal epithelial cells, which were
originally developed by Giard, et al., from the explanted lung tumour of 58-year-old cau-
casian male [57]. All experiments were carried out on cells between passages 9 and 15.
For routine cell culture, cells were grown in T75 tissue culture flasks (Corning) and
were maintained in DMEM10 (Dulbecco’s Modified Eagle Medium, 10 % (v/v) foetal calf
serum, Penicillin/Streptomycin (100 units/100 µg mL-1), L-Glutamine (2 mM), all ob-
tained from PAA laboratories, Yeovil, UK) at 37 °C in 5 % CO2 humidified air. DMEM10
was changed every 48 hours.
To sub culture cells in T75 flasks, media was removed from flask using a sterile glass
pipette with suction. Cells were washed twice with 5 ml of sterile PBS (pH 7.2) at 37
°C. 3 mL of 0.25 % Accutase (PAA Laboratories) was added and the flasks incubated
for 3-5 minutes at 37 °C. 9ml of DMEM10 was added to inhibit Accutase. The mixture
was transferred to a sterile tube and centrifuged for 4 mins at 900 rpm. Supernatant was
removed and cells were resuspended in 1ml DMEM10. Cells were counted and diluted
appropriately for freezing or division into plates or flasks.
For the cryogenic storage of cells, after passaging as described above, cells were
counted and resuspended in an appropriate volume of cryo-protective freezing mixture
(Dulbecco’s Modified Eagle Medium, 20% (v/v) foetal calf serum, Penicillin/Streptomycin
(100 units/100 µg mL-1), L-Glutamine (2 mM), 10% (v/v) Dimethyl Sulphoxide, all ob-
tained from PAA laboratories) to give a final concentration of 1 x 106 cells mL-1. Cell
were frozen by slowly adding appropriate volume of cold freezing mix in small quantities.
Cells were cooled at 1 °C min-1 in a -80 °C freezer, using a Nalgene 5100 Cryo 1 °C ”Mr
Frosty” Freezing Container (Thermo Scientific).
For experimentation and routine cell culture, cells were seeded at different densities
depending on the required number of cells or plate format. Seeding densities for A549
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cells and media volumes for different cell culture vessels are shown in Table (2.12). Fol-
lowing seeding cells were expected to form a monolayer that was 80-90 % confluent after
48 hours.
Table 2.12: Seeding densities for A549 cells and media volumes for different cell culture
vessels.
Cell culture vessel Seeding density Media volume
(cells mL-1) (mL)
12 well plate 1 x 105 1
6 well plate 3 x 105 3
T25 7 x 105 4
T75 2.1 x 106 12
2.5.2 Stimulation of cells with crude and recombinant A. fumigatus
allergen proteases
Cells were treated for varying lengths of time with both crude and recombinant A. fumiga-
tus protease preparations. All cell treatments were performed under serum free conditions
in 12 well cell culture clusters. Cells were maintained in T75 flasks and seeded to 12 well
cell culture cluster plates by subculture as described in section 2.5.1. To achieve serum
free conditions, 24 hours prior to treatment, serum containing media was removed and
replaced with 1 mL of serum free DMEM (Dulbecco’s Modified Eagle Medium, Peni-
cillin/Streptomycin (100 units/100 µg mL-1), L-Glutamine (2 mM), all obtained from
PAA laboratories). After incubation in serum free DMEM for 8 hours, media was re-
moved and replaced with 1 mL serum free DMEM. After a further 16 hours, cells were
ready for treatment.
All treatments were applied to cells in 1mL of serum free DMEM. A. fumigatus cul-
ture supernatants were lyophilised by freeze drying and resuspended in PBS such as to
concentrate the preparations 20 times and then diluted in serum free DMEM to achieve the
desired concentrations. PBS vehicle controls were prepared by adding equal volumes of
PBS to serum free DMEM. Following treatment, cells were photographed with an Olym-
pus IX51 microscope using a 10 x objective. For the assay of secreted cytokine amounts,
cell culture supernatants were frozen at -20 °C until required.
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2.5.3 PAR-2 blocking studies
PAR-2 receptors were blocked using the SAM11 mouse monoclonal IgG-2a anti-human
PAR-2 antibody (Insight Biotechnology Ltd, Wembley, UK). Cells were prepared under
serum free conditions as described in section 2.5.2, in 12 well tissue culture clusters.
Cells were incubated with 10 µg mL-1 SAM-11 antibody for 3 hours prior to the addition
of A. fumigatus proteases or the positive control TPCK trypsin (Thermofisher Scientific).
Proteases were prepared in 100 µL of serum free DMEM at 10x the final concentration
required then added directly the 1 mL of DMEM containing the SAM11 antibody already
present on the cells. Cells were incubated for a further 6 hours before the collection of
cell culture supernatants for the analysis of cytokine production.
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Chapter 3
The effect of different culture
conditions on the secretion of allergen
proteases by Aspergillus fumigatus
3.1 Introduction
The exact composition of A. fumigatus allergens that individuals are exposed to is un-
known and difficult to quantify. A. fumigatus allergens may be inhaled as individual
molecules from A. fumigatus growing on material available in the environment, as part
of hyphal fragments from the environment, or may be released by conidia germinating
within the lung. Understanding the conditions which lead to the secretion of allergens,
and specifically allergen proteases, by A. fumigatus, and the ways in which individuals are
exposed to them, is critical to understanding the relative exposure to and role of allergen
proteases in A. fumigatus related allergic diseases such as ABPA and SAFS. Additionally,
when using A. fumigatus allergen extracts in both research studies and clinically in skin
prick testing, the conditions under which the extracts are prepared are crucial in ensuring
relevant allergens are present in the extract.
Traditionally, A. fumigatus is grown in complete medium that is not representative of
substrates present during growth in the lung. However, a number of studies have inves-
tigated the secretion of proteases by A. fumigatus in vitro during growth in liquid culture
on substrates available present in the lung. Both Kolattukudy et al. and Frosco et al.
demonstrated that growth of A. fumigatus on insoluble elastin in liquid culture, resulted
in the secretion of the serine protease Asp f 13 (Alp1) [53, 94]. In two separate studies,
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Monod et al. showed the production of both Asp f 5 (Mep) and Asp f 13 by A. fumiga-
tus during growth on insoluble collagen in liquid culture [117, 119]. In a previous PhD
thesis, Riazanskaia showed that growth of A. fumigatus on insoluble casein resulted in
the production of aminopeptidase Y (Lap1), Asp f 5 and Asp f 13, however the relative
activities of the individual protease was not investigated [143]. Results from studies by
Tomee et al. showed that supernatants from A. fumigatus cultured on insoluble collagen,
were both proteolytically active and contained antigens that were capable of binding IgG
and IgE from patients with ABPA and PA [169]. Furthermore studies by others showed
that protease production was suppressed by growth of A. fumigatus in the presence of a
primary nitrogen source such as ammonia, even when complex nitrogen sources such as
BSA or serum were present [23, 58].
Other studies have demonstrated that the profile of proteases secreted by A. fumiga-
tus during growth on collagen or elastin is dependent on growth medium pH. Lee et al.
showed that under acid conditions, A. fumigatus secreted the aspartic protease, Aspartic
endopeptidase (Pep1), and that under neutral or alkaline conditions secretion of this pro-
tease was suppressed [105]. In a more extensive study, Sriranganadane et al. showed
that A. fumigatus secretes different sets of proteases depending on the pH of a common
growth medium [163]. At neutral pH, A. fumigatus was found to secrete alkaline serine
protease (Alp1), a metalloprotease (Mep), leucine aminopeptidases (Lap1 and Lap2) and a
X-prolylpeptidase (DppIV), whilst at acid pH, Tripeptidyl-peptidase, Aspartic endopepti-
dase (Pep1), Carboxypeptidase S1, Carboxypeptidase 5, Carboxypeptidase 4, Tripeptidyl
peptidase A, and Carboxypeptidase S1 were secreted. However, it is unknown if the pro-
teases demonstrated activity, as the study only investigated changes in the levels protease
and not their activities.
Finally, several studies investigated the transcriptional regulation of protease genes
during growth under different conditions. McDonagh et al. showed that the expres-
sion several allergens, including some proteases, were up-regulated during invasion of
the murine lung by A. fumigatus, including the major allergen Asp f 2, the elastinolytic
metalloproteinase Asp f 5 and the alkaline serine protease AorO [115]. Fraczek et al.
demonstrated changes in the expression of the major allergen genes, including proteases
during growth under a variety of conditions including, oxidative stress, hypoxia, mild
heat shock, phosphotidyl choline and cAMP. However, in both of these studies, it was
unknown if the proteases demonstrated activity, as they only investigated changes in the
levels gene of transcription. Studies by Bergmann et al. also showed that several pro-
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teases, including Asp f 5 and Asp f13, were regulated by the common transcription factor
prtT [23].
Despite the extensive investigation of the secretion of proteases by A. fumigatus, un-
der a variety of conditions, the secretion of allergen proteases by A. fumigatus on a range
of nitrogen sources, both physiological and non-physiological has not been investigated.
It was hypothesised that A. fumigatus may exhibit different growth morphologies, growth
rates, and changes in media pH, as well as differences in protease expression and levels of
protease secretion, during growth on different substrates. In this chapter a clinically de-
rived strain of A. fumigatus (AF293) was grown in media containing a variety of different
nitrogen sources including the control substrate, ammonium nitrate, a non-physiological
substrate, insoluble casein, and the physiological substrate, insoluble pig lung. The aim of
the chapter was to investigate changes in A. fumigatus growth morphology, growth rate,
and culture pH, as well as protease expression, secretion and activity during growth on
different substrates. The secondary aim of this chapter was to produce well characterised
A. fumigatus culture supernatants containing secreted A. fumigatus allergen proteases.
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3.2 Methods of quantification of A. fumigatus growth
In order to account for the affect of differences in growth rate on the levels of protease
produced in different cultures, it was necessary to accurately and reliably measure both the
total growth and growth rate of A. fumigatus in liquid culture. Although dry biomass had
been used in previous studies to measure growth of A. fumigatus, this method was labour
intensive, therefore aletrenative methods of measuring growth were also investigated.
The growth morphology of A. fumigatus in liquid culture made measurement of growth
by simple methods such as culture turbidity difficult. Previously Aspergillus niger has
been cultured in media containing polyacrylic acid, resulting in diffuse growth, allowing
measurement of growth by culture turbidity [171]. A. fumigatus was cultured in minimal
medium containing 0.8 g L-1 polyacrylic acid and the turbidity (OD600) and dry biomass
at different time points measured (Figure 3.1). The linear correlation coefficient between
dry biomass and OD600 was 0.77 suggesting, a positive correlation between the data.
However removing polyacrylic acid from the supernatant after growth, for application to
epithelial cells proved difficult, therefore this method was deemed inappropriate.
Figure 3.1: The correlation between dry biomass (mg mL-1) and culture turbidity (OD600)
in A. fumigatus cultured in Vogel’s minimal medium. The R square value for correlation
was 0.77 suggesting a positive correlation between dry biomass culture density and tur-
bidity. Data was combined from 3 separate culture experiments. R square values were
calculated using linear regression.
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A. fumigatus growth was also measured by total DNA per volume of culture. To es-
tablish a relationship between A. fumigatus DNA levels and dry biomass A. fumigatus
was cultured in Vogel’s minimal medium, and dry biomass and total DNA were measured
every 12 hours for 36 hours (Figure 3.2). Both dry biomass and total DNA showed a sim-
ilar curve relating to growth over time. There was a linear correlation coefficient between
dry biomass and total DNA culture of 0.89 suggesting a strong correlation between dry
biomass culture density and total DNA (Figure 3.3). However in practise, the extraction
of DNA and subsequent quantification also proved to be a lengthy process. Furthermore,
the analysis relied on the assumption that extraction efficiency was the same at all time
points, which may not have been the case.
Figure 3.2: Measurement of growth by dry biomass (mg mL-1) and total DNA (ng mL-1)
in A. fumigatus cultured in Vogel’s minimal medium over 36 hours. Data represents mean
± SEM (n=3 biological replicates).
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Growth on solid medium containing agar was has also been used as accurate mea-
surement of growth rate and to compare between growth under different conditions. A.
fumigatus was grown on Vogel’s minimal medium agar and in liquid culture in Vogel’s
minimal medium. Both dry biomass and radial growth were measured over 72 hours and
growth rate compared (Figure 3.4). On both Vogel’s minimal medium agar and liquid Vo-
gel’s minimal medium, growth rate was found to be linear when measured every 24 hours
for 72 hours, and correlated well with one another with an R square value of 0.94 (Figure
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Figure 3.3: The correlation between dry biomass (mg mL-1) and total DNA (ng mL-1)
in A. fumigatus cultured in Vogel’s minimal medium. The R square value for correlation
was 0.89 suggesting a correlation between dry biomass culture density and total DNA.
Data was combined from 3 separate culture experiments. R square values were calculated
using linear regression.
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3.5). It was decided that growth rate of A. fumigatus should be measured by both radial
growth on solid medium and by dry biomass culture density. These two measures corre-
lated well with one another and provided the simplest way of measuring and comparing
morphology and growth rate on different substrates. When measuring protease activity in
liquid cultures of A. fumigatus, dry biomass will be used to normalise protease activity
against A. fumigatus growth.
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Figure 3.4: Measurement of growth by dry biomass culture density in Vogel’s minimal
medium and radial growth in A. fumigatus on Vogel’s minimal medium agar over 72
hours. Data represents mean ± SEM (n=3 biological replicates).
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Figure 3.5: The correlation between dry biomass density and total radial A. fumigatus cul-
tured in Vogel’s minimal medium. The R square value for correlation was 0.94 suggesting
a correlation between dry biomass culture density and turbidity. Data was combined from
3 separate culture experiments. R square values were calculated using linear regression.
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3.3 Growth characteristics of A. fumigatus in different
culture media
The growth characteristics of A. fumigatus in different liquid media were investigated,
including, growth morphology, growth rate, culture pH and the secretion of proteases.
These experiments were used to characterise A. fumigatus growth and determine the op-
timum culture conditions for the production of proteases by A. fumigatus in different
media.
3.3.1 Effect of different media on growth morphology of A. fumigatus
Growth morphology of A. fumigatus in different liquid culture media was documented.
Shaking at high speed, a high culture volume to flask volume ratio and good aeration
resulted in diffuse cultures without clumping or pelleting. In liquid medium, A. fumigatus
cultured in pig lung medium showed the most diffuse growth morphology (Figure 3.6 C),
whereas more dense cultures were observed when A. fumigatus was cultured in Vogel’s
minimal medium and casein medium (Figure 3.6 A and B).
Growth morphology was also observed during growth on solid agar medium. Growth
on Vogel’s minimal medium agar showed the most typical growth morphology, with a
dense dark green disc forming on the surface of the agar (Figure 3.7 A). Growth on ca-
sein and pig lung medium agar resulted in diffuse growth and colonies that spread further
across the plate but were less dense (Figure 3.7 B and C). The differences in growth mor-
phology observed between different media types, in both liquid and solid media, may due
to nutrient availability, with more diffuse growth occurring due to the reduced availability
of nutrients. For example, in Vogel’s medium cultures, nutrients were readily available
and easily absorbed, resulting in dense non diffuse cultures, whilst in pig lung cultures,
nutrients required processing before absorption, making them less readily available, lead-
ing to diffuse solid and liquid cultures.
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Figure 3.6: Growth morphologies of A. fumigatus cultured in A. Vogel’s minimal
medium, B. Casein medium C. Pig lung medium. A. fumigatus was grown for 48 hours
at 37 °C, transferred to a 35 mm petri dish and photographed.
Figure 3.7: Growth morphologies of A. fumigatus cultured on A. Vogel’s minimal
medium agar, B. Casein medium agar, C. Pig lung medium agar. A. fumigatus was grown
for 96 hours at 37 °C and photographed.
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3.3.2 Effect of different media on the growth rate of A. fumigatus
Growth in Vogel’s minimal medium, casein medium and pig lung medium was measured
using dry biomass culture density (Figure 3.8). A. fumigatus cultured in Vogel’s medium
showed the shortest lag phase, between 0 and 12 hours, with significantly higher growth at
24 hours than casein or pig lung cultures, where the lag phase was from 0 to 24 hours. The
exponential phase was from 12 to 36 hours in Vogel’s minimal medium, and 24 to 36 hours
in casein and pig lung media. During the exponential phase, casein cultures demonstrated
the fastest growth rate, followed by Vogel’s medium and then pig lung medium (Table
3.1). Maximal growth occurred in all cultures at 36 hours. Growth in casein in medium
appeared to result in highest maximal growth, followed by Vogel’s minimal medium and
pig lung medium (4.7 vs. 4.1 vs. 1.1 mg mL-1). Growth of A. fumigatus in Vogel’s
and casein cultures significantly higher growth than pig lung cultures (both P<0.001), but
there was no significant difference between growth in Vogel’s and casein cultures. Vogel’s
minimal medium and pig lung medium cultures entered the stationary phase between 36
and 48 hours followed by decline from 48 to 72 hours. Casein cultures did not enter a
stationary phase but instead declined from 36 to 72 hours. As well as showing lower
growth than in other media, growth of A. fumigatus in pig lung medium also showed
very little change in biomass over the 72 hour time course. This may have been due to
the large amounts of insoluble pig lung in the cultures at early time points effecting the
measurement of growth by dry biomass. However, it would not have been appropriate
to normalise the data with a pig lung medium only blank, as the insoluble pif lung was
degraded over time by A. fumigatus.
For the measurement of radial growth on solid media, A. fumigatus was grown on
Vogel’s minimal medium agar, casein medium agar or pig lung medium agar. Radial
growth of these cultures was measured over 96 hours (Figure 3.9). Growth on pig lung
medium was shown to result in the fastest rate of growth followed by casein medium
and finally Vogel’s minimal medium (Table 3.1) and the rates of growth were considered
statistically different from one another (P<0.001). Growth was found to be significantly
different between Vogel’s, casein and pig lung cultures at 36, 48 and 72 hours (P<0.001,
each medium vs. all other media).
The rates of growth as measured by dry biomass and radial growth did not appear
to agree with one another. For example, in liquid medium, growth rate and total growth
of A. fumigatus were greater in Vogel’s medium than in pig lung medium. However,
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Figure 3.8: Growth of A. fumigatus on Vogel’s minimal medium, casein medium and
pig lung medium was measured by dry biomass. Cultures were grown for 72 hours at 37
°C and dry biomass was measured at 0,12, 24, 36, 48 and 72 hours. *** P<0.001, **
P<0.01, * P<0.05 vs. pig lung medium. Data represents mean ± SEM (n=3 biological
replicates).
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Table 3.1: Growth rates of A. fumigatus on solid agar medium or liquid medium con-
taining either Vogel’s minimal medium, pig lung medium or casein medium. For solid
medium, A. fumigatus was grown for 96 hours at 37 °C and growth was measured every
12 hours. Growth rate in mm h-1 calculated using linear regression. For liquid medium,
A. fumigatus was grown for 72 hours at 37 °C and dry biomass was measured at 0,12,
24, 36, 48 and 72 hours. Grow rate was measured during the exponential phase of the
cultures. Data represents mean ± SEM (n=3 biological replicates).
Media type Vogel’s
medium
Casein
medium
Pig-lung
medium
Solid media (mm h-1) 0.179 0.258 0.330
Liquid media (mg mL-1 h-1) 0.174 0.350 0.014
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Figure 3.9: Growth of A. fumigatus on Vogel’s minimal medium, Casein and Pig Lung
media measured by radial growth. Solid agar medium containing either Vogel’s minimal
medium, pig lung medium or casein with medium was inoculated with 1x103 spores and
incubated for 96 hours at 37 °C with growth measured every 12 hours. Differences in
growth and growth rate were compared by two way ANOVA and linear regression re-
spectively. *** P<0.001, ** P<0.01, * P<0.05, each medium vs. all other media. Data
represents mean ± SEM (n=3 biological replicates).
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on solid medium, A. fumigatus grown on pig lung medium had a higher rate of radial
growth and larger total radial growth compared with growth on Vogel’s medium. How-
ever, when taken together, growth morphology, dry biomass and radial growth explain the
growth characteristics of A. fumigatus on different culture media. In summary, growth
on Vogel’s medium resulted in slowly extending hyphae, producing dense cultures, with
a large amount of total biomass. Growth on casein medium resulted dense cultures in
more rapidly extending hyphae giving dense cultures but with a large amount of total
biomass. Growth on pig lung medium resulted in rapidly extending hyphae, cultures with
low density and low total biomass.
97
3.3.3 Effect of A. fumigatus growth on culture supernatant pH
Previous studies have shown that the pH of A. fumigatus growth medium change during
growth and that medium pH is important in determining the proteases secreted, protease
stability and protease activity [122,163]. Therefore changes in culture medium pH during
A. fumigatus growth in liquid media were measured. The pH of all of the growth media
were found to gradually increase from around pH 6.0 to pH 8.0 during A. fumigatus
growth (Figure 3.10). In Vogel’s minimal medium, the pH dropped between 0 and 24 hrs
before beginning to increase. Casein and pig lung cultures exhibited a significantly higher
pH than Vogel’s minimal medium cultures between 24 and 72 hours (at least P<0.05).
Despite the culture media being buffered at pH 6.0, growth in all culture media resulted
in a gross increase in culture pH to neutral pH and above.
Figure 3.10: Effect of A. fumigatus growth on culture supernatant pH in Vogel’s minimal
medium, casein medium and pig lung medium. Cultures were grown for 72 hours at 37
°C and pH was measured at 0,12, 24, 36, 48 and 72 hours. *** P<0.001, ** P<0.01,
* P<0.05 vs. Vogel’s minimal medium. Data represents mean ± SEM (n=3 biological
replicates).
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3.3.4 Effect of different media on secretion of proteases by A. fumi-
gatus
To investigate the effect of different media on the secretion of proteases by A. fumiga-
tus, protease activity in culture supernatants was measured between 0 and 72 hours post-
inoculation, using resorufin labeled casein. In this assay cleavage of resorufin linked
casein by proteases resulted in an increase in absorption at 574 nm. Protease activity was
measured by increased in absorption at 574 nm against an un-inoculated medium control
over an hour. Protease assay of blank medium that had not been inoculated with A. fumi-
gatus did not show any protease activity (Data not shown). It was therefore assumed that
any protease activity detected in the culture supernatants was due to secretion of proteases
by A. fumigatus.
Comparing overall protease activity, it was found that protease activity was higher
in pig lung cultures at all time points than in casein cultures (Figure 3.11). Protease
activity was not observed in Vogel’s culture supernatants at any time point. In pig lung
culture supernatants, protease activity was first detected at 12 hours, and increased rapidly
between 12 and 24 hours, before plateauing between 36 and 48 hours, followed by a
decline between 48 and 72 hours. In casein culture supernatants, protease activity was
first observed at 36 hours, peaked at 48 hours and declined between 48 and 72 hours.
These data suggested that pig lung medium was a more potent inducer of protease activity
than casein medium. Maximal protease activity was observed at 48 hours in both casein
and pig lung culture supernatants, suggesting that this was the optimum time to harvest
culture supernatants for a more thorough analysis of the differences in protease secretion
and protease activity observed in these cultures.
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Figure 3.11: Effect of A. fumigatus growth on protease activity in culture supernatants of
Vogel’s minimal medium, casein medium and pig lung medium cultures. Cultures were
grown for 72 hours at 37 °C and protease activity was measured at 0,12, 24, 36, 48 and 72
hours. Protease activity was measured from equal volumes of culture supernatant using
a universal protease assay. * P<0.05 vs. Vogel’s minimal medium. # P<0.05 vs. casein
medium. Data represents mean ± SEM (n=3 biological replicates).
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3.4 Characterisation ofA. fumigatus culture supernatants
In order to further analyse the proteases secreted in A. fumigatus cultures, proteins were
isolated from A. fumigatus grown in Vogel’s minimal medium, casein medium, and pig
lung medium for 48 hours at 37 °C. To obtain culture supernatant extracts containing se-
creted proteins, fungal biomass was removed by filtration, the remaining supernatant filter
sterilised, dialysed against dH2O using 10 kDa M.W.C.O membrane to remove excess salt
and low weight mycotoxins, and freeze dried. Preparation of supernatants in this way al-
lowed for the direct use of extract preparations in subsequent in vitro studies. Following
preparation of supernatants, they were analysed for differences in protein secretion profile
and protease activity.
3.4.1 Analysis of protein expression profiles in A. fumigatus culture
supernatants
The secreted protein expression profiles in culture supernatants from Vogel’s minimal
medium, casein medium and pig lung medium cultures of A. fumigatus were analysed by
SDS-PAGE (Figure 3.12). Both casein and pig lung media contained complex proteins.
However, these were not expected to be visualised as discrete bands in SDS-PAGE, as
much of the protein was insoluble, and any protein that was solublised was expected to
be degraded, either during preparation by autoclaving or by A. fumigatus proteases. The
smearing observed in the lane containing pig lung culture supernatant was suggested to
be due to degraded pig lung matrix proteins. Comparing the culture supernatants from A.
fumigatus grown in different media, few proteins of the same molecular weight appeared
across all three culture supernatants, suggesting different patterns of protein expression
in different media. Comparing staining intensity of the bands in each lane it was possible
to conclude that A. fumigatus grown in Vogel’s medium and casein medium resulted in
greater levels of protein secretion than when cultured in pig lung medium. This was
expected given the greater quantities of dry biomass present in these cultures at 48 hours.
Total protein was assayed in each culture supernatant, and casein supernatants were
found to contain the most protein followed by pig lung medium supernatants, with the
lowest in Vogel’s minimal medium supernatants (685.9 vs. 163.4 vs. 49.5 µg mL-1). The
presence of substrate proteins from the growth medium remaining in the supernatants
was expected to effect the accuracy of these result for casein and pig lung cultures. It
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was not possible to normalise data using protein amounts from media that had not been
inoculated with A. fumigatus because media proteins were initially insoluble in the growth
media, but will have been degraded over time by A. fumigatus. However Vogel’s minimal
medium contains no complex proteins, therefore all assayed protein was expected to be
from secreted A. fumigatus proteins.
Gelatin gel zymography was used to investigate the protease expression profiles of
supernatants from A. fumigatus culture on different media (Figure 3.13). Both casein and
pig lung culture supernatants appeared to contain a similar pattern of gelatin degradation
at approximately 56-175 kDa. The differences observed were in the lower molecular
weight regions of the gel. Pig lung culture supernatants contained a gelatinolytic protease
of approximately 40 kDa, that was not observed in casein culture supernatants. Casein
culture supernatants contained a protein at approximately 45 kDa that was not observed
in in pig lung culture supernatants.
Figure 3.12: SDS-PAGE of culture supernatants from cultures of A. fumigatus grown
in Vogel’s minimal medium, casein medium and pig lung medium. Lanes, A. Vogel’s
minimal medium culture supernatant, B. Casein medium culture supernatant, C. Pig lung
medium culture supernatant, M. Molecular weight standards. Equal volumes of 20x con-
centrated culture supernatant were loaded to the gel. Proteins were visualised by silver
staining.
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Figure 3.13: Gelatin Gel Zymography of A. fumigatus culture supernatants. Gelatinolytic
activity of proteins of a specific molecular weight was measured using gelatin gel zymog-
raphy. Lanes, A. Vogel’s culture supernatant, B. Casein culture supernatant, C. Pig lung
culture supernatant, M. Molecular weight markers. Areas of clearance were visualised by
staining with comassie blue.
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3.4.2 Analysis of secreted protease activity in A. fumigatus culture
supernatants
The total amounts of protease activity in equal volumes of 48 hour A. fumigatus culture
supernatants were assayed using resorufin labeled casein. To calculate protease activity a
linear increase of absorbance at A574 was required. Therefore, supernatants were diluted
such that a linear increase in absorbance was obtained (Figure 3.14). This data was then
used to calculate A. fumigatus protease activity in culture supernatants at 48 hours (Figure
3.15 and Table 3.2). Pig lung culture supernatants were found to contain the highest levels
of protease activity, followed by casein supernatants and Vogel’s culture supernatants
(1152 vs. 6.85 vs. 0.16 mIU mL-1). The level of protease activity seen in the Vogel’s
culture supernatant was not significantly different than that of the PBS control used in
the assay, suggesting low or undetectable levels of protease activity. Taken together these
results would suggest that despite showing lower total growth in pig lung medium, the
substrate that were more relevant to the environment A. fumigatus might encounter in the
lungs, resulted in higher levels of secreted protease activity.
Protease activity was normalised against both protein amount in the culture super-
natants and dry biomass at 48 hours, to attempt to account for any differences in protease
activity due to differences in growth (Table 3.2). Normalising protease activity against
growth measured by dry biomass provided the most accurate reflection of the differ-
ences in protease activity, i.e. low and high levels of protease activity in Vogel’s and
pig lung culture supernatants respectively. Normalising the protease activity against pro-
tein amount showed an even greater difference in protease activity between casein and
pig lung culture supernatants. However, the large differences in protein amount were
suggested to be due to proteins already in the culture medium. The results suggest A. fu-
migatus culture supernatant extracts should be loaded by equal levels of protease activity
rather than equal levels of protein in future studies.
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Figure 3.14: Protease activity assay of A. fumigatus culture supernatants at 48 hours
post inoculation. Supernatants were diluted such that a linear increase in absorbance was
obtained. Culture supernatants from A. fumigatus grown in Vogel’s minimal medium
(Vogel’s-Af), casein medium (Casein-Af) were assayed undiluted. Culture supernatants
from A. fumigatus grown pig lung medium (Pig Lung-Af) were diluted by a factor of
100. Protease activity was assayed by the hydrolysis of resorufin linked casein, measured
by change in A574 at 1, 30 and 60 minutes. PBS was used as a control. Differences
in gradient were calculated using linear regression. Data represents mean ± SEM (n=3
biological replicates).
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Table 3.2: Calculation of protease activity and in A. fumigatus culture supernatants. A
single batch of culture supernatants were assayed for use in future studies. Protease activ-
ity was assayed using resorufin labelled casein and calculated. Protein concentration was
assayed using the BCA test.
Culture supernatant Vogel’s
medium
Casein
medium
Pig lung
medium
Protease Activity (mIU mL-1) 0.16 6.85 1152.77
Protein Concentration (µg mL-1) 49.5 685.9 163.4
Protease Activity (IU g-1 protein) 3.2 10.0 7054
Protease Activity (IU g-1 biomass) 38 1.7 x 103 1.03 x 106
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Figure 3.15: Protease activity of Vogel’s minimal medium (Vogel’s-Af), casein medium
(Casein-Af) and pig lung medium (Pig Lung-Af) on resorufin labeled casein were calcu-
lated from the gradients obtained in Figure 3.14. Due to the large differences in activity
statistical differences were calculated by unpaired t-test with Welche’s correction for non-
equal variances. Data represents mean ± SEM (n=3 biological replicates). *** P<0.001,
** P<0.01, * P<0.05.
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3.4.3 Classification of protease activity in A. fumigatus culture super-
natants
Specific protease inhibitors were used to determine the class of protease in pig lung and
casein culture supernatants. Supernatants were pretreated with inhibitors prior to assay-
ing protease activity using resorufin linked casein (Figure 3.16). Controls confirmed that
protease activity and A574 were not affected by the inhibitor vehicles or inhibitors, re-
spectively. Inhibitors for the major classes of protease used included, Antipain (serine
proteases), PMSF (serine proteases), Ilomastat (matrix metalloproteases), EDTA (metal-
loproteases), Pepstatin A (aspartic proteases), and E64 (cysteine proteases). Protease ac-
tivity in casein culture supernatants was not significantly inhibited by Pepstatin A or E64.
Inhibition of protease activity by PMSF resulted in a 5% reduction in protease activity
whilst inhibition by Ilomastat and EDTA resulted in 86% and 89% reductions in protease
respectively. These results suggested that matrix metalloproteases were the major class of
protease present in casein culture supernatants.
Similarly, in pig lung culture supernatants, Pepstatin A and E64 were also not found
to significantly reduce protease activity. However conversely, EDTA and Ilomastat did
not cause significant inhibition of protease activity with only a 9% increase and a 6%
decrease in protease activities, respectively, compared with control. The serine protease
inhibitors, PMSF and Antipain however, were found to inhibit the majority of protease
activity with both causing 83% reductions in protease activity. These results suggested
that serine proteases were dominant in pig lung culture supernatants. Taken together these
results suggested that A. fumigatus was capable of sensing the nitrogen sources available
in it’s environment and regulated the proteases secreted in order to utilise them.
107
Figure 3.16: Classes of protease activity present in A. fumigatus culture supernatants.
A. Casein culture supernatants and B. Pig lung culture supernatants were incubated with
PMSF, Ilomastat, EDTA, Pepstatin A, or E64, prior to assaying for protease activity. Pro-
tease activity was expressed as a percentage of an untreated control. Statistical differences
were calculated by 1 way ANOVA followed by Bonferroni post tests. *** P<0.001, **
P<0.01, * P<0.05. vs untreated control. Data represents mean ± SEM (n=3 biological
replicates).
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3.4.4 Substrate specificity of proteases in A. fumigatus culture super-
natants
Substrate specificity of proteases in A. fumigatus culture supernatants was investigated
by assaying proteolytic degradation of collagen and a synthetic elastin substrate. Degra-
dation of collagen by proteases in culture supernatants was assayed using azo-collagen
(Figure 3.17). The degradation of collagen was found to be greatest with pig lung culture
supernatants, followed by casein culture supernatants and lowest with Vogel’s culture su-
pernatants (10.01 vs. 7.59 vs. 0.17 mIU mL-1, P<0.001). Elastinolytic protease activity
was assayed using a synthetic elastin substrate (Figure 3.18). Similarly, elastase activity
was found to be the greatest in pig lung culture supernatants, followed by casein culture
supernatants and Vogel’s culture supernatants (80,000 vs 5,900 vs. 0 IU mL-1, P<0.001).
Protease activity on elastin and collagen, showed a similar pattern to that seen on the
universal resorufin labelled casein protease assay, with greater activity in pig lung culture
supernatant than casein supernatants and little observable activity in Vogel’s culture su-
pernatants. However, on collagen, casein culture supernatants demonstrated a relatively
higher activity compared to pig lung supernatants (76 % of pig lung) than on the elastase
substrate where activity was much lower (7.4 % of pig lung). This 10 fold difference in
activities of casein culture supernatants on the elastase substrate and collagen compared
with pig lung culture supernatants, along with the different classes of protease activity
observed in each culture supernatant, suggested that different proteases, rather than dif-
ferent amounts of the same proteases, were secreted by A. fumigatus in casein and pig
lung culture supernatants.
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Figure 3.17: The collagenase activity of culture supernatants of A. fumigatus grown in
Vogel’s minimal medium (Vogel’s-Af), casein medium (Casein-Af) and pig lung medium
(Pig Lung-Af) were assayed on azo-collagen. Equal volumes of concentrated supernatants
were incubated for 3 hours at 37°C with azo-collagen substrate solution. Statistical dif-
ferences were calculated by 1 way ANOVA followed by Bonferroni post tests. Data
represents mean ± SEM (n=3 technical replicates). *** P<0.001, ** P<0.01, * P<0.05.
Figure 3.18: The elastase activity of culture supernatants of A. fumigatus grown in Vo-
gel’s minimal medium (Vogel’s-Af), casein medium (Casein-Af) and pig lung medium
(Pig Lung-Af) were assayed on the general elastase substrate, N-Succinyl-Ala-Ala-Ala-
p-nitroanilide. Equal volumes of concentrated supernatants were incubated for 2 hours
at 37°C with elastase substrate. Statistical differences were calculated by 1 way ANOVA
followed by Bonferroni post tests. Data represents mean ± SEM (n=3 technical repli-
cates). *** P<0.001, ** P<0.01, * P<0.05.
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3.5 Identification of proteases secreted by A. fumigatus in
liquid culture
As previously demonstrated, each supernatant contained a complex mix of secreted A.
fumigatus proteins (Figure 3.12). In order to identify the proteases responsible for the
different types of protease activity observed in casein and pig lung culture supernatants,
proteolytically active proteins were isolated by size exclusion chromatography, separated
by SDS-PAGE, then identified by liquid chromatography/mass spectrometry (LC-MS).
3.5.1 Isolation of proteolytically active proteases in A. fumigatus cul-
ture supernatants
To reduce the number of protease candidates for identification by mass spectrometry, su-
pernatants were concentrated, separated using size exclusion chromatography and then
fractions were tested for protease activity. In both casein and pig lung culture super-
natants protein was detected by A280 in fractions 7 to 27, however protease activity was
only detected in fractions 17 and 18 in casein culture supernatants (Figure 3.19) and frac-
tions 17-20 in pig lung culture supernatants (Figure 3.20). Fractions containing protease
activity were further concentrated and then analysed by SDS-PAGE. In casein culture su-
pernatants, 11 proteins were identified as possible proteases in fractions 17 and 18 (Figure
3.21). Proteins A to F were present in both fractions, whilst proteins G to K were only
found to be present in fraction 18. In pig lung culture supernatants, a total of 8 proteins
were identified as possible proteases. Proteins L, M and O were only observed in fraction
17, whilst protein N was only present in fractions 17 and 18. Proteins Q, R and S were
only present in fractions 18 and 19. Protein P was present in all fractions and was the
most likely protease candidate.
Comparing proteolytically active fractions from casein and pig lung supernatants, sev-
eral proteins of the same molecular weights were found in both supernatants, including
proteins A and L (≈ 100 kDa), proteins C and M (≈ 60 kDa), proteins E and N (≈ 50
kDa), proteins F and O (≈ 42 kDa) and proteins G and P (≈ 30 kDa). These proteins
are also suggested to be likely protease candidates due to their presence in proteolytically
active culture supernatants from two different media types.
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Figure 3.19: Protein amount and protease activity in fractions of casein culture super-
natant separated by size exclusion chromatography. Protein amount was detected in each
fraction by absorbance at 280nm. Fractions were tested for protease activity on resorufin
labelled casein.
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Figure 3.20: Protein amount and protease activity in fractions of pig lung culture super-
natant separated by size exclusion chromatography. Protein amount was detected in each
fraction by absorbance at 280nm. Fractions were tested for protease activity on resorufin
labelled casein.
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Figure 3.21: SDS-PAGE of casein culture supernatant fractions from size exclusion chro-
matography. Fractions containing protease activity were concentrated and analysed by
SDS-PAGE. Molecular weight markers were in lane M. Proteins were visualised by stain-
ing with comassie blue.
Figure 3.22: SDS-PAGE of pig lung culture supernatant fractions from size exclusion
chromatography. Fractions containing protease activity were concentrated and analysed
by SDS-PAGE. Molecular weight markers were in lane M. Proteins were visualised by
staining with comassie blue.
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3.5.2 Identification of proteins in proteolytically active fractions of
A. fumigatus culture supernatants
The proteins suggested by SDS-PAGE to be likely protease candidates in the previous sec-
tion, were identified by LC-MS. The identities of the proteins analysed by mass spectrom-
etry in proteolytically active fractions from casein and pig lung culture supernatants are
shown in Tables 3.3 and 3.4 respectively. Comparing casein and pig lung active fractions,
several proteins were found to be common to both. The following proteins were all found
in each culture supernatant at similar molecular weights, β-D-glucoside glucohydrolase
(A and L ≈ 100 kDa), Mannosidase MsdS, FAD-dependent oxygenase, Oxidoreductase,
FAD-binding (C and M ≈ 60 kDa), Elastinolytic metalloproteinase (E and N ≈ 50 kDa),
Cell wall β-1,3-endoglucanase (F and O ≈ 42 kDa) and Alkaline serine protease (G and
P ≈ 30 kDa). Some proteins were also found only in one culture supernatant. Most no-
table of these was aminopeptidase Y (B to D ≈ 75 to 55 kDa), which was only found in
casein culture supernatants. In casein culture supernatants, three major proteases along
with their degradation products were identified; Aminopeptidase Y (Lap1), Elastinolytic
metalloproteinase (Mep/Asp f 5), and Alkaline serine protease 1 (Alp1/Asp f 13). In pig
lung culture supernatants, only two proteases were identified, Elastinolytic metallopro-
teinase, and Alkaline serine protease 1. Investigation of the uncharacterised proteins A-D
using bioinformatic tools such as Pfam and InterPro, did not find any domains conferring
protease activity within the protein sequences.
All of the proteases identified were either found in a band with a different molecular
weight to those suggested by bioinformatic analysis, or in several bands at a number of
different molecular weights. For example, in pig lung fractions, Asp f 13 was shown to
have a molecular weight of 30 kDa, whilst database information suggested the molecular
weight should be 42 kDa. Bioinformatic analysis was performed on these proteins to iden-
tify their functional domains and any pro-peptide domains. The predicted protein domain
functions suggested by InterPro of Lap1, Asp f 5 and Asp f 13 are shown in table 3.5. This
data suggested that Lap1 was a metalloprotease with O-Glycosyl hydrolase activity. No
pro-peptide domains were identified, although the presence of multiple forms of Lap1 in
casein culture supernatants would suggest that some processing of the protein may occur.
Asp f 5 was suggested to be a metalloprotease with a cleavable pro-peptide or chaperone
domain. The molecular weight of the full Asp f 5 protein was 69 kDa, whilst the pro-
tein observed in the culture supernatants was approximately 50 kDa. The differences in
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size would suggest the presence of a cleavable chaperone/pro-peptide domain. Asp f 13
was suggested to be a serine protease with a cleavable pro-peptide domain, which would
explain the presence of cleavage products detected in the culture supernatants.
These results demonstrated that A. fumigatus produces Asp f 5 and Asp f 13 during
both growth on casein and pig lung medium but only produces Lap1 when grown on
casein medium. It is suggested that the serine protease activity detected in pig lung culture
is due to Asp f 13 and the metalloprotease activity observed in casein cultures is due to
Asp f 5 and Lap1. However, pig lung culture supernatants also contained Asp f 5, but
little metalloprotease activity was observed during experiments using protease inhibitors.
Similarly, Asp f 13 was present in casein culture supernatants, but little serine protease
activity was observed during inhibitor studies. It was suggested that this maybe due lower
levels or activities of these protease in the culture supernatants. In order to address these
issues, the transcriptional regulation of Asp f 5, Asp f 13 and Lap1 was investigated.
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Table 3.3: Proteins in casein culture supernatants identified by LC-MS. The number of
peptide matches for each protein is shown in the table. A confident match was considered
to be any protein with 3 or more matched peptides. Putative proteins are highlighted with
a *. Protein fragments that resulted from degradation are highlighted with a #. Proteases
are highlighted in bold. Protein molecular weights are quoted for protein translated from
the full open reading frame (ORF). Band molecular weights are approximate.
Band Band
MW
(kDa)
Peptide
Matches
Protein Name Protein
MW
(kDa)
UniProt
Ascession
Number
CADRE
Ascession
Number
A 100 18 β-D-glucoside glucohydrolase 78 Q4WGT3 AFUA 7G06140
B 75 13 Aminopeptidase Y (Lap1) (*) 54 Q5VJG5 AFUA 3G00650
C 60 14 Mannosidase MsdS 54 Q6PWQ1 AFUA 1G14560
11 FAD-dependent oxygenase (*) 55 Q4WFW0 AFUA 3G00840
4 Oxidoreductase, FAD-binding
(*)
50 Q4X072 AFUA 2G14480
11 β-D-glucoside glucohydrolase(#) 78 Q4WGT3 AFUA 7G06140
6 Aminopeptidase Y (*,#) 54 Q5VJG5 AFUA 3G00650
D 55 12 Uncharacterised protein A (*) 49 Q4W9Z5 AFUA 4G03200
5 Glucooligosaccharide oxidase(*) 51 Q4WL94 AFUA 6G14340
8 β-D-glucoside glucohydrolase(#) 78 Q4WGT3 AFUA 7G06140
5 Aminopeptidase Y (*,#) 54 Q5VJG5 AFUA 3G00650
E 50 5 Elastinolytic metalloproteinase 69 P46075 AFUA 8G07080
14 Uncharacterized protein A (*,#) 49 Q4W9Z5 AFUA 4G03200
F 42 7 Cell wall β-1,3-endoglucanase 45 Q4WG16 AFUA 3G00270
3 Class V chitinase (*) 46 A4D9F7 AFUA 3G07160
4 Uncharacterised protein B (*) 37 Q4WDY6 AFUA 5G01120
G 30 8 Alkaline serine protease 42 P28296 AFUA 4G11800
4 β-D-glucoside glucohydrolase(#) 78 Q4WGT3 AFUA 7G06140
H 28 9 Chitosanase 25 Q875I9 AFUA 4G01290
4 Uncharacterised protein C 33 Q4WV60 AFUA 5G10930
4 Alkaline serine protease (#) 42 P28296 AFUA 4G11800
I 24 4 Chitosanase (#) 25 Q875I9 AFUA 4G01290
3 Cell wall protein PhiA 19 Q4WF87 AFUA 3G03060
J 22 6 Chitosanase (#) 19 Q875I9 AFUA 4G01290
3 Cell wall protein PhiA 25 Q4WF87 AFUA 3G03060
K 19 12 Cell wall protein (*) 19 Q4WFT1 AFUA 3G01130
4 Cu/Zn Superoxide Dismutase 16 Q9Y8D9 AFUA 5G09240
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Table 3.4: Proteins in pig lung culture supernatants identified by LC-MS. The number of
peptide matches for each protein is shown in the table. A confident match was considered
to be any protein with 3 or more matched peptides. Putative proteins are highlighted with
a *. Protein fragments that resulted from degradation are highlighted with a #. Proteases
are highlighted in bold. Accession numbers are for UniProtKB. Protein molecular weights
are quoted for protein translated from the full open reading frame (ORF). Band molecular
weights are approximate.
Band Band
MW
(kDa)
Peptide
Matches
Protein Name Protein
MW
(kDa)
UniProt
Ascession
Number
CADRE
Ascession
Number
L 100 12 β-D-glucoside glucohydrolase 78 Q4WGT3 AFUA 7G06140
3 Exo-β-1,3-glucanase (*) 84 Q4WLJ9 AFUA 6G13270
M 60 14 Mannosidase MsdS 54 Q6PWQ1 AFUA 1G14560
9 FAD-dependent oxygenase (*) 55 Q4WFW0 AFUA 3G00840
4 Oxidoreductase, FAD-binding
(*)
50 Q4X072 AFUA 2G14480
N 50 10 Uncharacterised protein A (*) 49 Q4W9Z5 AFUA 4G03200
6 Class V chitinase (*) 46 A4D9F7 AFUA 3G07160
5 Elastinolytic metalloproteinase 69 P46075 AFUA 8G07080
O 42 4 Cell wall β-1,3-endoglucanase 45 Q4WG16 AFUA 3G00270
P 30 6 Alkaline serine protease 42 P28296 AFUA 4G11800
5 Uncharacterised protein D (*) 37 Q4WB08 AFUA 8G00630
Q 25 3 Alkaline serine protease (#) 42 P28296 AFUA 4G11800
R 18 8 Cell wall protein (*) 19 Q4WFT1 AFUA 3G01130
S 7 5 Alkaline serine protease (#) 42 P28296 AFUA 4G11800
5 Cell wall protein (*,# ) 19 Q4WFT1 AFUA 3G01130
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Table 3.5: Functional protein domains in Lap1, Asp f 5 and Asp f 13 identified by Inter-
Pro. Accession numbers are for InterPro.
Protein InterPro
Feature
Function
Aminopeptidase Y (Lap1) IPR001382 O-Glycosyl hydrolase activity
IPR007484 Metalloprotease activity, M28
family
IPR003137 Protease associated domain
Elastinolytic metalloprotease (Asp f 5) IPR001842 Metalloprotease activity, M36
family
IPR001570 Metalloprotease activity, M4
family
IPR011096 Propeptide domain, M4/M36
family
Alkaline serine protease 1 (Asp f 13) IPR000209 Serine protease activity
subtilisin-like, S8/53 family
IPR022398 Serine protease activity
sedolisin-like, S8/53 family
IPR015500 Subtilisin-like pro-protein
convertases, S8 family
IPR009020 Peptide proteinase inhibitor
domain
IPR010259 Peptide proteinase inhibitor
domain subtilisin-like
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3.5.3 Levels of protease mRNA in A. fumigatus during growth in dif-
ferent media
The relative level of Asp f 5, Asp f 13 and Lap1 mRNA in A. fumigatus, during growth in
casein and pig lung media at 48 hours, was investigated using quantitative PCR. Levels of
Lap1, Asp f 5 and Asp f 13 mRNA were normalised against mRNA of the housekeeping
gene β-tubulin. Base line levels of Lap1, Asp f 5 and Asp f 13 mRNA were measured
in Vogel’s cultures, in which no secreted proteases were detected, and used to compare
against expression in pig lung and casein cultures using the 2∆∆ct method. Baseline levels
of Asp f 13 were found to be higher than Asp f 5 and Lap1, however these differences
were not significant. Levels of mRNA from all genes was found to be significantly lower
than β-tubulin (P<0.05, Figure 3.23).
Comparing mRNA levels between the two culture conditions showed that levels of
Asp f 13 mRNA were significantly higher in pig lung cultures than in casein cultures
(6.861 vs 0.758, P<0.01). The results also demonstrated trends towards higher levels of
Asp f 5 mRNA in pig lung cultures than in casein cultures (3.456 vs. 0.428) and higher
expression of Lap1 in casein cultures than pig lung cultures (5.349 vs. 1.799), however
these results were not considered significant (P>0.05, Figure 3.24).
Comparing mRNA levels of genes in individual cultures, it was found that in casein
cultures Lap1 mRNA levels were significantly higher than both Asp f 5 and Asp f 13
mRNA levels (5.349 vs. 0.4284 vs. 0.7578, P<0.01, Fig 3.25A). In pig lung cultures,
Asp f 13 mRNA levels were highest followed by Asp f 5 and Lap1 (6.861 vs. 3.456 vs.
1.799), however these results were not found to be significantly different to one another
(P>0.05, Fig 3.25B). Taken together, these results suggested that the differences observed
in relative levels of protease activity may be due to the amount of protease present in the
culture supernatant due to differences in mRNA levels and potentially gene expression,
rather than post translational mechanisms.
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Figure 3.23: Levels of Asp f 5, Asp f 13 and Lap1 mRNA relative to β-tubulin during
growth of A. fumigatus on Vogel’s minimal medium, was measured by QPCR at 48 hours
post inoculation. Gene expression was normalised against expression of the housekeeping
gene β-tubulin. Statistical differences were calculated by 1 way ANOVA followed by
Bonferroni post tests comparing all means. Data represents mean± SEM (n=3 biological
replicates). *** P<0.001, ** P<0.01, * P<0.05.
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Figure 3.24: QPCR of Asp f 5, Asp f 13 and Lap1 mRNA levels during growth of A.
fumigatus in casein and pig lung cultures, was measured by QPCR at 48 hours post in-
oculation. Gene expression was normalised against expression of the housekeeping gene
β-tubulin and expression of genes in Vogel’s cultures, in which no protease were de-
tected, using the 2∆∆ct method. Statistical differences were calculated by 2 way ANOVA
followed by Bonferroni post tests comparing all means. Data represents mean ± SEM
(n=3 biological replicates). *** P<0.001, ** P<0.01, * P<0.05.
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Figure 3.25: Levels of Asp f 5, Asp f 13 and Lap1 mRNA in A. fumigatus, were com-
pared by QPCR at 48 hours post inoculation, in A. Casein medium cultures and B. Pig
lung medium. Gene expression was normalised against expression of the housekeeping
gene β-tubulin and expression in Vogel’s cultures, in which no protease activity was de-
tected, using the 2∆∆ct method. Statistical differences were calculated by 1 way ANOVA
followed by Bonferroni post tests comparing all means. Data represents mean ± SEM
(n=3 biological replicates). *** P<0.001, ** P<0.01, * P<0.05.
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3.6 Discussion
The aims of this chapter were to investigate the differences in growth characteristics and
protease production by A. fumigatus during growth on a variety of complex nitrogen
sources. Growth of A. fumigatus on different substrates was found to resulted in dif-
ferent growth rates and growth morphologies, with growth on complex proteins resulting
in more diffuse growth compared with growth on a complete minimal medium. Results
from this chapter also demonstrated that in the AF293 strain of A. fumigatus, the secre-
tion of proteases was tightly controlled, with proteases only secreted in the presence of
complex proteins as a nitrogen source. Furthermore it was demonstrated that the pro-
tease secretion profile of A. fumigatus modified in response to growth on different protein
sources, with growth on casein resulting in the secretion of Asp f 5, Asp f 13 and Lap1,
whilst growth on pig lung resulted in the secretion of Asp f 5 and Asp f 13.
3.6.1 Comparison of the methods used to measureA. fumigatus growth
Measurement of A. fumigatus growth in liquid cultures by dry biomass was a time con-
suming procedure and therefore alternative methods of measuring the growth were ini-
tially investigated. Using culture turbidity to measure growth, represented a viable al-
ternative, however this method was abandoned due to the difficulties associated with re-
moving polyacrylic acid after the supernatants had been harvested. The use of total DNA
also offered a promising method for the measurement of growth. However too much
variation was observed in the DNA concentration obtained, especially at higher biomass
levels. Furthermore this method relied on the assumption that extraction efficiency of the
DNA was equal in all reactions, which may not have been the case. It also relied upon
the assumption that A. fumigatus was equally distributed throughout the culture, such that
the sample that was removed for measurement was a true representation of the rest of the
culture.
Growth of A. fumigatus in liquid Vogel’s minimal medium was found to correlate well
with growth on Vogel’s minimal agar, suggesting that the measurement of radial growth on
solid media, might provide a good method for comparing growth rates of A. fumigatus on
different media. Measurement of growth rate by radial growth on solid medium resulted
in consistent reproducible results across biological replicates, however, measurements of
A. fumigatus growth on casein and pig lung medium did not show a similar pattern of
growth to that of A. fumigatus grown in liquid medium, suggesting that the two methods
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were not comparable when the medium was modified. Measurement of radial growth on
solid medium was still suggested to be a good method for comparing growth of different
A. fumigatus strains on the same medium, for example, when investigating the effects of
allergen protease gene disruption on A. fumigatus growth and viability.
Although other methods of measuring A. fumigatus growth might have been em-
ployed, these are not without problems. Studies by Loeffler et al. and Kabir et al. used
various PCR methods to quantify amount of A. fumigatus and other fungi in both animals,
humans and the environment [85, 108]. These methods were found to be demonstrate ex-
cellent sensitivity and were useful for detecting very low levels of A. fumigatus. However
this study, the amounts of A. fumigatus use would most likely exceed the upper limits
of detection in these assays. Additionally, these methods also relied on the assumption
that extraction efficiencies were equal in all samples, which may not have been the case.
Studies by Hope et al. and Hubbard et al. used fluorescence as a measurement of growth
in strains of A. fumigatus which constitutively expressed GFP [75, 76]. However, as with
measuring growth by DNA, this method relied on the assumption that A. fumigatus is ho-
mogeneously distributed throughout the culture, so that the sample taken is representative
of the whole culture. Studies by Joubert et al. demonstrated the use of laser nephelometry
to measure A. fumigatus growth [84]. This method would be useful for microplate assays
but not suitable for the large cultures used in this study and may have suffered from inter-
ference due to the presence of insoluble particles in casein and pig lung cultures. It was
possible to conclude that real time, accurate quantitative measurement of A. fumigatus
growth rate in liquid medium was difficult and that the measurement of growth by dry
biomass represented the best way of measuring growth in liquid A. fumigatus cultures.
Measurement of growth by dry biomass was for be used for normalising levels of pro-
tease activity detected in culture supernatants and has been used previously by Bergmann
et al. to normalise protease activity in culture supernatants from different strains of A.
fumigatus [23].
3.6.2 The effect of culture medium on A. fumigatus growth charac-
teristics
Growth of A. fumigatus on different media was measured using both dry biomass and
radial growth on solid medium. In liquid medium, growth rate was found to be highest
in casein medium, followed by Vogel’s medium, then pig lung medium, when measured
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by dry biomass. However on solid medium growth on pig lung was found to be fastest,
followed by casein then Vogel’s medium. The reversal in growth rate patterns may be
accounted for by considering the different growth morphologies of A. fumigatus on the
various media. The growth morphologies observed were similar in solid and liquid media
for a given type of medium. It was speculated that the differences in growth morphology
from different media may have been due to the availability of nutrients. It is suggested that
when nutrients were readily available, A. fumigatus formed high density cultures with fre-
quently branched hyphae to maximise the use of the available nutrients. However when
nutrients were less accessible, A. fumigatus formed diffuse colonies with low levels of
branching and long hyphae in order to search for more readily available carbon and nitro-
gen sources. This was exemplified by observing growth on Vogel’s and pig lung media.
Vogel’s medium contained glucose and ammonium nitrate as carbon and nitrogen sources
that were directly absorbed without any digestion. When A. fumigatus was cultured on
Vogel’s medium dense colonies were formed. However pig lung medium contained com-
plex proteins as both the carbon and nitrogen source, which required digestion and were
not immediately available. When grown on pig lung, A. fumigatus formed diffuse colonies
with low levels of branching and long hyphae.
The effect of culture media on supernatant pH was also measured during growth of A.
fumigatus in liquid medium. The results from this study showed that in all of the growth
media in which protease were secreted, the pH increased from ≈ pH 6 to ≈ pH 8 over 72
hours. Previous studies by Moutaouakil et al. demonstrated that growth in Sabouraud’s
liquid medium resulted in culture supernatants that were acidic, causing the degradation
of alkaline proteases, whilst growth in 0.2 % collagen resulted in neutral pH culture super-
natants in which alkaline proteases were intact [122]. Studies by Sriranganadane showed
that, at neutral pH, A. fumigatus was secretes alkaline serine protease (Alp1), a met-
alloprotease (Mep), leucine aminopeptidases (Lap1 and Lap2) and a X-prolylpeptidase
(DppIV) [163]. These results agreed with those from this study where active Asp f 5, Asp
f 13 and Lap1 were detected in culture supernatants.
3.6.3 The effects of culture medium on protein and protease secretion
in A. fumigatus
The results from this chapter demonstrate a clear dependance on substrate type for the se-
cretion of proteases. Protease activity was found to vary in both quantity and class in dif-
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ferent cultures. It was possible to observe a significantly higher level of protease activity
in pig lung culture supernatants followed by casein and Vogel’s minimal medium culture
supernatants. Weak protease activity was observed in Vogel’s culture supernatants, where
nitrogen was easily assimilated from soluble ammonium nitrate. These results implied
that protease secretion was dependent on the availability of nitrogen in the environment.
This agrees with the previous findings of both Gifford et al. and Bergmann et al. re-
spectively, which, using A. fumigatus strains ATCC 13073 and ATCC 46645, showed that
the presence of primary nitrogen source, such as ammonia, suppressed protease secretion
by A. fumigatus [23, 58]. Substrate specificity of the culture supernatants was assayed
using elastin and collagen degradation assays. Both casein culture supernatants and pig
lung culture supernatants were found to contain elastase and collagenase activity. Previ-
ous studies by Monod et al. and Frosco et al. showed the presence of both collagenase
and elastase activity in proteolytically active A. fumigatus culture supernatants grown on
insoluble elastin or collagen [53, 119].
Measurement of temporal secretion of proteases by A. fumigatus revealed that growth
in pig lung medium resulted in a more rapid secretion of proteases into the culture super-
natant in comparison to casein cultures, which could not be accounted for by differences
in growth, as casein cultures of A. fumigatus demonstrated greater growth than pig lung
cultures. It was also observed, that the class of protease dominant in the culture super-
natant, was dependent on the culture substrate used. In pig lung culture supernatants
serine protease activity was dominant whilst in casein culture supernatants MMP activity
was dominant. Identification of proteins in proteolytically active fractions of A. fumiga-
tus culture supernatants by LC-MS, revealed that the MMP Asp f 5 and the serine pro-
tease Asp f 13 were present in pig lung cultures, whilst Asp f 5, Asp f 13 and the MMP
aminopeptidase Y (Lap1), were present in casein cultures. However when investigating
the effect of pH on protease production Sriranganadane et al. showed the production of
a much wider range of proteases [163]. The method used to identify proteases in this
paper was restrictive, in the sense that it only identified proteases capable of cleaving the
casein substrate used in the protease assays. Other proteases such as AfuS28 and the Dp-
pIV are not capable of cleaving casein and therefore were not detected in this study. The
mass spectrometry method used by Sriranganadane et al. identified all proteins present in
the culture supernatants without the need to first identify proteolytically active fractions
and allowed for some quantification of the amount of protease present. This method may
give a more complete indication of protease production in culture supernatants, however
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it would not have indicated weather or not proteases were active as shown by our method,
or if the molecular weights of the mature proteases varied. A combination of the methods
used in both papers would provide a more complete picture of protease secretion profiles
in A. fumigatus.
Previous studies by Kolattukudy et al. demonstrated the production of Asp f 13 by A.
fumigatus during growth on insoluble material from bovine and murine lung [94]. Growth
of A. fumigatus on elastin and collagen by Frosco et al. and Monod et al., respectively,
was also shown to cause the production of Asp f 13 [53, 119]. The secretion of Asp
f 5 by A. fumigatus during growth on collagen was also demonstrated by Monod et al.
in a later study [117]. Whilst Asp f 5 was shown to be present in pig lung cultures by
mass spectrometry, very little MMP activity was detected during inhibitor studies. A
similar effect was observed with Asp f 13 in casein cultures. The secretion of Asp f 5,
Asp f 13 and Lap1 during growth on casein cultures was demonstrated previously by
Riazanskaia et al., however the relative activities of the individual proteases were not
investigated [143]. Assaying the protease activity of different culture supernatants using
both collagen and elastin degradation assays revealed that elastase activity was relatively
much lower than collagenase activity in casein culture supernatants compared with pig
lung culture supernatants. Studies by Monod et al. had demonstrated that disruption
of Asp f 13 resulted in reduced elastase activity, but not collagenase activity in culture
supernatants from A. fumigatus grown on collagen [117]. Along with the inhibitor studies,
where low levels of serine protease activity were detected, these results suggested that the
Asp f 13 present in casein culture supernatants may be at a lower level than Lap1 and Asp
f 5 or inactivated.
The production of different proteases by A. fumigatus on different protein substrates,
has not been previously well documented. Results from this study demonstrated a clear
difference in the protease secreted by A. fumigatus on two different protease only media,
and demonstrated that this resulted in different classes of protease activity dominating
overall culture supernatant activity in different cultures. These results suggest that A.
fumigatus is able to detect the presence of different protein sources in its environment,
and adjust the secretion of proteases accordingly.
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3.6.4 Regulation of protease secretion in A. fumigatus cultures
Results in the previous section demonstrated that growth of A. fumigatus resulted in dif-
ferences in the secretion of proteases into culture supernatants. The results also suggested
that in casein and pig lung culture supernatants, Asp f 13 and Asp f 5, respectively, were
found to be present by mass spectrometry, but were not found to be active during in-
hibitor studies. The presence of protease without activity suggests that proteases were
either, secreted in different amounts in the supernatant, not activated following secretion,
or inactivated or inhibited in the supernatant.
Regulation of the production of protease by A. fumigatus may have been due to dif-
ferences in transcription of the protease genes. In the current study, levels of allergen
protease mRNA were measured by QPCR, giving an indication of the levels of gene tran-
scription. However post transcriptional and post translational events may have resulted in
different levels of protein secretion. Measurement of the baseline levels of Asp f 5 and
Asp f 13 mRNA indicated that expression of these genes was significantly lower than the
housekeeping gene β-tubulin. This matched the results of Fraczek et al. where levels of
Asp f 5 and Asp f 13 mRNA were also found to be considerably lower than β-tubulin [52].
The current study also demonstrated that Asp f 5 and Asp f 13 were mRNA levels were
up-regulated in pig lung cultures compared with casein cultures. The results also showed
that Asp f 13 was up-regulated compared to Asp f 5 and Lap1 in pig lung cultures, whilst
Lap1 was up-regulated compared with Asp f 5 and Asp f 13 in casein cultures. Taken
together with the data for protease activity in culture supernatants, results from this study
suggested that the levels of Asp f 5, Asp f 13 and Lap1 found in culture supernatants may
have been regulated at the transcriptional level. Possible mechanisms for the secretion
and regulation of protease activity within A. fumigatus culture supernatants have been
proposed. Studies by Bergmann et al. showed that several proteases, including Asp f 5
and Asp f 13 were regulated by the transcription factor prtT [23]. Results from this study
also suggested that Asp f 5 and Asp 13 were co-regulated by the same transcription factor,
but a novel result suggests that Lap1 was regulated by a separate transcription factor, as
levels of Lap1 expression in casein cultures appeared to be increased relative to Asp f 5
and Asp f 13.
It is also possible that transcription may have not resulted in translation, and there-
fore measurement of Asp f 5, Asp f 13 and Lap1 levels in the culture supernatants would
confirm the results shown by quantitative PCR. If antibodies against these proteases were
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available, then protein levels in culture supernatants could have been assayed by western
blot or ELISA. Given the presence of of pro-peptide domains present in both Asp f 5 and
Asp f 13 it is also possible that proteases may have been secreted into the culture super-
natant but not activated. However in both cases the proteins present in the supernatants
had a much lower molecular weights than those of the full translation of the ORF of
the protein, which implied post-translational modifications involving cleavage of the pro-
peptide/chaperone domain had already occurred. Alternatively proteins may have been
inactivated post-translation due to cleavage by other proteases in the cell cytoplasm, dur-
ing secretion or in the culture supernatant. In casein and pig lung culture supernatants, the
fragmentation patterns of Asp f 13 were slightly different. Both supernatants contained a
30 kDa Asp f 13 protein fragment, however in casein culture supernatants only a 28 kDa
fragment was present, whilst pig lung culture supernatants contained 25 kDa and 7 kDa
fragments. It may be possible that differential cleavage or degradation of the Asp f 13 30
kDa fragment resulted in active and inactive forms of the protease. Finally A. fumigatus
has been shown to secrete the elastase inhibitor AFUEI (AFUB 034300), which was re-
cently shown to strongly inhibit A. fumigatus elastinolytic activity [181]. This inhibitor
may be secreted by A. fumigatus under certain growth conditions and bind selectively to
Asp f 13 resulting in inhibition.
Taken together, these observations show that A. fumigatus is capable of secreting dif-
ferent proteases depending on the available protein sources, and suggest a novel mech-
anism by which these proteins are detected and secretion of the appropriate proteases is
controlled at the transcriptional or post transcriptional level.
3.6.5 Conclusions
From this chapter it is possible to make several conclusions on the effect of culture sub-
strate and environment on A. fumigatus. Different culture substrates caused differences in
culture morphology, growth rate and total of A. fumigatus on both solid medium and in
liquid medium. Different growth substrates also resulted in different amounts and classes
of protease activity dominating different culture supernatants. These results suggested a
mechanism by which A. fumigatus was able to sense the type of substrate available as
a nitrogen source in its environment, and regulate the type of enzymes required to de-
grade the substrates either on the transcriptional level. Future work in this area would
involve investigating the mechanisms surrounding the control of Lap1 transcription and
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the mechanisms that control the suppression of proteases in the presence of a primary
nitrogen sources. In order to investigate the effects of Asp f 5 and Asp f 13 on strain
viability, strains in which Asp f 5 and Asp f 13 have been disrupted will be investigated.
Recombinant Asp f 5 and Asp f 13 will also be produced in a yeast expression system so
that the individual properties of Asp f 5 and Asp f 13 can be studied.
130
Chapter 4
The effects of Asp f 5 and Asp f 13 gene
disruption in A. fumigatus
4.1 Introduction
The previous chapter explored the secretion of proteases into culture supernatants when
A. fumigatus was grown in different culture media. Different protease secretion profiles
were observed depending on the medium used for A. fumigatus culture, with some pro-
teases being secreted but found to be inactive. The suppression of protease secretion in A.
fumigatus has been studied previously either by disruption of individual genes, or by sets
of genes via the disruption of a common transcription factor.
Monod et al. and Jaton-Ogay et al. studied the effect of disrupting Asp f 5 (Mep)
and Asp f 13 (Alp1) genes on protease activity in a collagen based culture [81, 117].
Disruption of Asp f 5 was found to result in culture supernatants dominated by serine
proteases whilst disruption of Asp f 13 was found to result in supernatants dominated by
serine protease activity. Disruption of proteases, both individually and together did not
show any effect on virulence in a mouse model of invasive aspergillosis.
Bergmann et al. and Sharon et al. investigated the suppression of a set of pro-
tease genes in A. fumigatus, including Alp, Mep, DppIV, CpdS, AFUA 2G17330, and
AFUA 7G06220, by disruption of the transcription factor prtT [23, 155]. Both of these
studies demonstrated that this group of proteases were essential for for growth on media
containing only complex protein but were dispensable for virulence in a mouse model of
invasive aspergillosis.
In this chapter, it was hypothesised that disruption of the Asp f 5 and Asp f 13 genes
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may result in changes in both the class of protease activity, and relative activities of pro-
teases present in a culture supernatants. Therefore, the aim of the chapter was to investi-
gate the relative contributions of Asp f 5 and Asp f 13 to the protease activity observed in
culture supernatants from Vogel’s, casein and pig lung culture supernatants using strains
of A. fumigatus in which Asp f 5 or Asp f 13 gene had been disrupted.
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4.2 Validation of gene disruption in A1160pyrg+, Af5∆
and Af13∆ strains
In order to understand the role of different proteases in different A. fumigatus culture
supernatants, strains of A. fumigatus in which protease genes had been disrupted were ob-
tained as a kind gift from Mike Bromley and Marcin Fraczek (University of Manchester).
Two separate gene disruptions of Asp f 5 (Af5∆ strain) and Asp f 13 (Af13∆ strain) had
been performed in the host strain A1160pyrg+. A third strain in which Aminopeptidase
Y had being disrupted was being developed but was not available in time for this study.
The disruption of Asp f 5 and Asp f 13 in A1160pyrg+ was validated previously by
both PCR analysis and Southern Blotting as part of the gene disruption protocol. In order
to check that the strains provided were uncontaminated and did not contain the deleted
gene in either locus, strains were checked again for gene disruption using PCR against
specific sections of the gene (Figure 4.1 A). Genomic DNA from A1160pyrg+ wild type,
Af5∆ and Af13∆ strains was probed for Asp f 5 and Asp f 13 DNA by PCR, using gene
specific primers for Asp f 5 and Asp f 13 (Figure 4.1 B). When probed using primers
against a 613 bp fragment of Asp f 5, DNA from A1160pyrg+ and Af13∆ strains resulted
in a band approximately 500-600 bp in size. In reactions containing genomic DNA from
the Af5∆ strain (lane 2), two PCR products were observed at approximately 200 bp and
600 bp, however, these products resulted in bands that were much less intense than in
lanes 1 and 3 and it is suggested that these bands were the result of either non-specific
priming or primer dimers in the absence of the appropriate template sequence rather than
failed gene deletion or contamination. Similar bands of the same molecular weights were
observed in lane 3 (Asp f 13 primers), again suggesting the formation of primer dimers
or non-specific priming in the absence of the appropriate template sequence. Therefor
it was expected that the Asp f 5 gene had been successfully disrupted by the inserted
hygromycin resistance cassette in the Af5∆ strain. When DNA from A1160pyrg+ and
Af5∆ strains was probed with primers against a 457 bp fragment of Asp f 13, bands were
observed were approximately 450 bp in size. No PCR products were observed at 457bp
bp in reactions containing genomic DNA from the Af13∆ strain, suggesting that the gene
had been successfully disrupted by the inserted hygromycin resistance cassette.
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Figure 4.1: Validation of gene disruption strains by PCR. A. Schematic of Asp f 5 and
Asp f 13 gene loci showing primer binding locations for primers, Asp f 5 SPF 3 (1), Asp
f 5 SPR 3 (2), Asp f 13 SPF 1 (3) and Asp f 13 SPR 2 (4). B. Strains of A1160 pyrg+ A.
fumigatus in which the Asp f 5 and Asp f 13 genes had been disrupted, were analysed by
PCR. Genomic DNA from A1160pyrg+ (1), Af5∆ (2) and Af13∆ (3) strains was probed
for Asp f 5 and Asp f 13 DNA by PCR, using gene specific primers for Asp f 5 and Asp
f 13. The resulting products were visualised by agarose gel electrophoresis on 2% gel.
Hyperladder IV was used as a ladder (M).
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4.3 Growth characteristics of A1160pyrg+, Af5∆ andAf13∆
strains
4.3.1 Growth morphology of gene disruption strains on solid and liq-
uid media
On solid media, no differences were observed in growth morphology of A1160pyrg+,
Af5∆ and Af13∆ strains of A. fumigatus when grown on the same substrate (Figure 4.2).
However, growth on different substrates resulted in different morphologies. Colonies
grown on Vogel’s medium were dense and had well defined boundaries, whilst those
grown on Casein and Pig Lung medium formed diffuse colonies with poorly defined
edges. These patterns were similar to those observed in the AF293 strain of A. fumi-
gatus and gene disruption of Asp f 5 and Asp f 13 appeared to have little effect on growth
morphology.
In liquid medium, diffuse growth was observed in all cultures, however, disruption
of Asp f 5 in Vogel’s minimal medium appeared to cause more clumping of the organ-
ism (Figure 4.3). In casein and pig lung media, disruption of Asp f 13 resulted in a
lighter colour of the growth medium after 48 hours compared with Af5∆ strain and parent
A1160pyrg+ strain. Considering both growth on solid and liquid medium, it was possible
to conclude that disruption of Asp f 5 and Asp f 13 did not have a significant impact on
growth morphology of A. fumigatus.
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Figure 4.2: Growth morphologies of A1160pyrg+, Af5∆ and Af13∆ strains grown on solid
media. A1160pyrg+, Af5∆ and Af13∆ strains were grown on Vogel’s minimal medium
agar, casein medium agar or pig lung medium agar for 96 hrs and photographed.
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Figure 4.3: Growth morphologies of A1160pyrg+, Af5∆ and Af13∆ strains grown in liq-
uid media. A1160pyrg+, Af5∆ and Af13∆ strains were grown in Vogel’s minimal medium,
casein medium or pig lung medium for 48 hrs and photographed.
137
4.3.2 Growth characteristics of the A1160pyrg+ strain of A. fumiga-
tus
In order to check that the growth characteristics of A1160pyrg+ mirrored those of AF293
used in previous experiments, the radial growth rate of strains was measured on solid
agar plates containing Vogel’s, pig lung and casein media (Figure 4.4 and Table 4.1).
As with AF293, growth rate was found to be greatest on pig lung followed by casein
then Vogel’s minimal medium. Analysis of the growth rate of A1160pyrg+ by linear
regression shows that the growth rates on Vogel’s minimal medium, casein and pig Lung
were significantly different from one another (P<0.001). Furthermore total growth on
pig lung and casein was found to be significantly greater than on Vogel’s medium at all
time points after 0 hours. Comparison of AF293 and A1160pyrg+ showed that there was
no significant difference in growth rate when grown on Vogel’s minimal medium (Table
4.1). However significant differences in growth rate were observed between AF293 and
A1160pyrg+ when grown on both casein and pig lung media. A1160pyrg+ was found to
grow significantly faster on both casein and pig lung medium than AF293 (P<0.001 and
P<0.01 respectively, Table 4.1).
Growth of A1160pyrg+ was also measured during growth in liquid media by dry
biomass (Figure 4.5). Growth on Vogel’s minimal medium and casein medium, resulted
in a short lag phase between 0-12 hours, followed by exponential growth between 12 and
24 hours, plateau between 12 and 36 hours and decline between 36 and 72 hours. Total
growth on pig lung was lower than in Vogel’s and casein cultures, but still demonstrated
a small increase between 12-24 hours followed by a plateau between 12 and 36 hours
and decline between 36 and 72 hours. Comparing the growth of A1160pyrg+ on differ-
ent types of media, results showed that growth was fastest on Vogel’s minimal medium
followed by casein and then pig lung medium. This was not the same pattern as observed
in cultures of AF293, where growth was fastest on casein medium, followed by Vogel’s
minimal medium and pig lung medium.
As well as showing different growth rates on different media types, the A1160pyrg+
strain of A. fumigatus also showed different growth rates in liquid medium compared
with AF293 (Figure 4.6). In Vogel’s minimal medium, both AF293 and A1160pyrg+
demonstrated the same length of lag time, around 12 hours, whilst in casein and pig
lung media, the lag time of A1160pyrg+ was shorter compared with AF293 (12 hours
vs 24 hours). In all media types maximal biomass levels were achieved earlier by the
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A1160pyrg+ compared with AF293. In cultures of AF293, maximal biomass levels were
observed at 36 hours whilst in cultures of A1160pyrg+ maximum growth occurred at 24
hours. Maximal biomass levels were however, not any higher in A1160pyrg+ compared
with AF293. Taken together all of these results suggested that growth rate is increased
in the A1160pyrg+ strain compared with the AF293 strain of A. fumigatus and culture
lag time is reduced significantly in A1160pyrg+ compared with AF293 when cultured on
casein and pig lung media but not Vogel’s medium.
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Figure 4.4: Growth rate of A1160pyrg+ on solid medium. Solid agar medium containing
either Vogel’s minimal medium, pig lung medium or casein medium was inoculated with
1x103 spores and incubated at 37°C for 96 hours. Growth in mm was measured every 24
hours. Statistical differences were calculated using linear regression and 2 way ANOVA
with Bonferroni post tests.* P<0.05, ** P<0.01. *** P<0.001 vs. Vogel’s minimal
medium. Data represent mean ± SEM (n=3 biological replicates).
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Table 4.1: Comparison of growth ares of wild type A1160pyrg+ and AF293 on solid agar
medium containing either Vogel’s minimal medium, pig lung medium or casein medium.
Radial growth was measured and the growth rate in mm/hour calculated using linear re-
gression. Statistical differences were calculated using linear regression. * P<0.05, **
P<0.01. *** P<0.001 AF293 vs. A1160pyrg+. Data represent mean ± SEM (n=3 bio-
logical replicates).
Strain Vogel’s Medium Casein Medium Pig Lung Medium
AF293 0.1792 ± 0.007 0.2583 ± 0.009 0.3306 ± 0.014
A1160pyrg+ 0.1778 ± 0.007 0.3292 ± 0.016 0.4153 ± 0.019
P>0.05 (ns) P< 0.001 (***) P<0.01 (**)
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Figure 4.5: Growth of the A1160pyrg+ strain of A. fumigatus in liquid culture. Liquid
cultures containing either Vogel’s minimal medium, pig lung medium or casein medium
were inoculated with 1x106 cfu ml-1 of A1160pyrg+ and incubated at 37°C for 72 hours.
Growth was measured by dry biomass at 0, 12, 24, 36, 48 and 72 hours post inoculation.
Data represents mean ± SEM (n=2 biological replicates)
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Figure 4.6: Growth of the AF293 strain of A. fumigatus in liquid culture. Liquid cultures
containing either Vogel’s minimal medium, pig lung medium or casein medium were
inoculated with 1x106 cfu ml-1 of AF293 and incubated at 37°C for 72 hours. Growth
was measured by dry biomass at 0, 12, 24, 36, 48 and 72 hours post inoculation. Data
represents mean ± SEM (n=3 biological replicates). Figure reproduced from results in
chapter 3.
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4.3.3 The effect of gene disruption on growth in Af5∆ and Af13∆
strains of A. fumigatus
In order to test the effect of gene disruption on growth of A. fumigatus, radial growth
of A1160pyrg+, Af5∆ and Af13∆ strains of A. fumigatus was measured on solid agar
plates containing Vogel’s, pig lung and casein media (Figures 4.7, 4.8 and 4.9). Analysis
by linear regression failed to show any significant differences in growth rate between
the A1160pyrg+, Af5∆ and Af13∆ strains on any of the different types of media (Table
4.2). Analysis by two way ANOVA showed some significant differences in growth at late
time points. On Vogel’s medium significantly greater growth was observed in Af5∆ and
Af13∆ strains than in the A1160pyrg+ strain (P<0.05) at 96 hours. Similar patterns were
observed on casein medium with significantly higher growth at 96 hours in the Af5∆ strain
(P<0.001) and significantly higher growth at 72 (P<0.01) and 96 (P<0.001) hours in the
Af13∆ strain. On pig lung medium growth of Af13∆ strains was found to be lower at 96
hours than the A1160pyrg+ strain (P<0.05). These results suggested that gene disruption
of Asp f 5 and Asp f 13 did not cause any significant reduction in growth rate that could
be measured on solid media.
Measurement of growth of A1160pyrg+, Af5∆ and Af13∆ in liquid media demon-
strated that there were no significant differences in growth rate or pattern of A1160pyrg+,
Af5∆ or Af13∆ on Vogel’s, casein and pig lung media (Figures 4.10, 4.11 and 4.12). Whilst
not significant, a difference in growth rate was observed when A1160pyrg+, Af5∆ or
Af13∆ were grown in casein medium with disruption of Asp f 5 or Asp f 13, resulting in
a trend towards increased growth in Af5∆ and Af13∆ strains respectively, compared with
the A1160pyrg+ strain at 24 hours. These results would suggest that any differences ob-
served in protein amount or protease activity in A1160pyrg+, Af5∆ and Af13∆ are due to
differences in the amount of protein production rather than growth.
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Figure 4.7: Growth rate of A1160pyrg+, Af5∆ and Af13∆ on solid Vogel’s minimal
medium. Vogel’s minimal medium agar was inoculated with 1x103 spores/ml from either
A1160pyrg+, Af5∆ and Af13∆ and incubated at 37°C for 96 hours. Growth in mm was
measured every 24 hours. Statistical differences between WT and KO strains were cal-
culated using linear regression and 2 way ANOVA with Bonferroni post tests. * P<0.05,
** P<0.01. *** P<0.001 vs. A1160pyrg+ strain. Data represents mean ± SEM (n=3
biological replicates).
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Figure 4.8: Growth rate of A1160pyrg+, Af5∆ and Af13∆ on solid casein minimal
medium. Casein medium agar was inoculated with 1x103 spores from either A1160pyrg+,
Af5∆ and Af13∆ and incubated at 37°C for 96 hours. Growth in mm was measured every
24 hours. Statistical differences between WT and KO strains were calculated using lin-
ear regression and 2 way ANOVA with Bonferroni post tests.* P<0.05, ** P<0.01. ***
P<0.001 vs. A1160pyrg+ strain. Data represents mean ± SEM (n=3 biological repli-
cates).
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Figure 4.9: Growth rate of A1160pyrg+, Af5∆ and Af13∆ on solid pig lung mini-
mal medium. Pig lung medium agar was inoculated with 1x103 spores from either
A1160pyrg+, Af5∆ and Af13∆ and incubated at 37°C for 96 hours. Growth in mm was
measured every 24 hours. Statistical differences between WT and KO strains were cal-
culated using linear regression and 2 way ANOVA with Bonferroni post tests.* P<0.05,
** P<0.01. *** P<0.001 vs. A1160pyrg+ strain. Data represents mean ± SEM (n=3
biological replicates).
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Table 4.2: Comparison of growth rates A1160pyrg+, Af5∆ and Af13∆ on solid media.
A1160pyrg+, Af5∆ and Af13∆ strains were grown on solid agar medium containing ei-
ther Vogel’s minimal medium, pig lung medium or casein medium. Radial growth was
measured and the growth rate in mm/hour calculated using linear regression. Statistical
differences were calculated using linear regression. Data represents mean ± SEM (n=3
biological replicates).
Strain Vogel’s Medium Casein Medium Pig Lung
Medium
A1160pyrg+ 0.1778 ± 0.007 0.3292 ± 0.016 0.4153 ± 0.019
Af5∆ 0.1931 ± 0.008 0.3514 ± 0.018 0.4125 ± 0.018
Af13∆ 0.1917 ± 0.008 0.3569 ± 0.017 0.3958 ± 0.016
P=0.2881 (ns) P=0.485 (ns) P=0.7069 (ns)
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Figure 4.10: Growth rate of A1160pyrg+, Af5∆ and Af13∆ in Vogel’s minimal medium.
Vogel’s minimal medium was inoculated with 1x106 cfu ml-1 of A1160pyrg+, Af5∆ or
Af13∆ A. fumigatus and incubated at 37°C for 72 hours. Growth was measured by dry
biomass at 0, 12, 24, 36, 48 and 72 hours post inoculation. Data represents mean ± SEM
(n=2 biological replicates).
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Figure 4.11: Growth rate of A1160pyrg+, Af5∆ and Af13∆ in casein medium. Casein
medium was inoculated with 1x106 cfu ml-1 of A1160pyrg+, Af5∆ or Af13∆ A. fumigatus
and incubated at 37°C for 72 hours. Growth was measured by dry biomass at 0, 12,
24, 36, 48 and 72 hours post inoculation.Data represents mean ± SEM (n=2 biological
replicates).
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Figure 4.12: Growth rate of A1160pyrg+, Af5∆ and Af13∆ in pig lung medium. Pig lung
medium was inoculated with 1x106 cfu ml-1 of A1160pyrg+, Af5∆ or Af13∆ A. fumigatus
and incubated at 37°C for 72 hours. Growth was measured by dry biomass at 0, 12,
24, 36, 48 and 72 hours post inoculation. Data represents mean ± SEM (n=2 biological
replicates).
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4.4 Characterisation of A1160pyrg+, Af5∆ andAf13∆ cul-
ture supernatants
It was expected that gene disruption of Asp f 5 and Asp f13 would alter the protease
expression profile of A. fumigatus, and the impact of gene disruption on both overall
protein and protease expression was investigated. Proteases were prepared for analysis
as in the chapter 3. Briefly, fungal biomass was removed by filtration, and the remaining
supernatant filter sterilised, dialysed against dH2O using 10 kDa M.W.C.O membrane
to remove excess salt and low weight mycotoxins, and then freeze dried. This allowed
for the direct comparison between protease secretion by AF293, A1160pyrg+, Af5∆ and
Af13∆ strains of A. fumigatus.
4.4.1 Protein expression in culture supernatants
Differences in protein expression between AF293 and A1160pyrg+ on Vogel’s minimal
medium, casein medium and pig lung medium, were examined. Differences in culture
supernatant protein were assayed using the BCA test (Table 4.3). As described in chap-
ter 3, the measurement of total protein in culture supernatants from casein and pig lung
cultures, cannot be easily used to determine differences in A. fumigatus protein secretion
between different media, due to the presence of substrate proteins in the growth me-
dia. However, in Vogel’s medium, there were no complex proteins present in the growth
medium, and therefore, all of the protein detected should be due to proteins secreted by
A. fumigatus. Comparing protein secretion between different strains of A. fumigatus in
Vogel’s medium, showed that protein secretion in the A1160pyrg+strain was higher than
in AF293, and Af5∆ and Af13∆ both produced more protein than A1160pyrg+.
Gene disruption of Asp f 5 also produced a noticeable increase in protein amount
in the supernatants of Af5∆ strains in both casein and pig lung cultures compared with
A1160pyrg+ and Af13∆ strains. This suggests that disruption of Asp f 5, either increases
overall protease production by A. fumigatus, although similar proportional increases were
not observed in Vogel’s medium, or that Asp f 5 is required for degradation of substrate
proteins, and without its presence, substrate proteins are solublised but not completely
digested. Statistical significance could not be attributed to these results as protein amounts
were only measured in one set of biological replicates.
Culture supernatants were concentrated by freeze drying, and the proteins from equal
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volumes of culture supernatant were separated according to size by SDS-PAGE (Figures
4.13, 4.14 and 4.15). Similar levels of protein were observed in AF293 and A1160pyrg+,
for Vogel’s minimal medium. However, in casein and pig lung media the intensity of
protein staining was lower in AF293 than A1160pyrg+, suggesting that the A1160pyrg+
strain might exhibit increased protein secretion in this media compared with AF293. The
protein expression patterns between AF293 and A1160pyrg+ were found to be different
in all three types of medium. In Vogel’s medium, protein expression in the 46 to 175 kDa
range appeared similar, with bands duplicated at approximately 58 kDa and 120 kDa.
However in the 7 to 30 kDa range, protein expression was less similar, with a protein
approximately 28 kDa in size observed in AF293 but not A1160pyrg+ and a protein at
approximately 33kDa in A1160pyrg+ but not in AF293. In casein medium, the protein
expression profiles were closer to one another, with bands of equivalent molecular weights
observed for AF293 and A1160pyrg+. However there were some notable differences, in
AF293, a protein greater than 175kDa was expressed which was not seen in A1160pyrg+
along with a protein at approximately 28 kDa. In A1160pyrg+ supernatant the protein
at approximately 120 kDa stained with a much higher intensity than in AF293. In pig
lung medium, the protein expression profile was similar between 7 and 30kDa, however
at molecular weights higher than 30kDa there were differences. Most noticeable amongst
these, was the protein observed at greater than 175kDa in AF293 but not A1160pyrg+ and
the differences in the 58 to 175 kDa range.
The effect of gene disruption on protein expression between A1160pyrg+, Af5∆ and
Af13∆ was observed on similar growth media (Figures 4.13, 4.14 and 4.15). In Vogel’s
minimal medium, almost identical protein expression profiles were observed between
A1160pyrg+ and Af5∆ strains, with significantly different protein expression in the Af13∆
strain. In casein medium, similar protein expression profiles were observed in all three
strains, however, notably in the Af5∆ strain the non-specific protein smear is more dense.
Taken together with the data for protein content in the media, where the Af5∆ strain su-
pernatant showed more protein than both the A1160pyrg+ and Af13∆ strains, this would
suggest that Asp f 5 had a key role in protein degradation. In pig lung medium, simi-
lar to Vogel’s medium, protein expression in A1160pyrg+ and Af5∆ strains was nearly
identical, whilst disruption of Asp f 13 appeared to cause a change in protein expression.
This might suggest that, Asp f 13 effected the expression or processing of other proteins
in A1160pyrg+ or that other proteins were produced to compensate for the disruption of
Asp f 13.
148
Table 4.3: Comparison of protein amount in A1160pyrg+, Af5∆ and Af13∆ strain culture
supernatants. Supernatants were assayed using the BCA test (n=1 biological replicate).
Strain Vogel’s Medium Casein Medium Pig Lung Medium
(µg mL-1) (µg mL-1) (µg mL-1)
AF293 49.5 685.9 163.4
A1160pyrg+ 94.1 694.0 276.4
Af5∆ 113.5 1218.7 335.6
Af13∆ 125.1 728.9 280.8
Figure 4.13: SDS-PAGE of culture supernatants from AF293, A1160pyrg+, Af5∆ and
Af13∆ strains grown in Vogel’s medium for 48hrs. A. AF293, B. A1160pyrg+, C. Af5∆,
D. Af13∆. Proteins were visualised using silver staining.
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Figure 4.14: SDS-PAGE of culture supernatants from AF293, A1160pyrg+, Af5∆ and
Af13∆ strains grown in casein medium for 48hrs. A. AF293, B. A1160pyrg+, C. Af5∆, D.
Af13∆. Proteins were visualised using silver staining.
Figure 4.15: SDS-PAGE of culture supernatants from AF293, A1160pyrg+, Af5∆ and
Af13∆ strains grown in pig lung medium for 48hrs. A. AF293, B. A1160pyrg+, C. Af5∆,
D. Af13∆. Proteins were visualised using silver staining.
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4.4.2 Protease activity in culture supernatants
Protease activity in culture supernatants of A1160pyrg+, Af5∆ and Af13∆ grown in Vo-
gel’s minimal medium, casein medium and pig lung medium were assayed using resorufin
labelled casein. Analysing just the data for protease activity in A1160pyrg+ supernatants,
the unexpected result was that in Vogel’s minimal medium culture supernatants protease
activity was observed (Figure 4.16 D). Previous results from AF293 culture supernatants
did not show any protease activity in Vogel’s culture supernatants. Direct comparison
between A1160pyrg+ and AF293 strains, showed that protease activity in both casein and
pig lung culture supernatants was lower in A1160pyrg+ than in AF293, although the same
general pattern was observed in AF293 and A1160pyrg+ with high protease activity in pig
lung culture supernatants than casein culture supernatants (Table 4.4).
Table 4.4: Comparison of protease activity in A1160pyrg+, and AF293 strain culture
supernatants. Supernatants were assayed using the BCA test (n=1 biological replicate).
Strain Vogel’s Medium Casein Medium Pig Lung Medium
(mIU mL-1) (mIU mL-1) (mIU mL-1)
AF293 0.2 6.9 1152.8
A1160pyrg+ 6.2 1.2 15.1
The relative contribution of proteases to the overall protease activity of a culture su-
pernatant was assessed by comparing the effects of protease gene disruption on protease
activity in culture supernatants. In Vogel’s culture supernatants, disruption of Asp f 5
(Af5∆) resulted in a 20% reduction in protease activity compared to the A1160pyrg+
strain, whilst disruption of Asp f 13 (Af13∆) resulted in an 86% reduction in protease
activity compared to the A1160pyrg+ strain (Figure 4.16 A). This would suggest that Asp
f 13 is the dominant protease present in Vogel’s culture supernatants. In casein medium,
supernatant from Af5∆ cultures contained 67% less protease activity than A1160pyrg+
supernatant, while Af13∆ supernatants contained 29% less protease activity, suggesting
both Asp f 5 and Asp f 13 contribute to the protease activity present in casein cultures
(Figure 4.16 B). In pig lung supernatants disruption of Asp f 5 and Asp f 13 individually,
resulted in a 10% increase and a 75% reduction respectively in protease activity compared
to A1160pyrg+ (Figure 4.16 C). This suggested that Asp f 13 was the dominant protease
in pig lung cultures. The increase in activity associated with Asp f 5 disruption, suggested
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that either, Asp f 5 may have inhibited the activity of other proteases, or that secretion of
other protease was increased to compensate for Asp f 5 disruption.
These results also demonstrated that even when proteases were constitutively pro-
duced in the A1160pyrg+ strain of A. fumigatus, as shown by the detection of protease
activity in Vogel’s minimal medium culture supernatants, proteases were still strongly
up-regulated in the presence of insoluble pig lung (Figure 4.16 D). Interestingly, it would
also appear that growth of A1160pyrg+ in casein medium actively reduced protease se-
cretion by A1160pyrg+ compared with growth in Vogel’s minimal medium. Given that it
would appear that Asp f 5 and Asp f 13 were the dominant secreted proteases in Vogel’s
minimal medium, it is suggested that growth in casein medium causes the suppression of
the secretion of Asp f 5 and Asp f 13. In order to fully characterise protease activity in
these cultures, protease inhibitors were used to determine the class of residual protease
activity in gene disruption culture supernatants.
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Figure 4.16: Comparison of protease activity of culture supernatants from A1160pyrg+,
Af5∆ and Af13∆ strains grown in Vogel’s minimal medium (A), casein medium (B) and
pig lung (C) medium for 48hrs. Comparison of relative levels of protease activity in
Vogel’s minimal, casein and pig lung media (D). Data represent results from a single
biological replicate.
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4.4.3 Inhibition of protease activity in culture supernatants
In order to better characterise the activity of proteases in A1160pyrg+, Af5∆ and Af13∆
culture supernatants and address the possibility of protease redundancy in A. fumiga-
tus, protease inhibitors were used to define the protease activity in A. fumigatus culture
supernatants from Vogel’s minimal medium, casein medium and pig lung medium cul-
tures. A panel of protease inhibitors were used including; Antipain (serine protease in-
hibitor), EDTA (metalloprotease inhibitor), Pepstatin A (Aspartic protease inhibitor) and
E64 (Cysteine protease inhibitor). Antipain and EDTA were the only inhibitors found
to have an effect on protease activity (Figure 4.17). Controls in which inhibitors or in-
hibitor vehicles alone were incubated with resorufin labelled casein, demonstrated that
the inhibitors had no effect on the assay (Data not shown).
The type of protease activity in Vogel’s culture supernatants from A1160pyrg+, Af5∆
and Af13∆ strains was investigated using Antipain and EDTA (Figure 4.17 panel A). In
culture supernatants from A1160pyrg+, inhibition of metalloproteases resulted in an in-
crease in protease activity (129% of control) whilst inhibition of serine proteases resulted
in an almost complete loss of protease activity (7% of control). This suggested that serine
protease activity was dominant in these cultures and that inhibition of metalloproteases
such as Asp f 5 increased protease activity. In supernatants from Af5∆ cultures, a sim-
ilar pattern was observed with EDTA causing an increase in protease activity (133% of
control) whilst inhibition of serine proteases resulted in an almost complete abrogation
of protease activity (3% of control), again suggesting that a serine protease was the main
protease in these cultures. EDTA increased protease activity in both A1160pyrg+ and
Af5∆ cultures, suggesting that EDTA might enhance the activity of serine proteases in
the culture supernatants, rather than preventing the potential inhibitory effects of metal-
loproteases such as Asp f 5. Finally in supernatants from Af13∆ cultures inhibition of
metalloproteases resulted in a total inhibition of protease activity (0% of control) whilst
inhibition of serine proteases resulted in a small reduction in protease activity (80% of
control). The results for the Af5∆ strain shows that, in the absence of Asp f 5, only serine
protease activity can be detected, and that this can be inhibited almost completely by An-
tipain. Similarly the results for theAf13∆ strain demonstrate that in the absence of Asp f
13, only metalloprotease activity can be detected and that this can be inhibited by EDTA.
Taken together these results suggest that only Asp f 5 and Asp f 13 are present in Vogel’s
culture supernatants but Asp f 13 is the dominant protease.
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Figure 4.17: Inhibition of protease activity of culture supernatants from A1160pyrg+,
Af5∆ and Af13∆ strains grown in Vogel’s minimal medium (A), casein medium (B) and
pig lung (C) medium for 48hrs. Proteases were inhibited with either Antipain or EDTA
and protease activity was compared with an uninhibited control. Data represent results
from a single biological replicate.
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The class of protease activity in casein culture supernatants was also investigated using
EDTA and Antipain (Figure 4.17 panel B). In A1160pyrg+ culture supernatants, protease
activity was partially inhibited by both Antipain and EDTA (69 % and 51% of control
respectively), suggesting that both serine and metalloproteases contribute to protease ac-
tivity in these cultures. In Af5∆ culture supernatants, the inhibition of metalloproteases
and serine proteases also resulted in a reduction in protease activity (84% and 47% of
control respectively). The presence of protease activity when when serine proteases were
inhibited in Af5∆ supernatants suggests the presence of another metalloprotease that is
not Asp f 5. Results from previous experiments suggest that this protease is Lap1. In
Af13∆ supernatants, inhibition of metalloprotease resulted in the almost total loss of pro-
tease activity (2% of control) whilst inhibition of serine protease resulted in a small loss
of protease activity (97% of control). This shows that in the absence of Asp f 13, the
protease activity in these supernatants is completely dominated by metalloproteases. This
result confirms the result shown by the inhibition of A1160pyrg+ culture supernatant with
antipain, as the levels of protease activity observed are nearly identical (A1160pyrg+ +
antipain = 0.855, Af13∆ = 0.872, Af13∆ + antipain = 0.845 mIU mL-1), suggesting that
Asp f 13 is the serine protease present in these cultures. Taken together, these results sug-
gest that both Asp f 5 and Asp f 13 contribute to protease activity in these culture super-
natants, although their precise contribution was difficult to calculate, due to the presence
of another metalloprotease, suspected to be Lap1.
Finally the classes of protease activity present in pig lung cultures were analysed using
the inhibitors EDTA and antipain. The results were similar to those demonstrated in Vo-
gel’s medium cultures. In A1160pyrg+ culture supernatants inhibition EDTA caused an
increase in protease activity (145% of control) whilst the addition of antipain caused a re-
duction in protease activity (12% of control). This suggested that serine protease activity
was dominant in these cultures and that inhibition of metalloproteases increased protease
activity. In Af5∆ culture supernatants, inhibition with EDTA also caused an increase in
protease activity (125% vs control) whilst inhibition with antipain caused a near total ab-
rogation of protease activity (3% vs control). The against suggested thats serine proteases
were the dominant in these culture supernatants. EDTA increased protease activity in
both A1160pyrg+ and Af5∆ cultures, suggesting that EDTA might enhance the activity of
serine proteases in the culture supernatants, rather than preventing the potential inhibitory
effects of Asp f 5. In the In Af13∆ culture supernatants inhibition of metalloprotease ac-
tivity, caused reduction of protease activity (17% of control) whilst inhibition of serine
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protease activity caused an increase in protease activity (138% of control). The results
for the Af5∆ strain shows that, in the absence of Asp f 5, only serine protease activity
can be detected, and that this can be inhibited almost completely by Antipain. Similarly
the results for theAf13∆ strain demonstrate that in the absence of Asp f 13, only metallo-
protease activity can be detected and that this can be inhibited by EDTA. Taken together
these results suggested that the dominant protease activity in pig lung culture supernatants
was Asp f 13 and that when Asp f 13 activity was inhibited, the residual activity was due
to Asp f 5.
The relative contributions of serine and metalloproteases in supernatants of AF293
and A1160pyrg+ cultured in casein and pig lung media were also compared (Table 4.5).
Comparing inhibition of protease activity in casein supernatants, inhibition with EDTA
resulted in a smaller decrease in protease activity in A1160pyrg+ supernatants than in
AF293 supernatants, whilst inhibition with a serine protease resulted in a larger decrease
in protease activity in A1160pyrg+ supernatants compared with AF293 supernatants. To-
gether, these results suggest that there is a serine protease present in larger quantities in
A1160pyrg+ casein culture supernatants than in AF293 culture supernatants. It is sug-
gested that this protease was Asp f 13, and was present in greater quantities due to the
reduced regulation of protease secretion in A1160pyrg+. Comparing inhibition of pro-
tease activity in pig lung culture supernatants of A1160pyrg+ and AF293, inhibition of
protease activity with EDTA was found in both cases to cause an increase in protease
activity, whilst inhibition with antipain resulted in comparable decreases in protease ac-
tivity.
Table 4.5: Comparison of protease activity in A1160pyrg+, and AF293 strain culture
supernatants during inhibition with serine and metalloprotease inhibitors. Data for AF293
was taken from chapter 3. Data for A1160pyrg+ was obtained from Figure 4.16.
Inhibitor Strain Casein Medium Pig Lung Medium
(% Control) (% Control)
EDTA AF293 11 108
A1160pyrg+ 51 145
Antipain/PMSF AF293 95 17
A1160pyrg+ 69 12
In summary, culture of the A1160pyrg+ strain of A. fumigatus in Vogel’s minimal
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medium resulted in the production of both Asp f 5 and Asp f 13, with Asp f 5 accounting
for approximately 80% of the total protease activity and Asp f 5 accounting for approxi-
mately 20% of the total protease activity, no other proteases were suggested to contribute
to protease activity. Culture of A1160pyrg+ in casein medium, resulted in the secretion
of both Asp f 5 and Asp f 13, although their precise contribution was difficult to calculate,
due to the presence of another metalloprotease, suspected to be Lap1. When A1160pyrg+
was cultured in pig lung medium, only Asp f 5 and Asp f 13 were found to be produced.
In these cultures Asp f 13 was found to be the dominant protease, with residual activity
being attributed to Asp f 5. No other proteases were suggested to contribute to protease
activity. The presence of protease activity in Vogel’s culture supernatants was unexpected,
and suggested that the mechanism regulating protease secretion may have been modified
in the A1160pyrg+ strain of A. fumigatus. The results in this section suggested that Asp
f 5 and Asp f 13 were the dominant proteases secreted by A1160pyrg+ when grown in
Vogel’s minimal medium. In the next section, the identification of proteases in culture su-
pernatants from A1160pyrg+ cultured in Vogel’s minimal medium was performed using
gel filtration chromatography and liquid chromatography-mass spectrometry.
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4.4.4 Identification of proteases responsible for constitutive protease
activity in A1160pyrg+
In order to identify the proteases secreted by A1160pyrg+ in Vogel’s minimal medium,
proteins present in the culture supernatant were separated by gel filtration chromatography
and the fractions assayed for protease activity on resorufin linked casein (Figure 4.18).
Protease activity was detected in a broad range of fractions, from 16 to 23. In an attempt to
identify proteases common to several fractions, proteins were concentrated and separated
by SDS-PAGE (Figure 4.19).
Six bands that were common to several fractions were identified as potential proteases
and selected for identification by liquid chromatography-mass spectrometry (Table 4.6).
The analysis for secreted proteases in AF293 during growth in Vogel’s minimal medium
was not performed, therefore comparisons could not be made to these cultures. However,
similar proteins were proteins identified in these culture supernatants compared with those
from AF293 casein and pig lung cultures. These included, Mannosidase MsdS, FAD-
dependent oxygenase, and Cell wall β-1,3-endoglucanase. Several proteases were also
identified, including both Elastinolytic metalloprotease (Mep/Asp f 5) and Alkaline serine
protease (Alp1/Asp f 13). Whilst Asp f 5 and Asp f 13 were detected as fragments, results
from the previous section suggested that both Asp f 5 and Asp f 13 were proteolytically
active. Lap1 was not identified by this method, supporting other data which suggested that
Lap1 secretion was regulated by a different transcription factor to Asp f 5 and Asp f 13. It
is suggested that Asp f 5 and Asp f 13 were responsible for the serine and metalloprotease
activities observed in Vogel’s minimal medium culture supernatants of A1160pyrg+, as
shown in section 4.4.2.
These results suggested that there might be some differences between strains with re-
gards to the regulation of protease secretion in A. fumigatus. The A1160pyrg+ strain used
in these experiments was derived from the CEA10 strain, which had been genetically
modified in order to make it more suitable for the disruption of genes. It was possible that
during the course of these modifications, mutations may have occurred or been inadver-
tently selected for that led to the loss of regulation of protease secretion. In the following
section, the secretion of proteases by several strains of A. fumigatus including the CEA10
strain was investigated.
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Figure 4.18: Gel filtration chromatography and protease activity in gel filtration chro-
matography fractions of supernatant from A1160pyrg+ growth in Vogel’s minimal
medium. Protein amount was detected in each fraction by absorption at 280nm. Frac-
tions were tested for protease activity on resorufin labelled casein.
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Figure 4.19: SDS-PAGE of fractions from supernatant of A1160pyrg+ growth in Vogel’s
minimal medium. Fractions were condensed using centrifugal concentrators, separated
by SDS-PAGE and visualised by comassie blue following electrophoresis.
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Table 4.6: Proteins in A1160pyrg+ culture supernatant identified by liquid
chromatography-mass spectrometry (LC-MS). The number of peptide matches for each
protein is shown in the table. A confident match was considered to be any protein with 3
or more matched peptides. Putative proteins are highlighted with a *. Protein fragments
that resulted from degradation are highlighted with a #. Proteases are highlighted in bold.
Protein molecular weights are quoted for protein translated from the full open reading
frame (ORF). Band molecular weights are approximate.
Band Band
MW
(kDa)
Peptide
Matches
Protein Name Protein
MW
(kDa)
UniProt
Ascession
Number
CADRE
Ascession
Number
A 65 22 Mannosidase MsdS 54 B0XMT4 AFUB 014090
15 FAD-dependent oxygenase (*) 55 B0XX33 AFUB 047560
B 58 5 Cell wall β-1,3-endoglucanase 45 B0XXF8 AFUB 048180
5 Glucan-1,4-α-glucosidase 67 B0XSV7 AFUB 017770
4 FAD-dependent oxygenase (*,#) 55 B0XX33 AFUB 047560
C 30 5 Cell wall β-1,3-endoglucanase
(#)
45 B0XXF8 AFUB 048180
4 Alkaline serine protease (#) 42 B0Y708 AFUB 068800
D 28 4 Cell wall β-1,3-endoglucanase 45 B0XXF8 AFUB 048180
3 Elastinolytic metalloprotease
(#)
69 B0Y9E2 AFUB 080720
3 FAD-dependent oxygenase (*,#) 55 B0XX33 AFUB 047560
5 Glucan-1,4-α-glucosidase (#) 67 B0XSV7 AFUB 017770
E 23 6 Superoxide dismutase [Cu-Zn] 16 B0Y476 AFUB 056780
F 19 3 FAD-dependent oxygenase (*,#) 55 B0XX33 AFUB 047560
6 Superoxide dismutase [Cu-Zn]
(#)
16 B0Y476 AFUB 056780
3 Elastinolytic metalloprotease
(#)
69 B0Y9E2 AFUB 080720
G 16 3 Alkaline serine protease (#) 42 B0Y708 AFUB 068800
3 Elastinolytic metalloprotease
(#)
69 B0Y9E2 AFUB 080720
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4.4.5 Protease secretion profiles of different strains of A. fumigatus
grown in Vogel’s minimal medium
It was suspected that the genetic modifications carried out in the A1160pyrg+ strain
caused dysregulation of protease production and secretion, resulting in the production
of proteases during growth in Vogel’s minimal medium, and that the parent strain CEA10
would not exhibit the same behaviour. Alternatively, it is possible that some strains of A.
fumigatus might exhibit protease secretion during growth on a primary nitrogen source
such as ammonium (as found in Vogel’s minimal medium). In order to investigate this
theory, the protease secretion profile of several strains of A. fumigatus grown in Vogel’s
minimal medium, was examined alongside CEA10, AF293 and A1160pyrg+.
Ten strains of A. fumigatus, including, AF10, AF65, AF71, AF72, AF90, AF210,
AF293, AF294, CEA10 and A1160pyrg+ were cultured in Vogel’s minimal medium for
48 hours and the protease activity in the culture supernatant measured using resorufin
labelled casein (Figure 4.20). The results showed that culture supernatants of the par-
ent strain CEA10 had similar levels of protease activity to culture supernatants from
A1160pyrg+. This confirmed that the protease activity observed in A1160pyrg+ was not
due to mutations acquired during modification for gene disruption. Secondly, the results
showed that other strains of A. fumigatus (AF90, AF210, AF65, AF10, AF294 from low-
est to highest protease activity), also produced proteases, and that the level of proteases
varied from strain to strain. In three strains (AF71, AF72 and AF293) no protease activity
was detected in the culture supernatants. These results showed that in some strains of
A. fumigatus, there was no suppression of protease secretion, in response to the presence
of a primary nitrogen source, in this case, ammonium. This suggested that the mech-
anisms governing nitrogen sensing and protease secretion had become dysregulated in
some strains of A. fumigatus.
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Figure 4.20: Comparison of protease activity in culture supernatants from A. fumigatus
strains grown in Vogel’s minimal medium. Data represent results from a single biological
replicate.
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4.5 Discussion
The aim of this chapter was to investigate the protease secretion profile of A. fumigatus in
casein and pig lung media, and specifically determine the relative contributions of Asp f
5 and Asp f 13 to overall protease activity in culture supernatants, by studying strains of
A. fumigatus in which protease genes had been disrupted. Results confirmed that Asp f 5,
Lap1 and Asp f 13 were all present and active in casein cultures whilst Asp f 13 was the
dominant protease in pig lung cultures, with only a small amount of activity contributed
by Asp f 5. Furthermore it was shown that disruption of either Asp f 5 or Asp f 13 did not
result in the up-regulation of other proteases. Disruption of protease genes was not found
to have a significant effect on A. fumigatus growth in Vogel’s minimal, casein or pig lung
medium.
The unexpected result from this chapter was the discovery of protease activity in Vo-
gel’s culture supernatants from A1160pyrg+, which was not not observed when AF293
was grown in Vogel’s minimal medium. This effect was observed in the CEA10 strain
of A. fumigatus, from which the A1160pyrg+ strain was derived, suggesting that natural
strain to strain variation in A. fumigatus resulted in dysregulation of protease secretion.
Further investigations revealed that several strains of A. fumigatus produced proteases
under conditions that were not expected to induce protease secretion. The results sug-
gested that strain variation may be important with respect to protease associated allergy
and virulence in A. fumigatus.
4.5.1 The effect of strain variation and gene disruption on A. fumi-
gatus growth
Growth of A. fumigatus strains AF293, A1160pyrg+, Af5∆, and Af13∆ was investigated
on both solid and liquid forms of Vogel’s minimal, casein and pig lung medium. Before
comparing the effects of gene disruption on growth, the effects of strain variation were
investigated between the strain of A. fumigatus used in the first chapter (AF293) and the
strain in which the gene disruptions were performed (A1160pyrg+). On solid media, the
growth rate of A1160pyrg+ was found to be higher than AF293 on both casein and pig
lung medium but not on Vogel’s minimal medium. Similarly, in liquid culture, the lag time
of A1160pyrg+ was found to be shorter than AF293 in casein and pig lung media but not
in Vogel’s minimal medium. Taken together with other results from the chapter, which
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demonstrated the constitutive production of proteases by A1160pyrg+, it is suggested
that the increased growth rate of A1160pyrg+ compared with AF293 in complex protein
media is the result of increased protease expression during the early stages of growth
providing a growth advantage compared with AF293. Differences in growth rate between
several strains of A. fumigatus have been demonstrated in previous studies by Paisley et
al., however, differences in growth rate were only investigated in one media type and the
mechanisms causing increased growth rate were not investigated [133].
Comparison of the growth rates of A1160pyrg+, Af5∆ and Af13∆ strains of A. fumi-
gatus on Vogel’s minimal, casein and pig lung media, in both solid and liquid culture
did not reveal any significant differences in growth rate associated with gene deletion. In
casein medium, deletion of Asp f 5 and Asp f 13 in the Af5∆ and Af13∆ strains demon-
strated a trend towards increased growth in these cultures, however, due to variation in
the results these trends were not considered statistically significant. Further repetition of
this experiment, allowing for more conclusive statistical analysis, may have indicated that
Asp f 5 and Asp f 13, caused retardation of growth, possible due to an interaction with
Aminopeptidase Y, the other major protease detected during growth of AF293 on casein
medium. Studies by Monod et al and Jaton-Ogay et al, investigated the effect of protease
gene disruption on protease activity in collagen culture supernatants, however the effect
of the disruption of Asp f 5 (Mep), Asp f 13 (Alp1) or both on growth rate in vitro was
not discussed.
4.5.2 The effect of protease gene disruption on protein secretion
Differences in protein secretion were analysed in terms of both the proteins secreted and
the amount of protein present in the culture supernatants. In Vogel’s minimal medium,
casein medium, and pig lung medium, gene disruption of Asp f 5 and Asp f 13 caused
changes in protein secretion. Disruption of Asp f 13 caused the largest changes in protein
expression profile, analysed by SDS-PAGE, in both Vogel’s and pig lung media. Dis-
ruption of Asp f 5 also caused a marked change in SDS-PAGE band profiles in casein
culture supernatants. Gene disruption of Asp f 5 produced a noticeable increase in pro-
tein in the supernatants of Af5∆ strains in both casein and pig lung cultures compared with
A1160pyrg+ and Af13∆ strains. This suggests that disruption of Asp f 5, either increases
overall protease production by A. fumigatus, although similar proportional increases were
not observed in Vogel’s medium, or that Asp f 5 is required for degradation of substrate
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proteins, and without its presence, substrate proteins are solublised but not completely
digested. This would suggest that Asp f 5 plays a major role in the digestion of pro-
teins for assimilation by the fungus. Disruption of Asp f 5 and Asp f 13 alone had been
performed previously by both Jaton-Ogay et al. and Monod et al., however the did not
analyse relative changes in protein expression by SDS-PAGE [81, 117].
Measurement of total protein in culture supernatants also demonstrated differences
between between the A1160pyrg+, Af5∆ and Af13∆ strains of A. fumigatus when grown
in different culture media. As discussed in chapter 3, measurement of total protein in
culture supernatants was a poor indicator of total fungal protein due to the presence of
contaminating proteins from the growth medium. However in this study differences in
total culture supernatant protein between A1160pyrg+, Af5∆ and Af13∆ strains demon-
strated the effect of protease disruption on medium protein digestion. Disruption of Asp
f 5, in both pig lung and casein cultures, resulted in higher levels of protein in culture
supernatants compared with cultures of A1160pyrg+ and Af13∆. These results supported
the suggestion that Asp f 5 is required for the effective digestion of protein in culture
media. Other studies in which Asp f 5 was disrupted have shown similar results. Monod
et al. showed that disruption of Asp f 5 led to and increase of total protein in culture su-
pernatants compared with controls (500 µg/ml vs 250 µg/ml) [81]. Bergmann et al. have
also shown that during complete suppression of the expression of a whole set of proteases
via the disruption of the prtT transcription factor gene, growth is restricted on BSA, but
not BSA with peptone compared with controls [23]. Their study showed that secreted
proteases were required for the hydrolysis of complex proteins. Whilst their results did
not demonstrate a dependance on a specific protease, these experiments could be repeated
with the gene disruption strains used in this study in order to confirm that Asp f 5 was
required for the hydrolysis of complex proteins.
4.5.3 The effect of protease gene disruption on protease secretion and
activity
The protease expression profile of the A1160pyrg+ strain of A. fumigatus on different cul-
ture media was found to be different to that of the AF293 strain of A. fumigatus demon-
strated in the previous chapter. In the A1160pyrg+ strain of A. fumigatus, protease activity
was observed in culture supernatants from Vogel’s minimal medium, casein and pig lung
cultures. This did not agree with the results from the previous chapter, where protease
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secretion was only observed when the AF293 strain of A. fumigatus was grown on casein
and pig lung media. It also disagreed with the results of previous experiments by both
Gifford et al. and Bergmann et al., which, using A. fumigatus strains ATCC 13073 and
ATCC 46645 respectively, showed that the presence of primary nitrogen source, such as
ammonium, suppressed protease secretion in A. fumigatus [23,58]. It is suggested that the
secretion of proteases by A1160pyrg+ in Vogel’s minimal medium, which contained the
primary nitrogen source, ammonium, was the result of dysregulation of the mechanisms
controlling protease secretion in A. fumigatus.
In casein and pig lung media, the expression of proteases by A1160pyrg+ was found
to follow a similar pattern to that of AF293 as described in chapter 3, with higher lev-
els of protease activity in pig lung culture supernatants than casein culture supernatants.
However, when supernatants were treated with protease inhibitors, supernatants from
A1160pyrg+ casein cultures were found to contain a higher proportion of serine pro-
tease activity. This is suggested to be the result increased constitutive secretion of Asp f
13 in the A1160pyrg+ strain, as demonstrated during growth in Vogel’s minimal medium.
Furthermore it would also appear that growth of A1160pyrg+ in casein medium actively
reduced protease secretion by A1160pyrg+ compared with growth in Vogel’s minimal
medium. Given that it would appear that Asp f 5 and Asp f 13 were the dominant se-
creted proteases in Vogel’s minimal medium, it is suggested that the presence of casein
medium causes the suppression of the secretion of Asp f 5 and Asp f 13. This supports
the results from chapter 3 which suggested that transcription of Asp f 5 and Asp f 13
was down regulated in casein cultures, whilst expression of Lap1 was up-regulated. The
transcription of Asp f 5 and Asp f 13 have been shown, by Bergmann et al. and Sharon et
al. to be regulated by the prtT transcription factor, whilst results from chapter 3 suggested
Lap1 was independently regulated [23,155]. The mechanisms involved in controlling the
transcriptional down regulation of Asp f 5 and Asp f13 and the up regulation of Lap1 in
A. fumigatus, in response to different media conditions, have not yet been described, and
may be interesting in the context of the response of A. fumigatus to available exongenous
nitrogen. Gene disruption of Lap1, alone or in combination with Asp f 5 and Asp f 13
may help further describe the mechanisms involved protease regulation by A. fumigatus
as well as the investigation of protease production by the ∆prtT strain of A. fumigatus on
different complex nitrogen sources.
The effects of the disruption of Asp f 5 and Asp f 13 genes in A1160pyrg+ on protease
activity in culture supernatants when A. fumigatus was grown on different substrates was
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also investigated. Gene disruption of Asp f 5 and Asp f 13 in Vogel’s cultures demon-
strated a 20% and 86% reduction in protease activity compared with control, which sug-
gested that protease activity was additive, with the sum of the proportions of protease
activity for Asp f 5 and Asp f 13 equalling approximately 100%. In casein culture su-
pernatants, Af5∆ and Af13∆ strains showed 67% and 29% reductions in protease activity
respectively, again suggesting that protease activity was additive. These results agreed
with studies by Jaton-Ogay et al. in which A. fumigatus grown on insoluble collagen [81].
The study demonstrated that the strain in which Asp f 5 had been disrupted, there was a
30% reduction in protease activity, whilst in the Asp f 13 gene disruption strain protease
activity was reduced by 70%. Disruption of Asp f 13 was also investigated by Monod et
al. and demonstrated similar results [117]. In pig lung cultures, however, a similar pattern
in protease activity in culture supernatants Af5∆ and Af13∆ was not observed. Disruption
of Asp f 5 and Asp f 13 respectively showed a 10% increased and a 75% decrease in
protease activity respectively. The increase in protease activity in pig lung culture super-
natants from the Af5∆ strain (10% increase vs A1160pyrg+) suggested that Asp f 5 might
have in some way repressed the production of Asp f 13, caused its inactivation or suggest
that Asp f 13 production was increased to compensate for the disruption of Asp f 5. The
possibility of protease interactions was investigated using protease inhibitors.
Inhibitor studies carried out on the supernatants generated in this study demonstrated
that in the A1160pyrg+ strain of A. fumigatus Asp f 5 and Asp f 13 were the major active
proteases secreted during growth on both Vogel’s minimal medium and Pig lung medium.
In both these experiments, the addition of EDTA to both A1160pyrg+ and Af5∆ super-
natants, resulted in an increase in protease activity, compared to an uninhibited control.
Controls in which EDTA was inhibited with the protease substrate alone did not show the
same effect. As this effect was observed in both A1160pyrg+ and Af5∆ supernatants, it
was possible to conclude that it was not a result of the inhibition of Asp f 5, which may
have been modifying the activity of Asp f 13 in some way. It was therefor suggested that
the addition of EDTA either modified the salt content or pH of the reaction buffer in a
way which made the reaction composition more suitable for Asp f 13 activity. In casein
medium presence of protease activity in Af5∆ supernatants, when serine proteases were
inhibited, suggested the presence of another metalloprotease that is not Asp f 5. Results
from chapter 3, suggested that this is most likely due to the activity of Lap1, a metallopro-
tease secreted by A. fumigatus. This result did not agree with conclusion made following
the analysis of the effect of gene disruption, which suggested that only Asp f 5 and Asp
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f 13 were responsible for protease activity in casein culture supernatants. This suggested
that there may have been interactions between Asp f 13 and Lap1 in culture supernatants
from Af5∆ strains as protease activity was lower than expected. It is suggested that Lap1
might degrade Asp f 13 causing its inactivation.
In the current study, protease activity was assayed using a universal casein substrate
based protease assay, and it is possible that proteases other than Lap1, Asp f 5 and Asp
f 13 may have been secreted but not detected by the protease assay used. Studies by
Sriranganadane et al. identified proteases by mass spectrometry from whole culture suo-
ernatants and showed that, when grown on insoluble collagen, A. fumigatus secretes an
alkaline serine protease (Alp1), a metalloprotease (Mep), leucine aminopeptidases (Lap1
and Lap2) and a X-prolylpeptidase (DppIV) [163]. However, identification of a protease
by mass spectrometry does not confirm that it is active. In the current study, during A.
fumigatus growth on pig lung medium, which was shown to produce comparable protease
activity with growth on insoluble collagen, only Asp f 5 and Asp f 13 were shown to be
secreted and active. It is suggested that for a complete analysis of secreted proteases, a
range of protease substrates should be used in combination with mass spectrometry to
identify active proteases.
4.5.4 Differences in the regulation of protease secretion in A. fumiga-
tus strains
As discussed previously, the A1160pyrg+ strain of A. fumigatus secreted proteases when
grown on Vogel’s minimal medium, which contained the primary nitrogen source am-
monium nitrate. The disagreed with the results of the previous chapter as well as other
studies by Gifford et al. and Bergmann et al. [23, 58], which showed the suppression of
protease secretion during growth in the presence of a primary nitrogen source such as
ammonium nitrate. It was preposed that the mechanism controlling protease secretion
had become dysregulated, probably due to mutations acquired during the genetic modifi-
cations carried out on A1160pyrg+ and so it was expected that the parent strain, CEA10,
would not exhibit the same properties. However this was not found to be the case and
therefore, protease secretion in the presence of a primary nitrogen source, was analysed
in 7 other strains of A. fumigatus to investigate this phenomenon further. It was found that
in 7 out of 10 of the strains investigated, including A1160pyrg+ and CEA10, secretion of
proteases was observed during growth in the presence of ammonium nitrate, as either the
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sole nitrogen source, or a supplement in pig lung medium. These results suggested that
in several strains of A. fumigatus, the mechanisms regulating the secretion of proteases
in response to environmental nitrogen availability are dysregulated. Several pathways
are known to control gene transcription and A. fumigatus development depending on the
nitrogen sources available to A. fumigatus including ammonium, nitrate and AreA reg-
ulation of the nitrate assimilation cluster [7], the SakA MAP kinase [180] and the cross
control pathway regulated by the sensor kinase CpcC [95,149], however their interactions
with the regulation of protease secretion has not been described [96].
The mechanisms by which A. fumigatus regulates protease secretion have been previ-
ously investigated. Studies by both Sharon et al. and Bergmann et al. demonstrated that
the transcription factor prtT, is involved in the up-regulation of several proteases, includ-
ing Asp f 5 and Asp f 13, in response to the absence of a primary nitrogen source [23,155].
Results from the current study showed that, Asp f 5 and Asp f 13 were secreted by
A1160pyrg+ during growth on a primary nitrogen source, suggesting the that the prtT
transcription factor may be involved in the dysregulation of protease secretion in some
strains of A. fumigatus. Results from this study also showed that several other strains of
A. fumigatus (CEA10, AF90, Af2F0, AF65, AF10, AF294) also exhibited protease secre-
tion during growth on a primary nitrogen source. However, as these proteases were not
fully identified, it is unknown if the same proteases were secreted by each strains, which
would have suggested a common mechanism. Additionally, the results from the current
study demonstrated the dysregulation of proteases at neutral pH. However as shown by
Sriranganadane et al., different subsets of proteases are produced at different pHs, there-
fore investigation of the regulation of protease production of acid pH may also demon-
strate differences in the regulation of protease secretion by different strains of A. fumiga-
tus [163].
Whilst the production of proteases by A. fumigatus during growth in the presence of
a primary nitrogen source has not previously been described, several studies have dis-
cussed differences in elastase production in different strains of A. fumigatus. Kolattukudy
et al. demonstrated that protease activity varied in A. fumigatus strains grown on an
elastin containing medium. However, because the levels of elastase activity were mea-
sured in culture supernatants from strains of A. fumigatus grown on an elastin containing
medium, it is unknown if the differences were the result of dysregulation of protease se-
cretion. Alvarez-Perez et al. also demonstrated the development of elastase activity in
A. fumigatus culture supernatants, due to the accumulation of random mutations in the J4
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strain of A. fumigatus [6]. However, the secretion of proteases was observed in a strain
of A. fumigatus, which was not capable of producing proteases when grown on elastin,
but rather acquired mutations allowing the secretion of protease in response to growth
on elastin. Whilst this study demonstrated the acquisition of elastase activity due to ge-
netic mutation, it did not describe its dysregulation as observed in this study or suggest a
mechanism by which it might occur.
Previous studies by Sharon et al., Bergmann et al., and Jaton-Ogay et al., have all
shown that disruption of both individual and clusters of proteases does not reduce viru-
lence in murine models of invasive aspergillosis [23,81,155]. However, all of these studies
used strains of A. fumigatus that did not demonstrate dysregulated protease production,
as observed in the Af90, Af210, Af65, Af10, Af294, CEA10 and A1160pyrg+ strains
of A. fumigatus in the current study. It is suggested that the dysregulation of protease
secretion, results in more rapid growth of A. fumigatus in a complex nitrogen environ-
ment, which provides an advantage during invasion, and therefore increased virulence
compared with strains in which protease production is regulated. Furthermore, it is also
suggested that increased protease secretion, may aid colonisation, resulting in increased
allergic inflammation as suggested by Porter et al. [140]. In order to demonstrate this
effect, it is suggested that protease genes or transcription factors, should be disrupted in
a strain of A. fumigatus, such as A1160pyrg+, and the virulence and allergenicity of this
strain compared to those of unmodified and reconstituted strains.
4.5.5 Conclusions
The initial aim of this chapter was to use strains of A. fumigatus in which Asp f 5 and
Asp f 13 had been disrupted, to investigate the relative contributions of Asp f 5 and Asp
f 13 to protease activity in casein and pig lung medium culture supernatants, and the
possibility of protease redundancy in A. fumigatus. Asp f 5 and Asp f 13 were both
found to contribute to the overall protease activity in culture supernatants and inhibitor
studies showed that disruption of a protease was not found to significantly increase the
production of other proteases. Inhibitor studies on culture supernatants from Af5∆ and
Af13∆ strains, also revealed that Asp f 5 and Asp f 13 were the only proteases detectable
in pig lung culture supernatants, whilst Asp f 5, Asp f13 and Aminopeptdiase Y were the
only proteases detectable in casein culture supernatants, as shown in AF293 in chapter 3.
Further research in this area, will involved identifying the mechanisms surrounding the
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coordinated regulation of Asp f 5, Asp f 13 and Lap1, as well as a more thorough analysis
of the proteins present in whole supernatants from A1160pyrg+, Af5∆ and Af13∆ strains,
using protein identification by LC-MS.
Outside of the initial aims of this chapter, several other findings were made, that were
not expected in the initial hypothesis. It was found that the A1160pyrg+ strain of A. fu-
migatus, unlike AF293 and contrary to other published studies, secreted proteases during
growth on a primary nitrogen source. Further investigation revealed that other strains of
A. fumigatus, including the parent strain of A1160pyrg+ (CEA10), also secreted proteases
in the presence of a primary nitrogen source. Comparison with data on A. fumigatus strain
virulence in a murine model of invasive aspergillosis revealed a tentative link between un
regulated protease secretion and virulence. As well as leading to the demonstration of
un regulated protease activity in several strains of A. fumigatus, the discovery of protease
secretion by A1160pyrg+ in Vogel’s minimal medium had a secondary benefit. The se-
cretion of Asp f 5 and Asp f 13, and their successful disruption in A1160pyrg+, during
growth in Vogel’s minimal medium, provided an excellent tool for investigating the ac-
tion of native Asp f 5 and Asp f 13, both separately and together in cell culture systems,
due to the lack of other proteases present in the system or contaminating media proteins.
Further work in this area will involve investigating the mechanism by which protease se-
cretion is controlled in different strains of A. fumigatus and the effect of gene disruption
on virulence in a strain of A. fumigatus where protease secretion is unregulated.
Taken together, the results from chapters 3 and 4 demonstrate that when investigat-
ing A. fumigatus protease in terms of allergy, the strain, medium and growth conditions
used in making allergen protease preparations is essential. Careful consideration of these
factors will ensure the production of a physiologically relevant allergen preparation, in
which the correct proteases are both present and active. Further more when investigating
proteases in the context of virulence, the ability of the A. fumigatus strain used to regulate
protease activity should be taken into consideration.
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Chapter 5
The cloning and expression of Asp f 5
and Asp f 13 in P. pastoris
5.1 Introduction
It was demonstrated in chapters 3 and 4 that crude culture supernatants from A. fumigatus
cultures show both serine and metalloprotease activity and that Asp f 5 and Asp f 13
are present in A. fumigatus culture supernatants. The secretion of Asp f 5 and Asp f
13, by A. fumigatus, has also been demonstrated by both Monod et al. in two separate
studies [117, 119]. Studies carried out by Borger et al. and Kauffmann et al. investigated
the effects of A. fumigatus proteases on lung epithelial cells [26, 88]. These studies used
the culture supernatant developed by Monod et al. as the source of A. fumigatus proteases.
Whilst these crude A. fumigatus protease preparations were useful for demonstrating the
general effects of A. fumigatus proteases, the presence of several proteases as well as other
allergens made it difficult to isolate the specific action of individual proteases and their
mechanisms of actions. These studies demonstrated a clear requirement for purified Asp
f 5 and Asp f 13 in the investigation of the effects of A. fumigatus allergens and protease
on airway epithelial cells. The use of purified allergens would allow for the effects of
individual or groups of protease to be investigated, as well as the reconstitution of a given
protease in supernatants from cultures of Af5∆ and Af13∆ strains of A. fumigatus.
Several attempts have been made to purify Asp f 5 and Asp f 13 from both A. fumiga-
tus culture supernatants and as recombinant proteins in E. coli. In studies by Monod et al.
Asp f 5 (MEP) was isolated from A. fumigatus different affinity and size exclusion chro-
matography methods [117]. Similarly Asp f 13 was isolated from culture supernatants by
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Monod et al., Frosco et al. and Larcher et al. using different combinations of affinity and
size exclusion chromatography methods [53, 101, 119]. The proteases isolated in these
studies were extensively characterised for protease activity, pH and temperature optima,
substrate specificity and alleregnicity. Whilst these methods all produced proteolytically
active enzymes, the purification processes involved were lengthy, and required large vol-
umes of starting material to obtain a reasonable yield of protein. Sirakova et al. described
the expression and purification of Asp f 5 in E. coli whilst the expression and purification
of Asp f 13 from E. coli was demonstrated by Moser et al. [121, 160]. However whilst
both of these studies demonstrated expression of the respective proteins, the formation
of inclusion bodies required that the proteins were purified under denaturing conditions
which resulted in the irretrievable loss of protease activity in these recombinant proteins.
Additionally prokaryotic systems do not perform post translational modifications seen
in eukaryotic cells such as glycosylation, which has been shown to be important in the
allergenicity of secreted proteins [168].
Given the problems described by previous studies with the purification of Asp f 5 and
Asp f 13, in both native and recombinant forms, the aim of this chapter was to express Asp
f 5 and Asp f 13 as recombinant proteins in the eukaryotic Pichia pastoris yeast protein
expression system. Recombinant Asp f 5 and Asp f 13 may then be characterised, com-
pared with the previously purified native enzymes and used to investigate the mechanisms
by which proteolytically active A. fumigatus allergen preparations might effect epithelial
monolayers.
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5.2 Cloning of Asp f 5 and Asp f 13 into E. coli and P.
pastoris
5.2.1 Cloning of Asp f 5 and Asp f 13 into E. coli
The EasySelect Pichia Expression Kit was used for the transformation of Asp f 5 and Asp
f 13 vector constructs into P. pastoris. The cloning procedure involved inserting a gene of
interest into an appropriate vector, followed by cloning into E. coli and then cloning into
P. pastoris. In this system, cloning directly into P. pastoris was inefficient and required
large quantities of the the vector gene construct in the reaction. Inserting the vector-gene
construct into E. coli first was therefore an important step in the cloning procedure, as it
allowed large amounts of the vector-gene construct to be produced quickly and cheaply.
Asp f 13 had previously been ligated into the pPICZαA and transformed into DH5α
E. coli by Paul Bowyer (University of Manchester). These constructs were provided as
glycerol stocks of transformed DH5α E. coli. Asp f 5 was cloned from the start of the
process by the author.
Asp f 5-pPICZαA and Asp f 13-pPICZαA vector construct plasmids extracted from
successfully transformed E. coli colonies were sequenced to confirm that Asp f 5 and Asp
f 13 had been correctly inserted into the vector without any mutations. Consensus DNA
sequences were produced from DNA sequence fragments and then translated in to protein
sequences. These were then compared with translated protein sequences available from
online databases, such as UniProt and CADRE, in order to identify possible errors.
Cloning and Sequencing of Asp f 5
RT-PCR was used to generate an Asp f 5 cDNA with MfeI and XbaI restriction sites at
either end with the native secretion signal peptide removed. The expected size of the
RT-PCR product was calculated in silico by analysing the region amplified between the
primers for Asp f 5 RT-PCR in the reference Asp f 5 transcript (AFUA 8G07080) from
the CADRE database. RT-PCR for Asp f 5 resulted in a product approximately 2 kb in
size, which correlated with the expected size of 1853 bp (Figure 5.1). Asp f 5 cDNA was
then double digested using MfeI and XbaI. The pPICZαA vector was double digested
with XbaI and EcoRI and run on the same gel as the RT-PCR product. This gave a single
major band of approximately 3.5 kb in size (Figure 5.1). The 3.5 kb band was directly
extracted from the gel to prevent the fragment removed by digestion from being ligated
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back into the vector.
Digested pPICZαA vector and Asp f 5 cDNA were then ligated. The resulting pPICZαA-
Asp f 5 cDNA vector construct was then transformed into competent DH5α E. coli. Suc-
cessfully transformed DH5α E. coli were identified using antibiotic resistance. Plasmid
DNA was extracted from successfully transformed colonies and the gene insertion vali-
dated using a PCR reaction against the AOX promotor regions of the plasmid. The AOX1
promotor sequence flanks the region into which the Asp f 5 cDNA had been inserted in the
vector. The expected size of this product was calculated in silico using the reference Asp
f 5 sequence from CADRE, and pPICZαA sequence from Invitrogen. The PCR products
were analysed by gel electrophoresis (Figure 5.2). Lane B shows several bands, however
the most intense band is approximately 2.5 kb in length. This band matched the size of
the AOX PCR product predicted by bioinformatics for Asp f 5. The predicted size was
2379 bp. This suggested that the Asp f 5 cDNA had been successfully inserted into the
vector in this colony.
Plasmid DNA was extracted from liquid cultures of the successfully transformed
colony and the inserted Asp f 5 cDNA sequenced. ClustalW was used to perform an align-
ment of the translated recombinant Asp f 5 (rAsp f 5) protein sequence and the reference
Asp f 5 protein isoforms from UniProt (Figure 5.3). Several differences were expected
between the sequences. The rAsp f 5 had the native secretion signal at its N-terminus
replaced by a P. pastoris secretion signal whilst the UniProt Asp f 5 sequences have the
native A. fumigatus secretion signal. The rAsp f 5 also had c-myc and poly histidine tags
added at its C-terminus. However there were also unexpected changes in the sequence.
By comparing the three sequences it was shown that the sequence of the recombinant
Asp f 5 protein agrees with both of the isofroms except for positions 158 and 628. These
mutations were considered either conservative (T628A) or semi-conservative (V158A). It
is unknown if the substitution was a result of errors during the RT-PCR reaction or due to
natural variation in the AF293 strain.
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Figure 5.1: Production of Asp f 5 cDNA by RT-PCR. A. Schematic showing the Asp f
5 gene (AFUA 8G07080) and the location of primer binding sites. Primer 1 = Asp-f5-F,
Primer 2 = Asp-f5-R, SS = Native secretion signal sequence. B. Agarose gel electrophore-
sis showing the insertion of Asp f 5 cDNA into the pPICZαA vector. Lanes, A. pPICZαA
digested with EcoRI and XbaI, B. Asp f 5 RT-PCR product, M. Molecular weight stan-
dards.
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Figure 5.2: Selection of successfully transformed E. coli colonies by AOX PCR. A.
Schematic showing section of pPICZαA vector amplified by PCR both with and with-
out insertion of Asp f 5 cDNA. Primer 1 = AOX 5’, Primer 2 = AOX 3’. B. Agarose
gel electrophoresis demonstrating cloning of Asp f 5 into DH5α E. coli. Lanes, A-C.
PCR products from an AOX1 primed PCR reaction carried out on DNA extracted from
successfully transformed DH5α E. Coli, M. Molecular weight standards.
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Figure 5.3: A ClustalW alignment of the recombinant Asp f 5 translated protein sequence
cloned into P. pastoris and the two published Asp f 5 isoform protein sequences from
UniProt (BOY9E2 and P46075). ‘*’ indicates that the sequences are identical, ‘:’ denotes
a conservative substitution and ‘.’ shows that a substitution is semi-conservative. Blue
highlights the native Asp f 5 secretion signal. Red highlights the P. pastoris secretion
signal and green shows the additional c-myc and his tags added to the recombinant Asp f
5 in P. pastoris.
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Cloning and Sequencing of Asp f 13
DH5α glycerol stocks containing the Asp f 13-pPICZαA construct and pPICZαA alone
were used to inoculate liquid LB medium containing Zeocin. The cultures were grown for
24 hrs and the plasmid DNA extracted. To check that the correct cDNAs were present in
the plasmids the extracted plasmid DNA was used as a template in a PCR reaction using
AOX1 primers (Figure 5.4). A single band at 1.6 kb was observed for Asp f 13. This band
matched the size of AOX PCR product predicted by bioinformatics for Asp f 13 (1683
bp). This confirmed that the stock E. coli contained pPICZαA plasmid transformed with
Asp f 13.
Plasmid DNA was extracted from liquid cultures of the successfully transformed
colony and the inserted Asp f 13 cDNA sequenced. ClustalW was used to perform an
alignment of the translated recombinant Asp f 13 protein sequence from the plasmid
DNA provided by Paul Bowyer and the reference Asp f 13 protein sequence (P28296)
from UniProt (data not shown). It was noted that an expected region of similarity between
the reference protein sequence and the recombinant protein sequence was not present. A
further ClustalW alignment was performed, including the sequenced recombinant Asp f
13 (sr Asp f 13), the published Asp f 13 reference sequence (P28296) and the theoreti-
cal sequence of recombinant Asp f 13 (tr Asp f 13) predicted by bioinformatic analysis
(Figure 5.5). This alignment revealed that the final 21 bases of the recombinant protein
sequence did not match the regions of expected similarity in the theoretical and native
protein, suggesting the presence of a mutation in the plasmid DNA sequence.
In order to determine the nature of the mutation a ClustalW alignment of the se-
quenced Asp f 13 plasmid DNA sequence and the theoretical Asp f 13 plasmid DNA
sequence was performed (Figure 5.6). This alignment revealed two individual base pair
deletions at 1422 bp and 1429 bp on the sequenced Asp f 13 plasmid DNA sequence
compared with the theoretical Asp f 13 plasmid DNA sequence. It was noted that these
deletions occurred in the primer binding region of the antisense primer, which was used to
generate the cDNA for insertion into the pPICZαA vector. The sequence of the original
primer used for the RT-PCR reaction was analysed. It was found that the mutations were
introduced due to missing base pairs in the primer sequence. A new primer was designed
and the cloning process repeated from the start. Differences in the primer sequences are
shown in table 5.1.
RT-PCR was used to generate a new Asp f 13 cDNA with EcoRI and XbaI restriction
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sites at either end and the native secretion signal peptide removed. RT-PCR for Asp f 13
resulted in a product approximately 1.2 kb in size, which correlated with the expected size
of 1167 bp (Figure 5.7). Asp f 13 cDNA was gel extracted and and double digested with
EcoRI and XbaI, then purified using a PCR purification kit. cDNA was then ligated into
the pPICZαA vector and transformed into E. coli. Antibiotic resistance was used to select
four successfully transformed colonies. Plasmid DNA was extracted and successful in-
sertion of the pPICZαA-Asp f 13 cDNA vector construct analysed by PCR using primers
against AOX1 (Figure 5.8). The expected size of Asp f 13 including the AOX flanking
region is 1683 kb. All four reactions showed a band at approximately 1.6 kb suggesting
Asp f 13 cDNA had been successfully cloned into E. coli.
Following the second cloning of the Asp f 13 gene, plasmid DNA was extracted and
sequenced. A ClustalW alignment was performed of the new translated recombinant
Asp f 13 (sr Aspf13n) protein sequence, the reference Asp f 13 protein from UniProt
(P28296) and the theoretical sequence of recombinant Asp f 13 (tr Asp f 13) (Figure 5.9).
The alignment shoeed that Asp f 13 had been successfully cloned into E. coli without
the frameshift mutations obserbed in previous cloning attempts. The sr Aspf13n pro-
tein sequence exactly matched the translated protein sequence predicted by bioinformatic
analysis (tr Aspf13). It also matched the reference protein sequence in the expected re-
gions of similarity, where changes in the protein sequence had not been introduced as part
of the cloning process.
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Figure 5.4: Confirmation of successfully transformed E. coli colonies by AOX PCR. A.
Schematic showing section of pPICZαA vector amplified by PCR both with and without
insertion of Asp f 13 cDNA. Primer 1 = AOX 5’, Primer 2 = AOX 3’. B. Agarose gel
electrophoresis showing the presence of Asp f 13 cDNA in plasmid DNA extracted from
DH5α E. coli expanded from glycerol stocks. Lanes, A. Products from a PCR reaction
against the AOX1 promotor region in pPICZαA, B. Products from a PCR reaction against
the AOX1 promotor region in Asp f 13-pPICZαA, M. Molecular weight standards.
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Figure 5.5: A ClustalW alignment of the recombinant Asp f 13 translated protein
sequence cloned into P. pastoris (sr Aspf13), the theoretical recombinant Asp f 13
(tr Aspf13) and the published Asp f 13 protein sequence from UniProt (P28296). ‘*’
indicates that the sequences are identical, ‘:’ denotes a conservative substitution and ‘.’
shows that a substitution is semi-conservative. Blue highlights the native Asp f 13 secre-
tion signal. Red highlights the P. pastoris secretion signal and green shows the additional
c-myc and his tags added to the recombinant Asp f 13 in P. pastoris. Orange shows
highlights the the region of sequence resulting from a frameshift mutation.
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Figure 5.6: A section of a ClustalW alignment of the recombinant Asp f 13 plasmid
DNA sequence cloned into (sAspf13) and the theoretical recombinant Asp f 13 (tAspf13)
plasmid DNA sequence. ‘*’ indicates that the sequences are identical.
Table 5.1: Antisense primers used to generate Asp f 13 cDNA. Asp-f13-R1 was the
original primer used and does not contain the missing bases. Asp-f-13-R2 is the new
primer which contains the missing A and T bases.
Primer Sequence
Asp-f13-R1 5‘-TATCTAGAGGAGCATTGCCATTGTAGGCAGCTTGTGGGGC-3‘
Asp-f13-R2 5‘-TATCTAGAGGAGCATTGCCATTGTAGGCAAGCTTGTTGGGGC-3‘
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Figure 5.7: Production of Asp f 13 cDNA by RT-PCR. A. Schematic showing the Asp
f 13 gene (AFUA 4G11800) and the location of primer binding sites. Primer 1 = Asp-
f13-F, Primer 2 = Asp-f13-R2, SS = Native secretion signal sequence. B. Agarose gel
electrophoresis showing RT-PCR products for Asp f 13 using corrected primers. Lanes,
A. Asp f 13 RT-PCR product, M. Molecular weight standards.
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Figure 5.8: Confirmation of successfully transformed E. coli colonies by AOX PCR. A.
Schematic showing section of pPICZαA vector amplified by PCR both with and without
insertion of Asp f 13 cDNA. Primer 1 = AOX 5’, Primer 2 = AOX 3’. B. Agarose gel
electrophoresis results for AOX PCR of plasmid DNA extracted from E. coli transformed
with Asp f 13. Lanes, A-D. PCR products from an AOX1 primed PCR reaction carried
out on DNA extracted from successfully transformed DH5α E. Coli, M. Molecular weight
standards.
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Figure 5.9: A ClustalW alignment of the recombinant Asp f 13 translated protein
sequence cloned into P. pastoris (sr Aspf13n), the theoretical recombinant Asp f 13
(tr Aspf13) and the published Asp f 13 protein sequence from UniProt (P28296). ‘*’
indicates that the sequences are identical, ‘:’ denotes a conservative substitution and ‘.’
shows that a substitution is semi-conservative. Blue highlights the native Asp f 13 secre-
tion signal. Red highlights the P. pastoris secretion signal and green shows the additional
c-myc and his tags added to the recombinant Asp f 13 in P. pastoris.
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5.2.2 Cloning of Asp f 5 and Asp f 13 into P. pastoris
Large quantities of plasmid DNA extracted was extracted from successfully transformed
E. coli colonies by MaxiPrep. The Asp f 5 and 13 pPICZαA-cDNA vector constructs
were then linearised with the restriction enzyme PmeI and subsequently transformed into
P. pastoris GS115. A control strain of P. pastoris GS115 was also created by performing
a transformation with pPICZαA vector alone.
Successfully transformed colonies were selected for by antibiotic resistance. Genomic
DNA was extracted and gene insertion was validated using a PCR reaction against the
AOX1 promotor sequence (Figures 5.10 and 5.11). In all colonies a single band approx-
imately 2 kb in size was found. This band represented the native AOX1 gene (2.2 kb)
suggesting that during transformation only one cross over event had occurred. This phe-
notype, described as Mut+, was preferable as the strains grow efficiently on a methanol
carbon source due to the presence of the AOX1 gene product. Three colonies were suc-
cessfully transformed with pPICZαA vector and showed a second band at approximately
600 bp (Figure 5.10). This represents the α-signal factor, MCS, c-myc and 6-His tags, all
of which lie between the AOX1 promotor sites in the pPICZαA vector (Figure 2.1, Mate-
rials and Methods). Three three distinct bands at approximately 2.5 kb were also seen in
colonies transformed with Asp f 5. This indicated that 3 colonies had been successfully
transformed with recombinant Asp f 5 cDNA (Figure 5.10). Similar results were also
seen for Asp f 13. All three colonies were successfully transformed with recombinant
cDNA. A band of 1.6 kb was seen in colonies transformed with Asp f 13 (Figure 5.11).
The predicted sizes were 1683 kb for Asp f 13. This confirmed that the colonies contained
pPICZαA plasmid transformed with Asp f 13.
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Figure 5.10: Confirmation of successfully transformed P. pastoris colonies by AOX PCR.
A. Schematic of P. pastoris AOX 1 gene locus transformed with or without pPICZαA or
the pPICZαA Asp f 5 cDNA construct. B. Products from PCR reactions against the
AOX promotor for P. pastoris GS115 colonies transformed with pPICZαA vector alone
or Asp f 5. Each lane represents a different successfully transformed colony. Lanes, A-C.
Colonies transformed with pPICZαA alone, D-F. Colonies transformed with pPICZαA-
Asp f 5 vector construct, M. Molecular weight standards.
189
Figure 5.11: Confirmation of successfully transformed P. pastoris colonies by AOX PCR.
A. Schematic of P. pastoris AOX 1 gene locus transformed with or without pPICZαA or
the pPICZαA Asp f 5 cDNA construct. B. Products from PCR reactions against the
AOX1 promotor for P. pastoris GS115 colonies transformed with pPICZαA vector alone
or Asp f 13. Each lane represents a different transformed colony. Lanes, A. Colonies
transformed with pPICZαA alone, B-D. Colonies transformed with pPICZαA-Asp f 13
vector construct, M. Molecular weight standards.
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5.3 Expression and purification of Asp f 5 and Asp f 13
from P. pastoris
5.3.1 Expression of Asp f 5 and Asp f 13 from P. pastoris
P. pastoris colonies that were successfully transformed with Asp f 5 and Asp f 13 were
analysed for levels of protein expression and secretion. Protease expression did not sig-
nificantly affect growth compared to wild type (Figure 5.12). The supernatant was har-
vested, concentrated and analysed by SDS-PAGE and Western blotting against the c-myc
tag. In the colonies transformed with Asp f 5, the supernatant from all three transformed
colonies contained a protein approximately 46 kDa in size that was not seen in the control
strains transformed with the pPICZαA vector alone (Figure 5.13). The supernatant from
the colony in lane F, was found to be the most efficient at expressing and secreting Asp
f 5 and was selected for use in further experiments. In colonies transformed with Asp f
13 a unique band, not observed in the control strain, was seen at approximately 30 kDa.
Equal amounts of protein were observed in supernatants from all three colonies (Figure
5.14). Colony A was selected for use in further expression experiments. Western blots
against the c-myc tag were carried out to confirm that the novel bands seen under analysis
by SDS-PAGE were recombinant proteins (Figures 5.15 and 5.16).
Culture supernatants were tested for protease activity before proceeding with opti-
misation of expression and purification. Supernatants were assayed for protease activity
on the universal protease substrate, resorufin-labelled casein (Figure 5.17). Supernatants
from cultures of P. pastoris transformed with pPICZα vector alone were found to contain
no detectable protease activity on resorufin-labelled casein. Culture supernatant from cul-
tures containing P. pastoris transformed with Asp f 5 and Asp f 13 were found to contain
protease activity. This suggested that secreted recombinant Asp f 5 and Asp f 13 were
proteolytically active. Analysis of the type of protease activity present in culture super-
natants using the inhibitors PMSF and EDTA confirmed that metalloprotease activity was
present in culture supernatants containing Asp f 5 and serine protease activity was present
in culture supernatants containing Asp f 13 (Figure 5.18).
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Figure 5.12: P. pastoris GS115 pPICZαA, Asp f 5 and Asp f 13 strain growth in BMMY
over 120 hrs. Growth was measured by OD600. Statistical differences were calculated by
linear regression (n=2 biological replicates).
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Figure 5.13: SDS-PAGE of culture supernatants from P. pastoris colonies transformed
with pPICZα and Asp f 5. Lanes, A-C. Colonies transformed with pPICZαA alone, D-
F. Colonies transformed with pPICZαA-Asp f 5 vector construct, M. Molecular weight
standards.
Figure 5.14: SDS-PAGE of culture supernatants from P. pastoris colonies transformed
with pPICZα and Asp f 13. Lanes, A. Colony transformed with pPICZαA alone, B-D.
Colonies transformed with pPICZαA-Asp f 13 vector construct, M. Molecular weight
standards.
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Figure 5.15: Western Blot against c-myc in culture supernatants from P. pastoris colonies
transformed with pPICZα, Asp f 5 and Asp f 15. Lanes, A-C. Colonies transformed with
pPICZαA alone, D-F. Colonies transformed with pPICZαA-Asp f 5 vector construct, M.
Molecular weight standards.
Figure 5.16: Western Blot against c-myc in culture supernatants from P. pastoris colonies
transformed with pPICZα and Asp f 13. Lanes, A. Colony transformed with pPICZαA
alone, B-D. Colonies transformed with pPICZαA-Asp f 13 vector construct, M. Molecu-
lar weight standards.
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Figure 5.17: Change in absorbance in resorufin linked casein cleaved due to protease
assay in culture supernatants from P. pastoris colonies transformed with pPICZα, Asp f
5 and Asp 13. Data represents technical replicates mean ± SEM (n=3).
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Figure 5.18: Class of protease activity in culture supernatants from P. pastoris colonies
transformed with pPICZα, Asp f 5 and Asp f 13. Proteases activity of Asp f 5 and Asp
f 13 was measured by change in absorbance on resorufin linked casein with or without
EDTA (metalloprotease inhibitor) or PMSF (serine protease inhibitor) respectively. Data
represents technical replicates mean ± SEM (n=3).
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5.3.2 Purification of Asp f 5 and Asp f 13 from P. pastoris
Following protein expression, culture supernatants were clarified by centrifugation, filter
sterilised, concentrated by freeze drying, resuspended in PBS and purified using affinity
chromatography.
Concentrated supernatants were mixed with denaturing or non-denaturing binding
buffer and applied to HisTrap columns under denaturing or non-denaturing conditions
respectively. Columns were washed with binding buffer then proteins were dissociated
from the nickel resin in the column across a gradient of 0-100% elution buffer (0.5M imi-
dazole in binding buffer). The UV absorbance of the column flow through was measured
to identify fractions containing the eluted proteins (Figures 5.19 and 5.20). For both Asp
f 5 and Asp f 13 under denaturing and non-denaturing conditions, large peaks were ob-
served in fractions 2 and 3 which represent flow through of unbound proteins from the
column. Peaks were also observed in fractions 16 and 17 during the elution steps suggest-
ing the release of bound proteins from the matrix. A gradual increase in UV absorbance
was observed after fraction 16 due to impurities in the imidazole used in elution.
In order to identify the proteins present in fractions 2, 3, 16 and 17, these fractions
were concentrated using centrifugal concentrators and analysed by SDS-PAGE (Figures
5.21 and 5.22). For both Asp f 5 and Asp f 13, under both denaturing and non-denaturing
conditions, there were no observable protein bands of the correct molecular weight in the
elution fractions (16 and 17). However bands of the appropriate molecular weight were
observed in the flow though fractions (2 and 3) suggesting that Asp f 5 and Asp f 13
did not associate with the matrix under either denaturing or non-denaturing conditions.
Protein purification was also attempted by batch purification and under different condi-
tions, including temperature and pH, however association of protein with the matrix and
purification by elution with imidazole was not achieved.
Given the issues associated with poor yield during expression and purification, no
further attempt was made to optimise the purification process, as better yields and purity
were obtained using strains of Pichia pastoris expressing codon optimised Asp f 5 and
Asp f 13. These strains were obtained from AlerGenetica and became available mid-way
through the project. The expression, purification and characterisation of Asp f 5 and Asp
f 13 from these strains is described in the following sections.
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Figure 5.19: Purification of recombinant Asp f 5 and Asp f 13 using affinity chromatog-
raphy under non-denaturing conditions. A. Recombinant Asp f 5. B. Recombinant Asp f
13. Proteins were bound to Ni-NTA resin using non-denaturing binding buffer. Proteins
were eluted using a continuous gradient (10% ml-1) of non-denaturing binding buffer
supplemented with 0.5M imidazole.
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Figure 5.20: Purification of recombinant Asp f 5 and Asp f 13 using affinity chromatog-
raphy under denaturing conditions. A. Recombinant Asp f 5. B. Recombinant Asp f
13. Proteins were bound to Ni-NTA resin using denaturing binding buffer. Proteins were
eluted using a continuous gradient (10% ml-1) of denaturing binding buffer supplemented
with 0.5M imidazole.
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Figure 5.21: SDS-PAGE of proteins purified by non-denaturing purification. Fractions
2 and 3 (Flow-though) and 16 and 17 (Eluted protein) were combined and separated by
SDS-PAGE. A. Asp f 5 fractions 2 and 3. B. Asp f 5 fractions 16 and 17. C. Asp f 13
fractions 2 and 3. D. Asp f 13 fractions 16 and 17. M. Molecular weight markers.
Figure 5.22: SDS-PAGE of proteins purified by denaturing purification. Fractions 2 and
3 (Flow-though) and 16 and 17 (Eluted protein) were combined and separated by SDS-
PAGE. A. Asp f 5 fractions 2 and 3. B. Asp f 5 fractions 16 and 17. C. Asp f 13 fractions
2 and 3. D. Asp f 13 fractions 16 and 17. M. Molecular weight markers.
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5.4 Expression and purification of Asp f 5 and Asp f 13
from P. pastoris transformed with codon optimised
cDNA
Following the issues experienced with protein yield and purification in the P. pastoris
strains generated in house, P .pastoris strains containing codon optimised Asp f 5 and Asp
f 13 were acquired as a kind gift from Ignacio Torrecilla (AlerGenetica, Canary Islands).
Due to the codon optimisation, Asp f 5 and Asp f 13 provided by AlerGenetica, had
different DNA sequences to the proteins cloned by the author but retained the same main
protein sequence. There were also some differences at the C and N termini of the proteins
arising from the cloning methods used. Codon optimised sequences were inserted into
the pPICZB vector during cloning, therefore the codon optimised recombinant proteins
used the native A. fumigatus secretion signal, rather than the P. pastoris secretion signal.
Additionally, they did not contain poly-his or c-myc tags, due to the inclusion of the native
stop codons at the end of the synthesised sequences, before the c-myc and poly-his tags
in the vector (Figures 5.23 and 5.24).
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Figure 5.23: A ClustalW alignment of recombinant Asp f 5 translated protein sequence
(rAspf5), codon optimised Asp f 5 translated protein sequence (rAspf5 CO) and the pub-
lished Asp f 5 protein sequence from UniProt (BOY9E2). ‘*’ indicates that the sequences
are identical, ‘:’ denotes a conservative substitution and ‘.’ shows that a substitution is
semi-conservative. Blue highlights the native Asp f 5 secretion signal. Red highlights the
P. pastoris secretion signal and green shows the additional c-myc and his tags added to
the recombinant Asp f 5 in P. pastoris.
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Figure 5.24: A ClustalW alignment of recombinant Asp f 13 translated protein sequence
(rAsp f 13), codon optimised Asp f 13 translated protein sequence (rAsp13 CO) and the
published Asp f 13 protein sequence from UniProt (P28296). ‘*’ indicates that the se-
quences are identical, ‘:’ denotes a conservative substitution and ‘.’ shows that a sub-
stitution is semi-conservative. Blue highlights the native Asp f 13 secretion signal. Red
highlights the P. pastoris secretion signal and green shows the additional c-myc and his
tags added to the recombinant Asp f 5 in P. pastoris.
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5.4.1 Validation of P. pastoris strains containing codon optimised Asp
f 5 and Asp f 13
Insertion of the relevant allergen proteases was confirmed by PCR against the flanking
AOX promotor sequence (Figures 5.25 and 5.26). The bands seen corresponded to the
expected sizes of the AOX PCR products. In the colony transformed with pPICZB alone
(A), two PCR products were observed, one at 0.3 kb and another at 2.2 kb. The 0.3 kb
band corresponds to the inserted vector sequence (324 bp), whilst the 2.1 kb band corre-
sponds to the native AOX gene (2105 bp). In the colony transformed with Asp f 5 (B), a
PCR product of approximately 2.2 kb was observed, which matched the expected size of
2177 bp. The native AOX gene was not easily observed as the band is approximately 2.1
kb and overlapped the inserted Asp f 5 gene. In the colony transformed with Asp f 13 (C)
two products were observed, the product at 1.5 kb corresponds to the inserted Asp f 13
(1484 bp) and the 2.1 kb PCR product represented the native AOX sequence (2105 bp).
These results showed that the relevant genes were inserted and that the phenotype of the
strains was Mut+.
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Figure 5.25: Schematic of P. pastoris AOX 1 gene locus transformed with or without
pPICZB, the pPICZB Asp f 5 cDNA construct, or the pPICZB Asp f 13 cDNA construct.
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Figure 5.26: PCR products from AOX1 primed PCR reactions for P. pastoris X-33
colonies transformed with pPICZB, codon optimised Asp f 5 and Asp f 13. Lanes, A.
P. pastoris X-33 transformed with pPICZB vector only, B. P. pastoris X-33 transformed
with codon optimised Asp f 5, C. P. pastoris X-33 transformed with codon optimised Asp
f 13, M, Molecular weight markers.
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5.4.2 Expression of codon optimised Asp f 5 and Asp f 13
P. pastoris strains containing codon optimised Asp f 5 and Asp f 13 were grown in BMGY
(Buffered Glycerol Complex Medium) for 72 hours then switched to BMMY (Buffered
Methanol Complex Medium) for 120 hrs to induce protein expression. Growth appeared
to be unaffected by secretion of Asp f 5 and was similar to wild type P. pastoris trans-
formed with the plasmid vector alone. However Asp f 13 expression appeared to cause
retardation of growth compared with wild type P. pastoris transformed with vector alone
(Figure 5.27). Analysis by SDS-PAGE showed proteins of the appropriate molecular
weight in culture supernatants at 120 hrs during the expression phase (Figure 5.28). A
protein approximately 50 kDa in size was expressed and secreted from P. pastoris con-
taining Asp f 5 cDNA whilst a protein approximately 30kDa in size was expressed and
secreted in the strain containing Asp f 13 cDNA.
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Figure 5.27: P. pastoris WT, Asp f 5 and Asp f 13 codon optimised strain growth in
BMMY over 120 hrs. Growth was measured by OD600. Error bars are SEM (n=2 biolog-
ical replicates).
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Figure 5.28: SDS-PAGE of P. pastoris WT, Asp f 5 and Asp f 13 codon optimised protein
expression in BMMY. Equal volumes of culture supernatant were loaded to a 12% SDS-
PAGE gel. Proteins were stained using the FastBlue stain. Lanes, A. supernatant from P.
pastoris with vector alone, B. supernatant from P. pastoris with Asp f 5, C. supernatant
from P. pastoris with Asp f 13, M, Molecular weight markers.
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5.4.3 Purification of codon optimised Asp f 5 and Asp f 13
Precipitation with Ammonium Sulphate
In order to concentrate and partially purify Asp f 5 and Asp f 13 from P. pastoris cul-
ture supernatants, proteins were precipitated using an ammonium sulphate gradient (20%-
80%). Precipitated proteins were resuspended in PBS and analysed by SDS-PAGE (Fig-
ures 5.29 and 5.30). Both Asp f 5 and Asp f 13 were found to precipitate in 80% am-
monium sulphate but not in 60% ammonium sulphate. An ammonium sulphate cut was
then performed to identify a narrower range of fractions in which the proteins precipi-
tated. Supernatants were sequentially incubated with increasing amounts of ammonium
sulphate between 60% and 80%. Following each addition of ammonium sulphate, precip-
itated proteins were pelleted by centrifugation and resuspended in PBS. Fractions were
analysed by SDS-PAGE (Figures 5.31 and 5.32). Both Asp f 5 and Asp f 13 were found
to precipitate between 65% and 80% ammonium sulphate.
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Figure 5.29: SDS-PAGE of recombinant Asp f 5 supernatant precipitated with ammo-
nium sulphate. Equal volumes of precipitated culture supernatant were loaded to a 10%
SDS-PAGE gel. Proteins were stained using Comassie blue. Lanes show proteins precip-
itated by different amounts of ammonium sulphate, M. Molecular weight marker.
Figure 5.30: SDS-PAGE of recombinant Asp f 13 supernatant precipitated with ammo-
nium sulphate. Equal volumes of precipitated culture supernatant were loaded to a 10%
SDS-PAGE gel. Proteins were stained using Comassie blue. Lanes show proteins precip-
itated by different amounts of ammonium sulphate, M. Molecular weight marker.
209
Figure 5.31: SDS-PAGE of recombinant Asp f 5 supernatant cut with ammonium sul-
phate. Equal volumes of precipitated culture supernatant were loaded to a 10% SDS-
PAGE gel. Proteins were stained using Comassie blue. Lanes show proteins precipitated
in different fractions of ammonium sulphate. Lanes, A. 60-65% ammonium sulphate, B.
65-70% ammonium sulphate, C. 70-75% ammonium sulphate, D. 75-80% ammonium
sulphate.
Figure 5.32: SDS-PAGE of recombinant Asp f 13 supernatant cut with ammonium sul-
phate. Equal volumes of precipitated culture supernatant were loaded to a 10% SDS-
PAGE gel. Proteins were stained using Comassie blue. Lanes show proteins precipitated
in different fractions of ammonium sulphate. Lanes, A. 60-65% ammonium sulphate, B.
65-70% ammonium sulphate, C. 70-75% ammonium sulphate, D. 75-80% ammonium
sulphate.
210
Purification by size exclusion chromatography
P. pastoris culture supernatants were fractioned between 65% and 80% Ammonium sul-
phate to maximise the amount of recombinant protein available. These fractions were
analysed by gel filtration chromatography using a 24ml Superdex S200 column (Figures
5.33 and 5.35). For Asp f 5, a large increase in absorbance at 280 nm was observed in
fractions 17 and 18 whilst for Asp f 13 an increase in the absorbance at 280 nm was
observed in fractions 18 and 19. In order to confirm that these fractions contained only
Asp f 5 and Asp f 13, the relevant fractions were analysed by SDS-PAGE. Gels were
stained using silver staining for increased sensitivity (Figures 5.34 and 5.36). Asp f 5
and its degradation products were observed in fractions 17 and 18, whilst Asp f 13 and
its degradation products were observed in fractions 18,19, 20 and 21. For use in future
experiments, Asp f 5 fractions 17 and 18 were combined and Asp f 13 fractions 18-20
were combined. These combined fractions will now be referred to as recombinant Asp f
5 and recombinant Asp f 13.
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Figure 5.33: Protein amount in fractions of 65-80% ammonium sulphate cut Asp f 5
separated by size exclusion chromatography.
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Figure 5.34: SDS-PAGE of gel filtration fractions containing recombinant Asp f 5. Equal
volumes of fractionated proteins were loaded to a 10% SDS-PAGE gel. Proteins were
silver stained. Lanes show proteins present in different fractions from the column. Unpu-
rifed supernatants were transformed and untransformed cells were also included. Lanes,
A. Supernatant from X-33 P. pastoris, B. Unpurified supernatant from P. pastoris trans-
formed with Asp f 5, C. Fraction 15, D. Fraction 16, E. Fraction 17, F. Fraction 18, M.
Molecular weight markers.
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Figure 5.35: Protein amount in fractions of 65-80% ammonium sulphate cut Asp f 13
separated by size exclusion chromatography.
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Figure 5.36: SDS-PAGE of recombinant Asp f 13 supernatant cut with ammonium sul-
phate. Equal volumes of fractionated proteins were loaded to a 10% SDS-PAGE gel.
Proteins were silver stained. Lanes show proteins present in different fractions from the
column. Unpurifed supernatants were transformed and untransformed cells were also in-
cluded. Lanes, A. Supernatant from X-33 P. pastoris, B. Unpurified supernatant from
P. pastoris transformed with Asp f 5, C. Fraction 18, D. Fraction 19, E. Fraction 20, F.
Fraction 21, M. Molecular weight markers.
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Purified Protein Yield
The concentrations of protein obtained by purification are shown in Table 5.2. The total
yields of protein obtained during protein purification are shown in Table 5.3. Asp f 5
was purified at a yield of approximately 19.9% compared with 74.5% for Asp f 13. The
amounts of protease activity retained during purification demonstrated a similar pattern
with 5% of the total protease activity recovered from P. pastoris supernatants containing
Asp f 5 and 63.4% of the total protease activity recovered from P. pastoris supernatants
containing Asp f 13 (Table 5.4).
Table 5.2: Protein quantity and size in purified recombinant protein preparations. Pro-
tein molecular weights were estimated by SDS-PAGE. Protein concentration was assayed
using the BCA test.
Allergen
Protease
Molecular
Weight
Protease
Concentration
Protease
Amount
(kDa) (µg ml-1) (µM)
Asp f 5 52 701 13.48
Asp f 13 36 1089 30.25
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Table 5.3: Protein yield in recombinant protein preparations following purification. Pro-
tein concentration was assayed using the BCA test. Total protein refers to the total protein
present in 40ml of supernatant from P. pastoris cultures. Purified protein refers to the to-
tal amount of protein obtained in purification of Asp f 5 and Asp f 13 from 40 ml of
supernatant from P. pastoris cultures.
Allergen Protease Total Protein Purified Protein Yield
(mg) (mg) %
Asp f 5 7.04 1.40 19.9
Asp f 13 4.40 3.28 74.5
Table 5.4: Protease activity in recombinant protein preparations during purification. Pro-
tease activity was assayed using the resorufin labeled casein. Total protease activity refers
to the total number of units of protease activity present in 40ml of supernatant from P.
pastoris cultures. Purified protease activity refers to the total number of units of pro-
tease activity in Asp f 5 and Asp f 13 purified from 40 ml of supernatant from P. pastoris
cultures.
Allergen
Protease
Total Protease
Activity
Purified
Protease Activity
Activity
Retained
(IU) (IU) %
Asp f 5 35.3 2.6 7.4
Asp f 13 29.6 27.9 94.3
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5.4.4 Characterisation of purified codon optimised recombinant pro-
teins
Following protein purification, recombinant Asp f 5 and Asp f 13 were characterised for
protein stability, protease activity, protease type, substrate specificity, pH and temperature
optima and IgE binding.
Protein Stability
Protein stability and auto-catalysis was analysed by incubating recombinant proteins at
37°C for 1, 2 and 4 hours. The stability of proteins was visualised using SDS-PAGE
(Figure 5.37). After 1 hour at 37°C, Asp f 5 was found to be completely degraded, with
no proteins visible on the gel at the 1 hour, 2 hour and 4 hour time points. Asp f 13 was
found to be more resilient than Asp f 5, however, over time smaller fragments (< 23 kDa)
were found to accumulate, and after 4 hours, larger fragments at approximately 30 kDa
had completely disappeared with only fragments < 17 kDa present.
Figure 5.37: SDS-PAGE demonstrating stability of Asp f 5 and Asp f 13 over time. Asp f
5 and Asp f 13 were incubated for 0, 1, 2 and 4 hours at 37°C. Reactions were stopped by
adding sample buffer and loaded in equal volumes on to a 10% SDS-PAGE gel. Proteins
were visualised using silver staining.
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Protease Activity
Following purification of the recombinant proteases, protein amount and protease activity
were assayed. Protease activity was assayed using resofurin labelled casein and calculated
as the change in absorbance relative to vehicle control. In order to obtain the optimum
concentration of Asp f 5 and Asp f 13 required for accurate calculation of protease activity,
recombinant protease solutions were diluted until a linear increase in absorbance was
observed after incubation with substrate for 1, 30 and 60 minutes. (Figure 5.38). A linear
gradient was obtained for Asp f 5 at 3.6µg/ml (70 nM) and at 1.08µg/ml (30nM) for Asp f
13. These concentrations were used for all further assays of Asp f 5 and Asp f 13 activity
using resorufin linked casein.
Protein concentration was determined and the amount of protease activity per mg of
protein was calculated (Table 5.5). Asp f 13 was found to be more proteolytically activity
than Asp f 5 for a given amount of protein (8.5 IU mg-1 vs.1.8 IU mg-1) . Michaelis-
Menten enzyme kinetics were performed to better characterise and compare the activity
of Asp f 5 and Asp f 13. Asp f 13 was found to have a significantly higher turnover
rate (kcat, 5333 min-1 vs 929.5 min-1) and maximum velocity (Vmax, 144.0 IU mg-1 vs
17.85 IU mg-1) than Asp f 5, confirming that Asp f 13 has a higher rate of activity in
the universal proteases assay, under the conditions studied, than Asp f 5 (Figure 5.39 and
Table 5.5).
Table 5.5: Calculation of protease activity in Asp f 5 and Asp f 13. Protease activity
values were calculated using linear regression on data from Figure 5.38 (n=3 technical
replicates). The Michaelis-Menten constant Km, maximum enzyme velocity (Vmax) and
catalytic constant (kcat) values were calculated using non-linear regression for Michaelis-
Menten enzyme kinetics on data from Figure 5.39. For the calculation of kcat, the
concentration of enzyme sites (Et) was estimated to be 0.0197µM/mg for Asp f 5 and
0.0277µM/mg for Asp f 13.
Allergen
Protease
Protease
Activity
Protease
Activity
Protease
Activity
Vmax Km kcat
(IU ml-1) (IU mg-1) (IU µmol-1) (IU mg-1) (µM) (min-1)
Asp f 5 1.3 1.8 93.6 17.85 570.5 929.5
Asp f 13 9.3 8.5 306 144.0 1723 5333
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Figure 5.38: Assay of recombinant Asp f 5 and Asp f 13 protease activity using resofurin
labelled casein. Asp f 5 and Asp f 13 were diluted until a linear gradient was obtained.
Asp f 5 was used at a concentration of 70 nM (3.6µg/ml). Asp f 13 was used at a con-
centration of 30 nM (1.08µg/ml). The gradient of the line was calculated using linear
regression (n=3 technical replicates).
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Figure 5.39: Michaelis-Menten enzyme kinetics for Asp f 5 and Asp f 13 protease ac-
tivity. Asp f 5 was used at a concentration of 140 nM (7.2µg/ml). Asp f 13 was used
at a concentration of 60 nM (2.16µg/ml) . Km and Vmax values were calculated using
non-linear regression for Michaelis-Menten enzyme kinetics. Initial rate (V0) of elastase
activity at different substrate concentrations ([S]) was calculated using Gen5 software
(n=3 technical replicates).
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Characterisation of protease activity type
The type protease activity of Asp f 5 and Asp f 13 was characterised using protease
inhibitors. Protease activity was inhibited using PMSF (serine proteases), Antipain (ser-
ine proteases), EDTA (metalloproteases), Ilomastat (matrix metalloproteases), Phospho-
amidron (metalloproteases), Pepstatin A (aspartic proteases), and E64 (cysteine proteases)
and expressed as a percentage of an uninhibited control. Recombinant proteases were
incubated with resofurin labelled casein along with protease inhibitors and appropriate
vehicle controls.
Protease activity in the presence of protease inhibitors was expressed as percentage ac-
tivity relative to an uninhibited control (Figure 5.40). Asp f 5 was found to be significantly
inhibited by EDTA (2.8% of uninhibited control), Ilomastat (4.1% of uninhibited control)
and Phosphoamidron (0% of uninhibited control) confirming that the recombinant protein
was a matrix metalloprotease. Asp f 13 was found to be significantly inhibited by PMSF
(0.2% of uninhibited control) and Antipain (3.4% of uninhibited control) confirming that
the recombinant protein was a serine protease.
Substrate specificity
The elastinolytic and collagenase activity of Asp f 5 and Asp f 13 was investigated. Elasti-
nolytic activity was measured using synthetic elastin substrate. Asp f 13 but not Asp f 5
was found to have elastase activity, as demonstrated by an increase in absorbance over
time due to cleavage of the substrate (Figure 5.41). Collagenase activity was measured
using azocollagen. Both Asp f 5 and Asp f 13 were found to cause an increase in mea-
sured absorbance due to the degradation of collagen and the release of the azo dye (Figure
5.42). The collagenase activity of Asp f 13 was found to be significantly greater than Asp
f 5 (48.62 vs. 12.92 ∆A520 h-1 mg-1, P<0.001).
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Figure 5.40: Classification of recombinant protease activity using resofurin labelled ca-
sein. Asp f 5 (A) or Asp f 13 (B) were incubated with PMSF, Antipain, Phophoamidron
(PAD), Ilomastat, EDTA, Pepstatin A, or E64 and the change in absorbance measured
after 60 minutes.Protease activity was expressed as a percentage of an untreated control.
Statistical differences were calculated by 1 way ANOVA followed by Bonferroni post
tests. *** P<0.001, ** P<0.01, * P<0.05. vs untreated control. Data represents mean ±
SEM (n=3 technical replicates).
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Figure 5.41: Assay of recombinant Asp f 5 and Asp f 13 elastase activity using a synthetic
elastin substrate. Asp f 5 was used at a concentration of 140 nM (7.2µg/ml). Asp f 13
was used at a concentration of 60 nM (2.16µg/ml). The gradient of the line was calculated
using linear regression. Data represents mean of technical replicates ± SEM (n=3).
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Figure 5.42: Assay of recombinant Asp f 5 and Asp f 13 collagenase activity using
azocollagen. Asp f 5 was used at a concentration of 140 nM (7.2µg/ml). Asp f 13 was
used at a concentration of 60 nM (2.16µg/ml). The gradient of the line was calculated
using linear regression. Data represents mean of technical replicates ± SEM (n=3).
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Thermal and pH stability
The effects of temperature and pH on the proteolytic activity of Asp f 5 and Asp f 13 was
measured using a resorufin linked casein.
To assay the effect of pH on protease activity, the assay was buffered using citrate
buffer (pH 3-5), Tris-HCl (pH 5-9) or Glycine-NaOH (pH 9-12). Proteases were pre-
incubated at 37°C at the desired pH for 10 minutes prior to the addition of the protease
substrate, then incubated for a further 60 minutes at 37°Cat the required pH. Change in
absorbance was measured against vehicle controls that were incubated at the same pH
and temperature, and used to calculate protease activity. Asp f 5 protease activity was
found to be maximal at pH 7 (Figure 5.43A). Protease activity was sensitive to low pHs
(0% of control at ≤ pH 5) but less sensitive to changes in pH in the alkaline range with
protease activity only lost at very high pHs (0% at ≥ pH 12, Figure 5.43A). Asp f 13 was
found to be have maximal protease activity at pH 9 (Figure 5.44A). In the neutral alkaline
range (pH 7-11) there was very little variation in protease activity (no greater than ± 8%
of maximum). Asp f 13 was also found to be more stable at high pH than Asp f 5 (76%
of max vs 0% of max at pH 12) and was also more stable at low pH than Asp f 5 (43% of
max vs 0% of max at pH 5).
To assay the effects of temperature, proteases were pre-incubated at the desired tem-
perature for 10 minutes prior to the addition of the protease substrate, then incubated for a
further 60 minutes at the target temperature. Change in absorbance was measured against
vehicle controls that were incubated at the same temperatures and used to calculate pro-
tease activity. At pH 7.4, Asp f 5 was found to have maximal protease activity at 50°C,
with protease activity reduced at extremes of temperature (23% at 4°C and< 7% of max-
imum at ≥ 70°C, Figure 5.43B). Similarly Asp f 13 was found to have maximal protease
activity at 50°C, with protease activity also reduced at extremes of temperature (23% of
maximum at ≤ 4°C and < 12% of maximum at ≥ 70°C, Figure 5.44B).
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Figure 5.43: Thermal and pH stability of recombinant Asp f 5 protease activity. A.
The effect of pH on Asp f 5 protease activity. B. The effect of temperature on Asp f 5
protease activity. Protease activity was assayed using universal protease substrate buffered
at various pHs (3-5 Citrate Buffer, 7 Tris-HCl and 9-12 Glycine-NaOH) or incubated at
different temperatures during the assay. Data represents mean of technical replicates ±
SEM (n=3).
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Figure 5.44: Thermal and pH stability of recombinant Asp f 13 protease activity. A.
The effect of pH on Asp f 13 protease activity. B. The effect of temperature on Asp f 13
protease activity. Protease activity was assayed using universal protease substrate buffered
at various pHs (3-5 Citrate Buffer, 7 Tris-HCl and 9-12 Glycine-NaOH) or incubated at
different temperatures during the assay. Data represents mean of technical replicates ±
SEM (n=3).
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Antigenicity and reactivity with human IgE
As well as being proteases, Asp f 5 and Asp f 13 are also known allergens, therefore it
was expected that recombinant Asp f 5 and Asp f 13 should bind IgE in patients sensitised
to A. fumigatus. The IgE binding properties of recombinant Asp f 5 and Asp f 13, were
demonstrated using a modified western blotting technique. Asp f 5 and Asp f 13 were
probed with pooled serum from ten patients allergic to A. fumigatus and IgE binding
detected using a mouse anti-human-IgE IgG conjugated to HRP. For Asp f 5, a clear band
was observed at approximately 52kDa, the expetced molecular weight of recombinant
Asp f 5, as determined by SDS-PAGE. Similarly, Asp f 13 showed binding to IgE at
approximately 30kDa and 25 kDa, which corresponded to the expected molecular weights
of Asp f 13 and its fragments (Figure 5.45). These results showed that both Asp f 5
and Asp f 13 bound IgE from patient serum, suggesting that the recombinant proteins
maintained their properties as allergens.
Figure 5.45: Detection of IgE binding in recombinant Asp f 5 and Asp f 13 using western
blotting. Equal volumes of recombinant proteins were loaded to a 10% SDS-PAGE gel,
separated by molecular weight, and blotted to a nitrocellulose membrane. Proteins were
then probed with with pooled serum from ten patients allergic to A. fumigatus and IgE
binding detected using a mouse anti-human-IgE IgG conjugated to HRP. Lanes, A. B.
textbfM. Molecular weight markers.
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5.5 Discussion
Results from previous chapters demonstrated the secretion of Asp f 5 and Asp f 13 from
A. fumigatus during growth on casein, lyophilised pig lung and mucin. In order to inves-
tigate the characteristics of these proteins, recombinant proteins were created using the P.
pastoris expression system. By using a yeast expression system, in which proteins were
secreted, rather than a bacterial expression system, it was expected that the recombinant
proteins produced would contain post translational modification only performed during
secretion in eukaryotic cells. Additionally it was expected that generating a recombinant
protein would lead to the production of high yields of pure protein without the need for
the extensive protein purification procedures required to isolate native protein from cul-
tures of A. fumigatus. The results in this chapter demonstrated the successful cloning,
expression, purification and characterisation of the A. fumigatus allergen proteases Asp f
5 and Asp f 13 in the yeast P. pastoris.
5.5.1 Cloning of recombinant proteins
Two different methods of cloning and purification in P. pastoris were investigated in order
to obtain the best yield of recombinant protein. In the first method, Asp f 5 and Asp f 13
were cloned in to P. pastoris using cDNA generated from RNA obtained from AF293,
with the replacement of the A. fumigatus secretion signal with a P. pastoris secretion
signal and the addition of poly histidine and c-myc tags for purification. Cloning of
Asp f 5 and Asp f 13 into both E. coli and P. pastoris was successful, as demonstrated by
sequencing, which showed that the native cDNA sequence had been successfully modified
to include the P. pastoris secretion signal, along with c-myc and his tags. Sequencing also
demonstrated that the native sequence had been successfully cloned without modifications
that would have resulted in a non conservative amino acid substitution. It was of interest,
that a small mutation in the last few amino acids of Asp f 13, introduced by an error in
the primer sequence, resulted in a complete loss of protein expression, despite the lack
of alteration to much of the protein. Had the protein been expressed, but in an inactive
form, it may have been a useful tool for differentiating between the allergen and protease
properties of Asp f 13.
In the second method, Asp f 5 and Asp f 13 were cloned in P. pastoris from synthesised
cDNA that was codon optimised for optimal protein expression in P. pastoris, using the
native A. fumigatus secretion signal without any tags for purification (method B). The
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codon optimisation, synthesis, cloning and transformation of Asp f 5 and Asp f 13 cDNA
was performed by Ignacio Torrecilla at Allergenetica. Successfully cloned cDNAs were
also sequenced to confirm cloning had occurred without the introduction of unplanned
errors in the sequence. Following extensive protein purification it was expected that both
methods would produce recombinant proteins with the same amino sequence despite the
differences in the cloning process. However it was also expected that the codon optimised
sequence would result in a much higher yield of protein, due to increased expression
efficiency. Additionally, given the uncertainties in cloning cDNA sequences by method
A, including potential genetic variations in the A. fumigatus strain used to provide the
mRNA template for cDNA production and the possibility of the introduction or errors
during RT-PCR, method B appeared to be the best method for creating cDNA sequences
for protein expression.
5.5.2 Expression of recombinant proteins
Asp f 5 and Asp f 13 were both successfully expressed from P. pastoris using methods
A and B, which resulted in two mature proteins 52kDa and 33kDa in size respectively.
In both methods, protein expression using two different types of medium was investi-
gated. Buffered minimal methanol medium (BMMH) was the preferred medium for the
expression of recombinant proteins from P. pastoris as it does not contain any contaminat-
ing protein and therefore, makes the quantification and purification secreted recombinant
proteins easier. However previous studies have suggested the use of buffered complex
methanol medium (BMMY) was preferable in the expression of proteases as it helped
stabilise the secreted proteases in the supernatant and protected the yeast from the effects
of the proteases. For both methods A and B analysis of the supernatants by SDS-PAGE
confirmed that the secretion of Asp f 5 and Asp f 13 by P. pastoris in BMMH was in-
efficient compared with expression in BMMY. During expression in BMMY, it was also
demonstrated that method B resulted in much higher levels of protein than method A,
to obtain a comassie stained band on SDS-PAGE gels, supernatants containing proteins
produced from method A had to be concentrated over 80x to give a signal, whilst a clear
comassie stained band was visible using neat supernatants from containing Asp f 5 and
Asp f 13 from method B. It was not possible to accurately quantify the levels of Asp f
5 and Asp f 13 due to other proteins in the medium and the lack of a suitable specific
antibody for western blotting or ELISA.
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In both method A and B, proteins were secreted from the yeast due to the inclusion
of a secretion signal. In method A, the native A. fumigatus secretion signal was removed
and replaced with the P. pastoris secretion signal, whilst in method B, the native A. fumi-
gatus was not replaced. In both cases proteins were found to be secreted into the culture
supernatants, suggesting that both the A. fumigatus and P. pastoris secretion signals are
capable of inducing secretion in P. pastoris. In order to further optimise protein produc-
tion, it would have been interesting to investigate the relative expression and secretion
efficiencies of protein in methods A and B using both the A. fumigatus and P. pastoris
secretion signals, however, due to the lack of specific antibodies for in use in western
blotting, to quantify levels of Asp f 5 and Asp f 13 in culture supernatants, this was not
attempted. Also it would have been interesting to investigate the efficiency of expression
in an intracellular expression system, without the use of a secretion signal. This may have
allowed for protein to be obtained at higher concentrations, especially in method A, where
protein concentrations in the supernatant were found to be at very low levels.
5.5.3 Purification of recombinant proteins
Recombinant Asp f 5 and Asp f 13 generated by methods A and B, were purified by affin-
ity chromatography and gel filtration chromatography respectively. The yield of purified
protein, was found to be significantly higher using method B compared with method A.
Purification of recombinant proteins from method A, by affinity chromatography on Ni-
NTA resin using the poly-histidine tag, was found to be ineffective. Asp f 5 and Asp f
13 were visible in the unbound protein fractions suggesting a poor interaction with the
resin under both non-denaturing and denaturing conditions and there was no detectable
recombinant Asp f 5 and Asp f 13 in the elution fractions. Purification of Asp f 5 and
Asp f 13 produced by this method was also attempted using batch purification, however,
this method also failed to produce a satisfactory yield of protein. Purification of proteins
by this method could have been further optimised by investigating the effects of buffer
pH and flow rate or attempting purification using the c-myc tag, however given the lower
amounts of starting material provided by method A compared with method B this was not
deemed to be a viable method for producing large quantities of purified recombinant pro-
tein. However, purification of proteins from culture supernatants generated by method B,
using fractionation with ammonium sulphate and size exclusion chromatography, resulted
in good yields of purified, proteolytically active, recombinant protein.
228
For Asp f 5, 1.4 mg of purified, proteolytically active protein was obtained from 40ml
of culture supernatant (19.9% yield). Analysis of the total protease activity recovered
from each supernatant was also used to estimate specific protease yield, with 7.4% of
protease activity recovered from Asp f 5. The disparity between the recovery of protein
and protease activity suggested that some protease activity had been lost during purifi-
cation. Asp f 5 was puridied in previous studies by both Monod et al. and Sirakova
et al. [117, 160]. Asp f 5 was isolated by Monod et al. from 2L batches of A. fumi-
gatus culture supernatants using a combination of different affinity and size exclusion
chromatography methods, including hydroxylapatite elution, CM-Sephadex elution and
polyacrylamide P60 gel filtration [117]. This method yielded 220 µg of proteolytically
active purified protein, but required a long and complex purification procedure. Asp f 5
was also expressed in E. coli by Sirakova et al. resulting the production of a 43 kDa pro-
tein which was confirmed to be Asp f 5 [160]. However due to the formation of inclusion
bodies, much of the protein was difficult to purify in its native form. Extraction of the
protein under denaturing conditions resulted in the loss of metalloprotease activity, which
could not be recovered, suggesting that Asp f 5 expression in E. coli was not efficient.
Comparing Asp f 5 derived from A. fumigatus culture or produced by E. coli and P.
pastoris, it is clear that, whilst the yields obtained appear to be similar, the quality of
the protein produced by expression and secretion from P. pastoris was higher. Proteins
were secreted into the culture supernatant and could be purified under native conditions
producing good yields of protein from relatively small quantities of culture supernatant.
The use of a native purification technique, meant that proteins did not have to be refolded
resulting in a loss or reduction in protease activity. Purity of the Asp f 5 protein prepa-
ration made in this study, was confirmed using a silver stained SDS-PAGE gel. Several
bands were observed on the silver stained gel, however it was suspected that these bands
were the result of auto-catalysis. In both the native and recombinant protein purification
systems used by Monod et al. and Sirakova et al. respectively, the protein was isolated
as protein approximately 42 kDa in size. However in the P. pastoris expression systems
used in this study, it was isolated as a 52kDa protein, with bands at 42 kDa observed in
purified samples alongside bands at 52 kDa [117, 160]. It is suggested that the 52 kDa
band represents the immature form of Asp f 5 that has not undergone auto-catalytic acti-
vation, whilst the 42 kDa band represents the mature, active Asp f 5. It is expected that
activation of Asp f 5 occurs by autocatalysis, and that this process occurs over time when
the enzyme is incubated at 37°C. It is suggested that auto-catalysis does not occur during
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expression of the protease due to the inhibitory effects of other proteins in the culture
medium and that purification results in increased auto-catalysis.
In this study 3.28 mg Asp f 13 was obtained from 40ml of culture supernatant (74.5%
yield). Analysis of total protease activity showed that 93.4% of Asp f 13 activity recov-
ered. The increase in protease activity suggested that purification may have enhanced
protease activity in Asp f 13. Previously, Asp f 13 isolated from A. fumigatus culture
supernatants, by several groups including Monod et al., Frosco et al. and Larcher et al.,
using a variety of methods including anion and cation exchange, polyacrylamide P60 gel
filtration and Sephadex G75 column chromatography gel filtration in combination with
affinity chromatography on immobilised phenylalanine [53, 101, 119]. Using these meth-
ods yields of between 140 and 1300 µg native proteolytically active Asp f 13 were ob-
tained. Whilst these methods all produced proteolytically active enzymes, the purification
processes involved were lengthy, and required large volumes of starting material to obtain
a reasonable yield of protein, compared with the technique used in this study. Expression
of Asp f 13 in E. coli by Moser et al., resulted in a protein approximately 30.4kDa in size
with yields of 40-50 mg of purified protein obtained per litre of culture [121]. However,
despite good yields, this protein was expressed in inclusion bodies and had to be extracted
and purified under denaturing conditions. Refolding of the denatured protein resulted in
a 10 fold reduction in protease activity compared with an equivalent amount of native
protein, although some protease activity was still observed.
Comparing the Asp f 13 produced in this study with the native protein purified from
A. fumigatus or recombinant protein expressed and purified from E. coli, it was demon-
strated that greater yields of proteolytcially active, purified protein could be produced
from P. pastoris than from A. fumigatus or E. coli, with less complex purification meth-
ods. As with Asp f 5, the secretion of protein into the supernatant, along with a native
purification technique, meant that proteins did not have to be refolded resulting in a loss
or reduction in protease activity. Purity of the Asp f 13 protein preparations in this study,
were confirmed using a silver stained SDS-PAGE gel, and, as with Asp f 5, suspected
auto-degradation products were observed. A major band at approximately 32kDa, and
smaller bands observed at lower molecular weights. Similar degradation products, at
the same molecular weights, were observed during purification of the native protein by
Larcher et al. and Frosco et al. [53, 101].
There were however some improvements that could have been made to the techniques
used in this study. Due to the presence of peptone and yeast extract in the culture super-
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natant it is not possible to determine how much of the total protein was Asp f 5 or Asp f
13, therefore yields calculated by this method may be inaccurate. The best way of calcu-
lating specific protein amount would have been to use either western blotting or ELISA
with an antibody specific to Asp f 5 or Asp f 13, however these were not available. Ad-
ditionally, it was suspected that some of the protease was lost to auto-degradation. It may
have been possible to obtain better protein yields, by purifying the proteins in the pres-
ence of reversible protease inhibitors or under denaturing conditions, however, this may
have resulted in the partial or total loss of protease activity in the recombinant proteins
which it may not have been possible to recover.
5.5.4 Characterisation of recombinant Asp f 5 and Asp f 13
Purified Asp f 5 and Asp f 13 were extensively characterised for protease activity, in-
cluding substrate specificity, thermal stability and pH range, as well as IgE binding from
human sera. On the whole, Asp f 5 and Asp f 13 displayed similar properties to previously
characterised recombinant and native Asp f 5 and Asp f 13.
The type of protease activity exhibited by Asp f 5 and Asp f 13 were investigated
using protease inhibitors. These studies demonstrated that, Asp f 5 was a metalloprotease
and Asp f 13 was a serine protease. The types of protease activity for Asp f 5 and Asp
f 13 found in this study, agreed with those for native proteins investigated using protease
inhibitors, in previous studies carried out by Monod et al. [117,119]. Both Asp f 5 and Asp
f 13 were found to cleave casein, as had been shown by Monod et al., however, due to the
use of different casein based substrates and inconsistent methods of calculating protease
activity, it was not possible to make direct comparisons between the levels of protease
activity measured in this study and other studies [117,119]. Comparing the activity of the
recombinant proteases in this study, Asp f 13 was found to display significantly higher
levels of protease activity than Asp f 5 for a relative amount of protein, by all methods
used to quantify protease activity on casein. This did not agree with results of Markaryan
et al., where Asp f 5 and Asp f 13 protease activities were compared on casein, they were
found to possess, similar levels of protease activity per mg of protein, as measured by dye
release from azo-casein [112].
Asp f 5 and Asp f 13 were measured for collagenase activity using the azo-collagen
protease assay. As shown for the native proteins in previous studies, both Asp f 5 and Asp
f 13 were found to have collagenase activity, resulting in dye release from azo-collagen,
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due to collagen cleavage [117, 119]. Asp f 13 was also found to demonstrate higher
collagenase activity than Asp f 5 per mg of protein. This was found to be in agreement
with the results of Markaryan et al., where Asp f 5 was found to shower lower activity than
Asp f 13 on azo-collagen [112]. Elastase activity in Asp f 5 and Asp f 13 was measured
using the synthetic elastin substrate N-Succinyl-Ala-Ala-Ala-p-nitroanilide. Asp f 13 was
found to cleave the synthetic elastase substrate whilst Asp f 5 was not. These agreed with
previous investigations by Monod et al., using elastin conjugated to the dye congo red,
had shown that both Asp f 13 but not Asp f 5 was capable of cleaving elastin [117, 119].
The relatively lower activity of Asp f 5 than Asp f 13 on different substrates was
demonstrated by Markaryan et al. [112]. This study found that whilst Asp f 5 and Asp f
13 demonstrated similar activity levels on casein, Asp f 5 activity was lower than Asp f 13
on both collagen and elastin protease substrates. In this study, Asp f 5 activity was found
to be lower on casein, collagen and elastin. The lower levels of Asp f 5 activity may
have been due to reduced activity at the pH the assays were performed or alternatively
inactivation due to the presence of a non-cleaved pro domain as previously discussed. Pre-
incubation of Asp f 5 before carrying out the assays may have allowed time for activation
to take place and therefore give a more accurate representation of Asp f 5 activity.
The effect of both temperature and pH were investigated on protease activity of Asp
f 5 and Asp f 13. Both Asp f 5 and Asp f 13 were found to display optimal protease
activity on resorufin linked casein at 50°C. Both were also found to be inactive at tem-
peratures lower than 4°C and higher than 70°C. These compared well with the native
proteins characterised previously by Larcher et al. and Monod et al. [101, 117]. Results
from those studies showed maximal activity in both Asp f 5 and 13 at 50°C, with loss of
activity occurring at temperatures approaching 70°C. However, these studies used a syn-
thetic substrate and azocollagen respectively, and therefore may not be fully comparable
with the results obtained in tis study for activity on casein.
The effect of pH on protease activity was also investigated in this study and in previous
studies. Results showed that, Asp f 5 was optimally active at pH 7, which agreed well with
the results of Monod et al. and Markaryan et al., where maximum activity was observed
around pH 7 [112,117]. Asp f 13 was shown to have optimal activity between pH 7 and pH
9, which agreed with studies by Monod et al., Frosco et al and Larcher et al., where native
Asp f 13 had been isolated from A. fumigatus culture filtrates [53, 101, 119]. However as
with the studies involving protease activity dependence on temperature, different protease
activity assays were employed, therefore, the results may not be directly comparable.
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Indeed, Frosco et al. demonstrated that the buffer used to carry out the assay in resulted in
different maximal protease activities on the same substrate [53]. This may have explained
why, unlike Asp f 5, the activity of Asp f 13 could not be abrogated at high pH. Monod
et al. showed that, Asp f 13 activity was eliminated at pH >12 [119], whilst Larcher et
al demonstrated Asp f 13 activity was retained at pH 12 [101]. Assaying activity, using a
different buffering system may have resulted in the total loss of Asp f 13 at pH >12.
The immunological significance of the recombinant Asp f 5 and Asp f 13 produced
in this study was analysed by immunoblotting using patient sera. The immunogenicity of
native Asp f 5 and Asp f 13 was analysed previously by Monod et al. and Moutaouakil et
al. respectively [117, 122]. Both studies demonstrated that Asp f 5 and Asp f 13 bound
IgE from patients with sensitisation to A. fumigatus. In this study, it was found that both
Asp f 5 and Asp f 13 were capable of binding IgE from pooled serum of individuals
sensitised to A. fumigatus. Had purified native proteins been available during this study,
a comparison of the relative abilities of native and recombinant proteins would have been
useful in demonstrating the relative immunogenicity of the recombinant proteins.
5.5.5 Conclusions
The results from this chapter clearly demonstrate the successful cloning, expression, pu-
rification and characterisation of Asp f 5 and Asp f 13 using P. pastoris. They also show
that the recombinant proteins generated are similar in their, molecular, biochemical, and
immunogenic properties to purified native proteins generated in previous studies. Further-
more they represent the first time that these allergens have been produced as recombinant
proteins in a secretory eukaryotic expression system, and that this system produces pro-
teins that can be more easily purified without the loss of proteases activity, compared with
the prokaryotic E. coli systems used in previous studies. The results also describe that the
codon optimisation of the A. fumigatus allergen proteases, Asp f 5 and Asp f 13, prior to
their expression in P. pastoris results in efficient expression of proteins with an amino acid
sequence identical to that of the native protein. Further more they show that expression of
codon optimised cDNA from P. pastoris results in significantly higher protein yields than
than from non codon optimised cDNA. The recombinant proteins generated in this study,
were of sufficient quality and quantity to be used alongside the crude culture supernatants
generated in chapters 3 and 4, to investigate the effects of Asp f 5 and Asp f 13 on cell
monolayers in vitro as described in subsequent chapters.
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Chapter 6
The effects of Aspergillus fumigatus
allergen proteases on airway epithelial
cells
6.1 Introduction
In chapter 3, the secretion of proteases from A. fumigatus and the mechanisms controlling
protease secretion were investigated. Furthermore, in chapters 3 and 4, several different
proteolytically active A. fumigatus culture extracts were prepared, using AF293 and gene
disruption strains of A. fumigatus. Recombinant proteases were also produced in the yeast
P. pastoris and their activity characterised in chapter 5. The effects of these proteases
on airway epithelial cells, in relation to the inflammatory processes observed in allergic
airway diseases was investigated in this chapter.
Allergen proteases from several different organisms, including filamentous fungi, have
been shown to be involved in the processes of inflammation and airway wall remodelling
through a variety of pathways, including the degradation of the airway epithelial cell
monolayer and its associated tight junctions, the activation of cell surface receptors, such
as protease activated receptors (PARs) and Toll like receptors (TLRs), and the activa-
tion of other molecules and enzymes involved in airway inflammation and remodelling,
for example MMP-9 [80]. Several allergen proteases have been suggested act through the
protease-dependent activation of PARs, a small family of seven transmembrane domain G
protein couple receptors, which are activated by cleavage of the receptor at a specific site,
which releases a tethered ligand that binds to the receptor causing activation. The cleavage
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of the active site of PAR-2, 33SKGRSLIGKV42, by the PAR-2 agonist trypsin, resulted
in cleavage at the R36/S37 site and generation of the active tethered ligand SLIGKV [10].
Activation and blocking of PAR-2 has also been demonstrate using a series of short pep-
tide PAR-2 active fragment homologs including, including SLIGRL, SLIGKV (agonists)
and LSIGKV (antagonist) [10, 113].
Fungal proteases have been shown to cause the release of cytokines from a variety
of cells by activation of protease activated receptors. Two separate studies have shown
the protease mediated release of pro-inflammatory cytokines from airway epithelial and
inflammatory cells by extracts from Alternaria alternata. Matsuwaki et al. demonstrated
that an aspartic protease from A. alternata was capable of activating the PAR-2 receptor
causing the release of pro-inflammatory cytokines from eosinophils by cleavage of the
PAR-2 receptor at a novel site different to the trypsin cleavage site [113]. Boitano et
al. demonstrated the activation of PAR-2 and the release of calcium from airway epithe-
lial cells in response to activation of PAR-2 by serine proteases from A. alternata [25].
Similarly, closely related serine proteases, Pen c 13 and Pen ch 13, from Penicillium
citrinum and Penicillium chrysogenum, were shown by Chiu et al. and Tai et al. re-
spectively to cause the release of pro-inflammatory cytokines by a protease-dependent
mechanism [38,167]. Chui et al. further demonstrated that Pen c 13 activated both PAR-1
and PAR-2 by investigating phosphorylation in the ERK-1/2 pathway.
Allergen extracts from A. fumigatus have also been shown to cause the protease-
dependent release of pro-inflammatory cytokines from airway epithelial cells. Tomee
et al., Kauffman et al. and Borger et al. all demonstrated the serine protease-dependent
release of MCP-1, IL-6 and IL-8 from airway epithelial cells during stimulation with
A. fumigatus extracts and culture supernatants [26, 88, 170]. Furthermore, Borger et al.
demonstrated that secretion of IL-6 and IL-8 was mediated on the transcriptional level
through the NF-κB and NF-IL6 transcription factors. Findings from Bellanger et al. also
demonstrated that growth of A. fumigatus conidia mediated the release of IL-8, GM-CSF
and TNF-α from airway epithelial cells. These result were confirmed in studies by Bal-
loy et al., which demonstrated the release of IL-8 A. fumigatus conidia was controlled by
the ERK-1/2, PI3-K and p38 MAPK pathways [13]. In these studies, cells were either
treated with whole A. fumigatus extracts, culture supernatants, or conidia and the specific
proteases involved in were not fully identified.
Given the findings of studies with other fungal protease and the specific evidence
from studies on A. fumigatus proteases, it was hypothesised that a serine protease from A.
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fumigatus, caused the release of pro-inflammatory cytokines by activation of the PAR-2
pathway. The aim of this chapter was, therefore to demonstrate the protease-dependent
release of IL-8 from epithelial cells by A. fumigatus culture supernatants containing the
serine protease Asp f 13 and by recombinant Asp f 13 via activation of the PAR-2 receptor.
The secondary aim of this chapter was to investigate the effects of A. fumigatus culture
supernatants dominated by metalloprotease activity and recombinant Asp f 5 on epithelial
cell monolayer integrity and IL-8 secretion.
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6.2 Effect of A. fumigatus culture supernatants on airway
epithelial cells
Previous studies have demonstrated epithelial cell monolayer desquamination in response
to allergen proteases as well as from incubation with live organism, and that cytokines
including interleukin 8 (CXCL8/IL-8), eotaxin and RANTES are secreted in response to
fungal allergen preparations in a protease-dependent manner. However in these exper-
iments whole A. fumigatus culture supernatants were used containing several different
proteases, which were not fully identified. Culture supernatants from the AF293 strain
of A. fumigatus were applied to cells to investigate the role of different A. fumigatus pro-
teases on epithelial cell monolayer disruption and IL-8 release.
Normalising the loading doses of A. fumigatus supernatants between cultures grown
on different media was difficult. Loading by equal protein was not appropriate, due to
the presence of media proteins in the supernatants as discussed in chapter 3. Loading
by equal protease activity was also not appropriate as Vogel’s minimal medium culture
supernatants did not contain any protease activity. Therefore supernatants were loaded
by equal volume with the amount of protein applied to the cells related to the amount of
protein in a given dilution of a culture supernatant (Table 6.1).
Table 6.1: Protein concentrations in dilutions of A. fumigatus culture supernatants used
in dose response studies on airway epithelial cells.
Dilution Factor Vogel’s medium Casein medium Pig lung medium
(µg mL-1) (µg mL-1) (µg mL-1)
1 10 137 32.7
1:2 5 69.5 16.3
1:4 2.5 34.75 8.17
1:10 1 13.7 3.27
1:20 0.5 6.85 0.16
1:40 0.25 3.43 0.08
1:100 0.1 1.37 0.03
1:1000 0.01 0.14 0.003
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To prepeare A. fumigatus culture supernatants for application to cells, fungal biomass
was removed by filtration, the remaining supernatant filter sterilised, dialysed against
dH2O using 10 kDa M.W.C.O membrane to remove excess salt and low weight mycotox-
ins, and then freeze dried. Freeze dried proteins were prepared for dilution in serum free
culture supernatant by re-suspending freeze dried proteins from 10 mL of dialysed culture
supernatant in 500 µL of sterile PBS. Control cells were treated with an equal volume of
PBS diluted in serum free culture medium as a control.
6.2.1 Monolayer disruption by A. fumigatus culture supernatants
To investigate the effect of culture supernatants from the AF293 strain of A. fumigatus
on epithelial cell monolayers in vitro, A549 cell monolayers were treated with varying
concentrations of A. fumigatus culture supernatants for 24 hours. At all concentrations
tested (0.1 to 10µg mL-1 protein) Vogel’s culture supernatants were not found to cause
any visible damage to the epithelial cell monolayer (Figure 6.1). However both casein
and pig lung culture supernatants were found to cause epithelial cell monolayer desquam-
ination in a dose-dependent manner (Figures 6.2 and 6.3). Casein culture supernatants
were found to cause desquamination within 24 hours, at protein concentrations above 137
µg mL-1, at proetin concentrations of 69.5 µg mL-1 and lower, no desquamination was
observed within 24 hours. Pig lung culture supernatants were found to induce epithelial
cell desquamination at much lower protein concentrations than casein supernatants, with
desquamination within 24 hours occurring at concentrations of 0.16 µg mL-1 and higher.
The lack observable desquamination in cells treated with Vogel’s culture supernatants,
compared with casein and pig lung culture supernatants, would suggest that protease ac-
tivity may be responsible for desquamination. In order to investigate this proposal, pro-
tease activity was inhibited in casein and pig lung culture supernatants prior to exposure
on cell monolayers. Casein and pig lung culture supernatants were inhibited with iloma-
stat (MMP inhibitor) and antipain (serine protease inhibitor) respectively before applica-
tion to A549 cell monolayers for 24hours. Inhibition of protease activity in both super-
natants rescued the integrity of epithelial cell monolayers with no observable desquami-
nation of A549 cell monolayers (Figure 6.4). This data suggested that A. fumigatus pro-
teases were capable of causing epithelial cell monolayer in a manner that was dependent
on protease activity.
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Figure 6.1: Effect of Vogel’s culture supernatants on A549 cell monolayer integrity. Cells
were treated for 24 hours with A. 5 µg mL-1, B. 2.5 µg mL-1, C. 1 µg mL-1, or D. 0.1 µg
mL-1 protein from Vogel’s culture supernatants. As a control cells were treated with PBS
alone (E). Cells monolayers were photographed under light microscopy.
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Figure 6.2: Effect of casein culture supernatants on A549 cell monolayer integrity. Cells
were treated with A. 137 µg mL-1, B. 69.5 µg mL-1, C. 34.75 µg mL-1 or D. 13.7 µg mL-1
protein from casein culture supernatants. As a control cells were treated with PBS alone
(E). Cells monolayers were photographed under light microscopy.
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Figure 6.3: Effect of pig lung culture supernatants on A549 cell monolayer integrity.
Cells were treated with A. 8.17 µg mL-1, B. 3.27 µg mL-1, C. 0.16 µg mL-1 or D 0.08 µg
mL-1 protein from pig lung culture supernatants. As a control cells were treated with PBS
alone (E). Cells monolayers were photographed under light microscopy.
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Figure 6.4: Effect of culture supernatants treated with protease inhibitors on A549 cell
monolayer integrity. Cells were treated with A. 137 µg mL-1 casein culture supernatant,
B. 137 µg mL-1 casein culture supernatants + 2.5 µM ilomastat, C. 0.16 µg mL-1 pig lung
culture supernatant or D. 0.16 µg mL-1 pig lung culture supernatant + 10 µg mL-1 antipain.
As a control cells were treated with E. 2.5 µM ilomastat or F. 10 µg mL-1 antipain alone.
Cells monolayers were photographed under light microscopy.
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6.2.2 Release of IL-8 in response toA. fumigatus culture supernatants
A549 epithelial cell monolayers were treated with different doses of Vogel’s, casein and
pig lung culture supernatants for 24 hours and levels of secreted IL-8 protein measured
by enzyme linked immunosorbent assay. Levels of IL-8 secreted by treated cells were
normalised against those secreted by cells treated with a PBS control. Vogel’s culture su-
pernatants were not found to cause any significant changes in IL-8 secretion compared to
the PBS control. Additionally there were no significant changes in IL-8 secretion caused
by different doses of Vogel’s culture supernatants (Figure 6.5). Casein culture super-
natants were also found not to cause a significant increase in IL-8 secretion compared
with the PBS control at any dose (Figure 6.6). However, pig lung culture supernatants
were found to cause secretion of IL-8 from A549 cells with significantly higher amounts
of IL-8 secretion than the vehicle control when cells were treated with doses of pig lung
culture supernatants between 0.003 µg mL-1 and 3.27 µg mL-1 (Figure 6.7). Release of
IL-8 was also found to be dose-dependent, with maximal IL-8 release occurring when
cells were treated with 0.16 µg mL-1 pig lung culture supernatant (15.33 fold increase vs
control). At both high and low concentrations of pig lung culture supernatant, IL-8 secre-
tion was also found to be significantly lower than the maximal level of IL-8 secretion. It
was suspected that at high concentrations of pig lung culture supernatant, degradation of
IL-8 and cell detachment, may have resulted in reduced IL-8 levels, whilst at lower con-
centrations, reduced levels of IL-8 may have been due to lower amounts of the inducing
factor in pig lung culture supernatants.
The time dependent secretion of IL-8 by A549 cells was measured over 24 hours in
order to investigate the profile of IL-8 secretion. Casein culture supernatants were only
found to cause a small increase in IL-8 levels at 24 hours compared with the PBS control.
Pig lung culture supernatants were found to cause significant increases in the levels of
IL-8 after 6, 12 and 24 hours of treatment, compared with the PBS control (Figure 6.8).
In both cases, culture supernatants caused a time dependent increase in IL-8 levels over
24 hours, with the peak occurring at 24 hours.
As secretion of IL-8 was induced by casein and pig lung culture supernatants, but not
by Vogel’s culture supernatants, it was suggested that IL-8 secretion was dependent on
protease activity. Either MMP or serine protease activity in casein and pig lung culture
supernatants was inhibited with ilomastat or antipain respectively prior to exposure to
A549 cells for 24 hours (Figure 6.9). Inhibition of pig lung culture supernatant serine
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proteases with antipain showed a significant decrease in protease activity, with inhibi-
tion causing a reduction of IL-8 secretion to basal levels (4 vs. 1 fold increase in IL-8,
P<0.01). Inhibition of casein culture supernatants with ilomastat showed a small but sig-
nificant decrease in IL-8 secretion (1.028 vs. 1.416 fold increase in IL-8, P<0.05). Taken
together, these results suggested that increases in IL-8, observed during treatment with pig
lung culture supernatants were mainly associated with serine protease activity, whereas
the small increases in IL-8 secretion observed when cells were treated with casein culture
supernatants were an indirect response associated with cell monolayer desquamination.
In order to test this proposal, cells were treated with Vogel’s culture supernatants
from A1160pyrg+, Af5∆ and Af13∆ strains of A. fumigatus. As shown in chapter 4,
A1160pyrg+ culture supernatants contained both Asp f 5 and Asp f 13, whilst Af5∆
supernatants contained only Asp f 13 and Af13∆ supernatants contained only Asp f 5.
Treatment of A549 cells with A1160pyrg+ or Af5∆ Vogel’s culture supernatants resulted
in significant increases in IL-8 levels compared with PBS control (1.830 and 2.254 re-
spectively vs. 1 fold increase in IL-8 secretion). However, Vogel’s culture supernatants
from the Af13∆ strain, even at higher concentrations, were not found to cause a significant
increase in IL-8 levels (Figure 6.10). These results suggested that a serine protease, most
probably Asp f 13, was responsible for the increases in IL-8 observed by the treatment of
A549 cells with proteolytically active A. fumigatus culture supernatants. This suggestion
was investigated by the treatment of A549 cell monolayers with recombinant Asp f 5 and
Asp f 13.
244
Figure 6.5: Dose-dependent release of IL-8 by A549 cells incubated with Vogel’s culture
supernatant. Different concentrations of Vogel’s culture supernatant were incubated with
A549 cells for 24 hours. Statistical differences were calculated by one way ANOVA with
Dunnett post tests to compare differences in column means to the PBS control. * P<0.05,
** P<0.01. *** P<0.001. Data represent mean ± SEM (n=3 biological replicates).
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Figure 6.6: Dose-dependent release of IL-8 by A549 cells incubated with casein culture
supernatant. Different concentrations of casein culture supernatant were incubated with
A549 cells for 24 hours. Statistical differences were calculated by one way ANOVA with
Dunnett post tests to compare differences in column means to the PBS control. * P<0.05,
** P<0.01. *** P<0.001. Data represent mean ± SEM (n=3 biological replicates).
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Figure 6.7: Dose-dependent release of IL-8 by A549 cells incubated with pig lung culture
supernatant. Different concentrations of pig lung culture supernatant were incubated with
A549 cells for 24 hours. Statistical differences were calculated by one way ANOVA with
Dunnett post tests to compare differences in column means to the PBS control. * P<0.05,
** P<0.01. *** P<0.001. Data represent mean ± SEM (n=3 biological replicates).
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Figure 6.8: Time dependent release of IL-8 by A549 cells incubated with casein and pig
lung culture supernatants. A549 cells were incubated with 0.003 µg mL-1 of pig lung
culture supernatant or 69.5 µg mL-1 of casein culture supernatant. Statistical differences
were calculated by two way ANOVA with Bonferroni post tests to compare differences in
time point means compared with the PBS control.*** P<0.001. Data represent mean ±
SEM (n=3 biological replicates).
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Figure 6.9: Protease-dependent release of IL-8 by A549 cells incubated with casein and
pig lung culture supernatants. A549 cells were incubated with 69.5 µg mL-1 of casein
culture supernatant or 0.003 µg mL-1 of pig lung culture supernatant, inhibited with ilo-
mastat or antipain respectively. Statistical differences were calculated by t-test to compare
differences in means. * P<0.05, ** P<0.01. *** P<0.001. Data represent mean ± SEM
(n=3 biological replicates).
247
Figure 6.10: Release of IL-8 by A549 cells incubated with culture supernatants from
gene disruption strains. A549 cells were incubated with Vogel’s culture supernatants from
A1160pyrg+ (0.3125 µg mL-1), Af5∆ (0.3125 µg mL-1) or Af13∆ (2.5 µg mL-1) strains of
A. fumigatus. Statistical differences were calculated by one way ANOVA with Bonferroni
post tests to compare differences in means. * P<0.05, ** P<0.01. *** P<0.001. Data
represent mean ± SEM (n=3 biological replicates).
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6.3 Effect of recombinant Asp f 5 and Asp f 13 on airway
epithelial cells
Results from the previous section suggested that a serine protease in pig lung culture su-
pernatants was responsible for epithelial cell monolayer desquamination and the protease-
dependent secretion of IL-8 from airway epithelial cells in vivo and the findings from
chapters 3 and 4 demonstrated that the metalloprotease Asp f 5 and the serine protease
Asp f 13 were present and active in A. fumigatus pig lung culture supernatants. The ef-
fects of Asp f 5 and Asp f 13 on epithelial cells were investigated using recombinant Asp
f 5 and Asp f 13 produced an characterised in chapter 5.
6.3.1 Monolayer disruption due to recombinant A. fumigatus pro-
teases
In order to investigate the effects of specific proteases within A. fumigatus cell culture
supernatants on epithelial cell monolayer integrity, A549 cells were incubated with re-
combinant Asp f 5 and Asp f 13. Both Asp f 5 and Asp f 13 were found to induce cell
monolayer desquamination in a dose-dependent manner compared with cells treated with
PBS alone (Figures 6.11 and 6.12). Asp f 5 caused cell monolayer desquamination at
24 hours at concentrations between 0.125 µg mL-1 and 0.25 µg mL-1 and epithelial cell
detachment at concentrations of ≥ 0.05 µg mL-1. At concentrations ≤ 0.05 µg mL-1 no
desquamination was seen after 24 hours. Asp f 13 induced cell monolayer desquamination
after 24 hours in A549 cells 0.05 µg mL-1 and epithelial cell detachment at concentrations
≥ 0.125 µg mL-1. At concentrations of ≤ 0.01 µg mL-1 no desquamination was observed
after 24 hours. Asp f 13 appeared to cause epithelial cell monolayer disruption at lower
level of protein than Asp f 5.
To investigate if the cell monolayer desquamination was protease-dependent, Asp f 5
and Asp f 13 were pretreated with protease inhibitors before being applied to A549 cell
monolayers for 24 hours. Inhibition of Asp f 5 and Asp f 13 with ilomastat or antipain
respectively, resulted in maintenance of monolayer integrity compared with cells treated
with uninhibited proteases (Figure 6.13). These results suggested that Asp f 5 and Asp f
13 caused the protease-dependent disruption of epithelial cell monolayer integrity.
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Figure 6.11: Effect of recombinant Asp f 5 on A549 cell monolayer integrity. Cells were
treated with A. 0.5 µg mL-1, B. 0.25 µg mL-1, C. 0.125 µg mL-1 or D. 0.05 µg mL-1.
As a control cells were treated with PBS alone (E). Cells monolayers were photographed
under light microscopy.
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Figure 6.12: Effect of recombinant Asp f 13 on A549 cell monolayer integrity. Cells were
treated with A. 0.125 µg mL-1, B. 0.05 µg mL-1, C. 0.01 µg mL-1 or D. 0.005 µg mL-1.
As a control cells were treated with PBS alone (E). Cells monolayers were photographed
under light microscopy.
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Figure 6.13: Effect of recombinant proteins treated with protease inhibitors on A549 cell
monolayer integrity. Cells were treated with A. 0.5 µg mL-1 recombinant Asp f 5, B. 0.5
µg mL-1 recombinant Asp f 5 + 2.5 µM ilomastat, C. 0.05 µg mL-1 recombinant Asp f 13
or D. 0.05 µg mL-1 recombinant Asp f 13 + 10 µg mL-1 antipain. As a control cells were
treated with E. 2.5 µM ilomastat or F. 10 µg mL-1 antipain alone. Cells monolayers were
photographed under light microscopy.
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6.3.2 Release of IL-8 in response to recombinant A. fumigatus pro-
teases
A549 cells were treated with various doses of Asp f 5 and Asp f 13 for 24 hours, and the
release of IL-8 was measured by ELISA. Asp f 5 caused the release of significant levels
IL-8 compared with a PBS control, at concentrations between 0.5 and 20 µg mL-1 (Figure
6.14). This range of concentrations at which Asp f 5 caused IL-8 secretion was found to
correlate with the concentration of Asp f 5 shown to cause epithelial cell detachment, as
demonstrated in section 6.3.1 (Figure 6.11). These results suggested that IL-8 secretion
due to treatment with Asp f 5 is associated with epithelial cell detachment. Asp f 13 also
caused a dose-dependent release of IL-8 from A549 cells, with significant levels of IL-8
being released between 0.01 and 1 µg mL-1. In a pattern that was similar to that observed
during the treatment of A549 cells with pig lung culture supernatants, at concentrations
above 1 µg mL-1 and below 0.01 µg mL-1, no significant increase in IL-8 was observed
(Figure 6.15). Secretion of IL-8 from epithelial cells mediated by Asp f 13, occurred at
concentrations of Asp f 13 that caused monolayer cell detachment (≥ 0.125 µg mL-1)
as well as at concentrations that caused desquamination (0.05 µg mL-1) and that did not
compromise the epithelial cell monolayer (0.01 µg mL-1) (Figure 6.12). This suggested
that, unlike Asp f 5, Asp f 13 mediated release of IL-8 may be due to the activation of a
cellular receptor rather than due to cell detachment and death.
Time dependent release of IL-8 from A549 cells induced by Asp f 5 or Asp f 13 was
investigated. It was found that both Asp f 5 and Asp f 13 caused the release of IL-8 in
a time dependent manner. Both Asp f 5 and Asp f 13 caused a significant increase in
IL-8 compared with a PBS control at 24 hours. Asp f 13 also induced increases in IL-8
compared with PBS control at 3, 6 and 12 hours but these were not considered significant
(Figure 6.16). To investigate if the release of IL-8 induced by Asp f 5 and Asp f 13
was dependent on protease activity, proteases were pretreated with ilomastat and antipain
respectively, before application to A549 cells for 24 hours. The inhibition of both Asp f
5 and Asp f 13 was found to significantly abrogate the release of IL-8 from A549 cells
compared with uninhibited proteases (Figure 6.17). This suggested that for both Asp f 5
and Asp f 13, the release of IL-8 was protease-dependent, however it did not account for
the differences in the amount of IL-8 secretion or the mechanism by which IL-8 secretion
was induced.
It was observed that when A549 cells were treated with high concentrations of pig
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lung culture supernatants or Asp f 13, IL-8 levels were reduced, and it was suggested
that Asp f 13 might degrade IL-8. The degradation of IL-8 by Asp f 13 was assayed by
incubating 2000 µg mL-1 of recombinant IL-8 with different amounts of recombinant Asp
f 13 for 3 hours at 37 °C. Following treatment, Asp f 13 was inhibited with antipain to
confirm that elements of the ELISA assay were not effected by the protease. It was found
that Asp f 13 degraded IL-8 in a dose-dependent manner with higher doses of Asp f 13
resulting in significantly lower levels of detectable IL-8 after 3 hours (Figure 6.18).
Taken with the the results from section 6.3.1, it was suggested that the increase in IL-8
associated with Asp f 5 was the result of IL-8 secretion in response to detachment of the
epithelial cell monolayer. Inhibition of protease activity was suggested to be protective,
preventing damage to epithelial cells and the release of IL-8. Conversely, Asp f 13 was
found to induce significant levels of IL-8 secretion, both with and without the detachment
of epithelial cells, suggesting that secretion of IL-8 was induced by the activation of a
cellular receptor. As this was demonstrated to be protease-dependent, it was suggested
that Asp f 13 might act through the protease activated receptor PAR-2.
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Figure 6.14: Dose-dependent release of IL-8 by A549 cells incubated with different con-
centrations of recombinant Asp f 5 for 24 hours. Statistical differences were calculated
by one way ANOVA with Dunnett post tests to compare differences means to the PBS
control. *** P<0.001. Data represent mean ± SEM (n=3 biological replicates).
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Figure 6.15: Dose-dependent release of IL-8 by A549 cells incubated with different con-
centrations of recombinant Asp f 13 for 24 hours. Statistical differences were calculated
by one way ANOVA with Dunnett post tests to compare differences means to the PBS
control. * P<0.05, ** P<0.01. *** P<0.001. Data represent mean ± SEM (n=3 biologi-
cal replicates).
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Figure 6.16: Time dependent release of IL-8 by A549 cells incubated with 0.5 µg mL-1
of Asp f 5 or 0.05 µg mL-1 of Asp f 13. Statistical differences were calculated by two way
ANOVA with Bonferroni post tests to compare differences in time point means compared
with the PBS control. * P<0.05, ** P<0.01. *** P<0.001. Data represent mean ± SEM
(n=3 biological replicates).
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Figure 6.17: Protease-dependent release of IL-8 by A549 cells with 0.5 µg mL-1 of Asp
f 5 or 0.05 µg mL-1 of Asp f 13, inhibited with 2.5 µM ilomastat or 10 µg mL-1 antipain
respectively. Statistical differences were calculated by t-test to compare differences in
means. * P<0.05, ** P<0.01. *** P<0.001. Data represent mean± SEM (n=3 biological
replicates).
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Figure 6.18: Dose-dependent degradation of IL-8 by recombinant Asp f 13. Different
doses of Asp f 13 were incubated with 2000 pg mL-1 IL-8 for 3 hours at 37 °C. Statistical
differences were calculated by 1 way ANOVA with Dunnett post tests to compare differ-
ences in means compared with a PBS control. * P<0.05, ** P<0.01. *** P<0.001. Data
represent mean ± SEM (n=3 biological replicates).
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6.4 Activation of the PAR-2 receptor byA. fumigatus pro-
teases
6.4.1 Protease-dependent cleavage of the PAR-2 receptor
The protease-dependent release of IL-8 may be the result of activation of PAR 2 by A.
fumigatus proteases. The cleavage of PAR-2 by the A. fumigatus recombinant proteases,
was assayed using a fluorogenic peptide substrate, Abz-SKGRSLIGKdD, which was rep-
resentative of the cleavage site of the PAR 2 receptor (33SKGRSLIGKV42). Cleavage
of the peptide resulted in an increase in fluorescence in the assay used. The serine pro-
tease trypsin, has been shown previously to be a potent activator of the PAR-2 receptor at
the Arg36/Ser37 site and was used in this study as a positive control for the activation of
PAR-2.
The PAR 2 peptide was incubated with different amounts of trypsin, Asp f 5 or Asp
f 13. The positive control, trypsin, demonstrated a dose-dependent cleavage of the PAR-
2 peptide, with 1nM of trypsin providing a near linear increase in fluorescence over 30
minutes, with significant increases in fluorescence after 5 minutes (Figure 6.19). High
doses of trypsin cause rapid degradation of PAR-2-FP, resulting in maximal fluorescence
at 5 minutes at 10 nM and nearly instantaneously at 100 nM. Both Asp f 5 and Asp f
13 were also found to show cleavage of PAR2-FP (Figures 6.20 and 6.21). Cleavage of
PAR-2-FP by Asp f 5 was found to result in a significant increases in fluorescence after
5 minutes at all concentrations tested, with a near linear increase in fluorescence over 30
minutes at a concentration of 10 nM. Cleavage of PAR-2-FP by Asp f 13 was found to
cause a significant increase in fluorescence at the maximum concentration of 1 µM only,
but not at lower concentrations.
Protease inhibitors were used to investigate the dependance of PAR-2-FP cleavage
on protease activity. Prior to incubation with PAR-2-FP, proteases were inhibited with
relevant protease inhibitors. In control samples, inhibition of trypsin with PMSF resulted
in no significant increase in fluorescence at any time point over the 30 minute incubation
period, compared to the uninhibited trypsin control (Figure 6.22). Similar results were
found for both Asp f 5 and Asp f 13 with cleavage of PAR-2-FP by Asp f 5 and Asp f 13
was abrogated by the addition of the protease inhibitors ilomastat and PMSF, respectively
(Figure 6.22). In both cases, inhibition of protease activity resulted in no significant
increase in fluorescence at any time point over the 30 minute incubation period, compared
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with uninhibited controls.
These data suggested that cleavage of PAR-2-FP was protease-dependent and that
Asp f 5 showed a greater affinity for cleavage of the PAR-2 receptor than Asp f 13, as
cleavage occurred at lower molar concentrations of enzyme than Asp f 13. The sites at
which Asp f 5 and Asp f 13 cleaved the PAR-2-FP were analysed using MALDI-MS. MS
spectra demonstrated that Asp f 5 and Asp f 13 both cleaved the PAR-2-FP but at differ-
ent positions (Figure 6.23). Asp f 5 was found to cleave the peptide at Ser37/Leu38 and
Leu38/Ile39, producing two detectable peptide fragments, IGKdD and Abz-SKGRS. The
active IGKdD fragment, was shown to cause the PAR-2 dependent release of cytokines
from eosinophils [113]. Asp f 13 was found to cleave the PAR-2-FP at the Arg36/Ser37
producing a single detectable peptide fragment, Abz-SKGR. The remaining active frag-
ment of PAR-2-FP (SLIGKdD) was not detected following cleavage with Asp f 13, sug-
gesting that it may have been further degraded. Peptide cleavage sites are summarised in
Table 6.2.
Taken together, these data suggested that Asp f 13 activates PAR-2 at the same cleav-
age site as trypsin (Arg36/Ser37), but was less efficient and required a thousand fold higher
concentration (1 µM Asp f 13, vs. 1 nM trypsin) to achieve a similar increase in fluores-
cence. Asp f 5 was shown to cleave the PAR-2 receptor with a similar efficiency to
trypsin, at both the Ser37/Leu38 and Leu38/Ile39 cleavage sites, generating the active pep-
tide IGKdD, suggesting that Asp f 5 might also cause efficient activation of the PAR-2
receptor. The role of Asp f 5 and Asp f 13 in the activation of PAR-2 was investigated
using antibodies that blocked the activation of PAR-2 and stimulation of PAR-2 using
fragments of the PAR-2 FP generated by cleavage with Asp f 13.
Table 6.2: Peptide fragments generated by cleavage of PAR-2-FP by Asp f 5 and Asp f
13 as determined by MALDI-MS. Data for trypsin was obtained from [113].
Protease Inactive fragments Active fragments
None Abz-SKGRSLIGKdD -
Trypsin Abz-SKGR -SLIGKdD
Asp f 5 Abz-SKGRS -IGKdD
Asp f 13 Abz-SKGR -
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Figure 6.19: Dose-dependent activation of PAR-2 fluoropeptide by trypsin. Different
amounts of trypsin were incubated at 37 °C with PAR-2 fluropeptide for 30 minutes. Sta-
tistical differences in means were calculated by two way ANOVA. * P<0.05, ** P<0.01.
*** P<0.001 vs. PBS control. Data represent mean ± SEM (n=2 technical replicates).
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Figure 6.20: Dose-dependent activation of PAR-2 fluoropeptide by Asp f 5. Different
amounts of Asp f 5 were incubated at 37 °C with PAR-2 fluropeptide for 30 minutes. Sta-
tistical differences in means were calculated by two way ANOVA. * P<0.05, ** P<0.01.
*** P<0.001 vs. PBS control. Data represent mean ± SEM (n=3 technical replicates).
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Figure 6.21: Dose-dependent activation of PAR-2 fluoropeptide by Asp f 13. Different
amounts of Asp f 13 were incubated at 37 °C with PAR-2 fluropeptide for 30 minutes. Sta-
tistical differences in means were calculated by two way ANOVA. * P<0.05, ** P<0.01.
*** P<0.001 vs. PBS control. Data represent mean ± SEM (n=3 technical replicates).
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Figure 6.22: Protease-dependent activation of PAR-2 by Asp f 5 and Asp f 13. Trypsin (1
nm), recombinant Asp f 5 (10nM) and Asp f 13 (1µM) were inhibited with, 2 mM PMSF,
2.5 µM Ilomastat and 2 mM PMSF respectively prior to incubation at 37 °C with PAR-2
fluoropeptide for 30 minutes. Statistical differences in means were calculated by two way
ANOVA. * P<0.05, ** P<0.01. *** P<0.001 inhibited vs un-inhibited controls. Data
represent mean ± SEM (n=3 technical replicates).
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Figure 6.23: MS spectra of PAR-2-FP peptide fragments resulting from the cleavage
of PAR-2 peptide by Asp f 5 and Asp f 13. Recombinant Asp f 5 (10nM) and Asp f 13
(1µM) or a PBS control were incubated at 37 °C with PAR-2 fluoropeptide for 30 minutes.
Peptide fragments were analysed by MALDI-MS.
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6.4.2 Activation of the PAR-2 receptor in A549 cells by A. fumigatus
proteases
Attempts were made to demonstrate the activation of the PAR-2 receptor by Asp f 5 and
Asp f 13, in vitro, in experiments using A549 cells. Previous studies have demonstrated
the release of IL-8 via the activation of the PAR-2 receptor by blocking of the PAR-2
receptor using a function blocking antibody such as SAM-11 [125]. In the current study,
PAR-2 receptors on A549 cells were blocked for 1 hour at 37 degrees using the SAM-11
antibody, before the addition of trypsin, Asp f 5 and Asp f 13. Cells were also incubated
with normal mouse IgG as a negative control. Blocking of the PAR-2 receptor during
treatment with trypsin resulted in a small but significant reduction in the secretion of IL-
8 (2029 vs 1919 pg mL-1, * P<0.05) compared with the cells treated with IgG alone.
However, blocking of the PAR-2 receptor during treatment with Asp f 5 or Asp f 13
resulted in small but non-significant reductions in the levels of IL-8 secretion (Figure
6.24). It was thought that optimisation of the concentrations of Asp f 5, Asp f 13 and
SAM-11 used in this assay, as well as increased samples, may have lead to significant
results.
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Figure 6.24: The effect of PAR-2 blocking antibodies on the protease-dependent, PAR-2
mediated release of IL-8 in A549 cells. Cells were blocked with either 10 µg mL-1 of
the PAR-2 function blocking antibody SAM11 or 10 µg mL-1 of control normal mouse
IgG antibody. Cells were then treated with either trypsin (0.05 µg mL-1) , Asp f 5 (0.5
µg mL-1), Asp f 13 (0.05 µg mL-1), or PBS. Statistical differences were calculated by
t-test. * P<0.05, ** P<0.01. *** P<0.001. Data represent mean ± SEM (n=3 biological
replicates).
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6.5 Discussion
The aim of this chapter was to investigate the mechanisms controlling the protease-
dependent release of cytokines from epithelial cells in response to proteolytically active
A. fumigatus culture supernatants and recombinant A. fumigatus protease in vitro. The
results from this chapter demonstrated that A. fumigatus culture supernatants with both
serine and metalloprotease activity were capable of causing epithelial cell monolayer dis-
ruption. Further investigation, using culture supernatants from gene disruption strains of
A. fumigatus and recombinant protease demonstrated that both Asp f 5 and Asp f 13 were
responsible for causing epithelial cell desquamination in a protease-dependent manner.
Furthermore, using culture supernatants from gene disruption strains of A. fumigatus
and recombinant proteases, it was shown that the serine protease Asp f 13 was a potent
inducer of the protease-dependent release of IL-8 from epithelial cells, and was capable of
cleavage PAR-2 at the same site as trypsin, suggesting that it may play a role in the PAR-2
mediated release of cytokines. Asp f 13 was also demonstrated to be able to degrade IL-8
in dose-dependent manner, suggesting a role for the protease in immune modulation. Asp
f 5 was also shown to cause the release of IL-8 from epithelial cells, and cleaved the PAR-
2 receptor at an atypical cleavage site, suggesting that Asp f 5 might also cause efficient
activation of the PAR-2 receptor.
6.5.1 The effect ofA. fumigatus proteases on epithelial cell monolayer
integrity in vitro
The investigation of the effects of A. fumigatus culture supernatants on epithelial cell
monolayer integrity in this study, showed that both casein culture supernatants and pig
lung culture supernatants were able to cause significant levels of protease-dependent ep-
ithelial cell monolayer disruption. The results from chapters 3 and 4, suggested that pig
lung culture supernatants were dominated by serine protease activity, most probably from
Asp f 13 and that casein cultures were dominated by metalloprotease activity, most likely
from Lap1 and Asp f 5. Previous studies by Kauffman et al. demonstrated that pro-
teases from collagen driven cultures of A. fumigatus were capable of causing epithelial
cell desquamination in a serine protease activity dependent manner [88]. The A. fumigatus
collagen culture supernatants used by Kauffman et al. had been characterised previously
by Monod et al. and, similar to the pig lung culture supernatants used in this study, were
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found to be dominated by the serine protease Asp f 13 (Alp 1) [119]. Previous studies
by Riazanskaia (PhD thesis, unpublished), indicated that casein culture supernatants were
capable of causing protease-dependent epithelial cell monolayer desquamination and the
cleavage of occludin in cell monolayer tight junctions in a manner similar to that observed
in casein culture supernatants in the current study [143]. However the A. fumigatus culture
supernatants from the Riazanskaia study were derived from CEA10 and found to contain
active Lap1, Asp f 5 and Asp f 13, therefore the protease responsible for these effects was
not identified.
The use of culture supernatants from gene disruption strains of A. fumigatus and re-
combinant proteases in this study, confirmed the results from previous studies where crude
preparations of proteolytically active A. fumigatus culture supernatants were found to
cause epithelial cell monolayer desquamination. Culture supernatants from A1160pyrg+,
Af5∆ and Af13∆ strains of A. fumigatus cultured in Vogel’s minimal medium were an
excellent tool for investigating the role of native A. fumigatus proteases. Vogel’s culture
supernatants from Af5∆ and Af13∆ strains, were shown in chapter 4, to contain only Asp
f 13 or Asp f 5 respectively. Using these supernatants both Asp f 5 and Asp f 13 were
shown to be capable of causing epithelial cell monolayer disruption in A549 cells, a result
which was confirmed using recombinant Asp f 13 and Asp f 5. Results from this current
study definitively demonstrated that, the cell desquamination and detachment associated
with proteolytically active A. fumigatus culture supernatants observed in the current study
and others, was mediated by the allergen proteases Asp f 5 and Asp f 13. A serine pro-
tease closely related to Asp f 13 from Penicillium chrysogenum, Pen ch 13, was shown by
Tai et al. to cause epithelial cell monolayer desquamination and occludin cleavage by a
protease-dependent mechanism [167]. This indicated that future work in this area should
focus on the degradation of epithelial cell monolayer tight junctions by Asp f 5, Asp f 13
and Lap1.
6.5.2 The effect of A. fumigatus proteases on IL-8 secretion from ep-
ithelial cell monolayers in vitro
The effect of A. fumigatus culture supernatants on IL-8 secretion from airway epithelial
cells was investigated. Culture supernatants from A. fumigatus grown in pig lung medium,
resulted in the dose-dependent release of IL-8 from epithelial cell monolayers [26, 88].
Previous results from Kauffman et al. and Borger et al. showed both increased secre-
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tion and transcription, respectively, of IL-8 by A549 cells, during treatment with culture
supernatants, from A. fumigatus grown in a collagen containing medium (ECol-CF). In
both this study and those by Kauffman et al. and Borger et al. increase in IL-8 was
found to be dependent on serine protease activity, which was shown to be present in these
supernatants. These results agreed with those obtained for the current study, which also
suggested that IL-8 release was dependent on serine protease activity in A. fumigatus cul-
ture supernatants. Results from chapters 3 and 4 suggested that the serine protease in A.
fumigatus pig lung culture supernatants was Asp f 13 (Alp1).
Culture supernatants from A. fumigatus grown in Vogel’s minimal medium and casein
medium failed to induce any significant increases in IL-8 production. The lack of IL-8
secretion in response to Vogel’s medium, suggested that IL-8 secretion was dependent on
protease activity, and not due to the activation of a protease independent pathway, such
as a Toll like receptor driven pathway. The lack of a significant increase in IL-8 secre-
tion in response to casein culture supernatants, which contained mainly metalloproteases,
demonstrated that IL-8 release was likely to be dependent on serine protease, such as Asp
f 13, and unlikely to be induced by the metalloproteases present in casein culture super-
natants, such as Lap1. It also confirmed that the Asp f 13 detected by LC/MS in casein
culture supernatants in chapter 3 was possibly inactivate an unable to induce IL-8 secre-
tion from epithelial cells as demonstrated in pig lung culture supernatants. However, it is
also possible that proteases in present in casein culture supernatants were not applied in
high enough concentrations to demonstrate an effect on IL-8 secretion from airway ep-
ithelial cells, as only the maximum concentration used caused epithelial cell monolayer
desquamination.
The effects of both culture supernatants from gene disruption strains of A. fumigatus
and recombinant proteases, were investigated on IL-8 secretion by A549 cells. Studies
using Vogel’s culture supernatants from the Af5∆ strain of A. fumigatus, in which the only
active protease was shown to be Asp f 13, showed an increase in IL-8 secretion com-
pared with the PBS control. Studies in which cells were treated with recombinant Asp
f 13, also demonstrated the protease activity dependent release of IL-8 from epithelial
cells. Furthermore IL-8 release was found to be dose-dependent, and produced a similar
pattern to the dose-dependent release of IL-8 in response to treatment with pig lung cul-
ture supernatants, and A. fumigatus culture supernatants with serine protease activity as
described by Kauffman et al. [88]. However in the current study, it was not possible to
quantify the amounts of Asp f 13, in AF293 pig lung culture supernatants or Af5∆ Vogel’s
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culture supernatants precisely, so it was not known if the doses of recombinant Asp f 13
were equivalent to those present in culture supernatants. Taken together with the results
showing the abrogation of IL-8 release when culture supernatants or recombinant Asp
f 13 were inhibited with the serine protease inhibitors, it is suggested that the protease
responsible for causing IL-8 release from airway epithelial cells, in A. fumigatus culture
supernatants containing serine protease activity, was Asp f 13.
Results from the current study also demonstrated that significant levels of IL-8 re-
lease occurred at concentrations of Asp f 13 that caused monolayer cell detachment, as
well as at concentrations that caused desquamination and that did not compromise the
epithelial cell monolayer. In two separate studies by Daly et al., both A. fumigatus culture
supernatants and A. fumigatus growth on A549 cell monolayers was shown to cause cell
detachment and death by necrosis [43, 44]. Daly et al. did not investigate if cell death by
necrosis lead to increased IL-8 secretion, this has been shown in other studies, where cell
death and necrosis mediated by the influenza virus caused increased IL-8 release from
NHBE cells [8]. These results suggested that at higher concentrations of Asp f 13, IL-8
release may have been mediated by cell detachment and death whilst at lower concentra-
tions, where no cell detachment was observed, Asp f 13 may have mediated the release of
IL-8 via another mechanism, such as PAR-2 activation.
As previously described treatment of cells with pig lung culture supernatants and re-
combinant Asp f 13 in this study, and with A. fumigatus culture supernatants with serine
protease activity in studies by Kauffman et al. all showed a dose-dependent relationship
between quantity of protease and IL-8 release, with high and low doses of protease result-
ing in low levels of IL-8 and intermediate doses showing high levels of IL-8 release [88].
It was suggested by Kauffman et al, that serine protease from A. fumigatus might of di-
rectly cleavage and degrade IL-8. Incubation of recombinant Asp f 13 with recombinant
IL-8, agreed wit the results of Kauffman et al., which showed a dose-dependent relation-
ship between reduction in IL-8 levels and increasing concentration of A. fumigatus culture
supernatants with serine protease activity [88]. Taken together these results suggested that
degradation of IL-8 by Asp f 13 may be responsible for the low levels of IL-8 observed at
high doses of A. fumigatus protease preparations.
Whilst Asp f 5 has been previously purified and characterised by Monod et al., the
action of Asp f 5 on epithelial cell monolayers and its role in mediating the secretion of
cytokines has has not been previously described in the literature [119]. Airway epithe-
lial cells were treated with recombinant Asp f 5 and native Asp f 5 in gene disruption
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supernatants, in order to investigate the differences between IL-8 release in response to
activation of a receptor and IL-8 release during cell detachment and death. Treatment of
A549 cells with Vogel’s culture supernatants from Af13∆ strains of A. fumigatus, in which
the only active protease was shown to be Asp f 5, no significant increase in IL-8 was ob-
served. Recombinant Asp f 5 did not show the same dose response patterns observed for
Asp f 13, pig lung culture supernatants, although significant levels of IL-8 were observed
at higher doses of Asp f 5. The threshold dose of Asp f 5 found to induce IL-8 secretion,
was shown to correlate with the dose required to cause epithelial cell monolayer detach-
ment suggesting that the increase in IL-8 associated with Asp f 5 may be the result of
IL-8 secretion in response to damage of the epithelial cell monolayer and associated cell
death [8,43,44]. Inhibition of protease activity, reduced IL-8 secretion and was suggested
to be protective, preventing damage to epithelial cells and the release of IL-8. However,
later results showed that Asp f 5 may activate PAR-2, which could also mediate IL-8 re-
lease, therefore further investigation was required to determine the precise mechanism by
which Asp f 5 mediated IL-8 secretion from airway epithelial cells.
The results from this section suggested that both Asp f 5 and Asp f 13 may have
mediated some release of IL-8 due to the stress responses associated with epithelial cell
monolayer damage. It is also possible that both Asp f 5 and Asp f 13 may activate a
cellular receptor causing the release of IL-8. The mechanisms of IL-8 release caused by
the activation of the PAR-2 receptor are discussed in the next section.
6.5.3 Activation of the PAR-2 receptor by A. fumigatus proteases
Several studies were performed in order test the theory that the A. fumigatus protease
mediated secretion of IL-8 from A549 cells was due to the activation of the protease
activated receptor, PAR-2.
Studies investigating the cleavage of a fluorogenic peptide sequence representative of
the PAR-2 active site revealed that both Asp f 5 and Asp f 13 were capable of cleaving
PAR-2 but that Asp f 5 cleaved the peptide at lower concentrations that Asp f 13. This sug-
gested that Asp f 5 was a more efficient activator of PAR-2 than Asp f 13, although, cleav-
age may not have occurred at a site that caused receptor activation. Activation of PAR-2
involves cleavage of the receptor by a protease at a specific site (33SKGRSLIGKV42),
which results in the release of the N-terminal region of the protein (N-33SKGR) and ex-
posure of the activate portion of the tethered ligand (SLIGKV42). The tethered ligand
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then binds back to the receptor, causing the G-protein mediated activation of a number of
pathways including the p38 and PI3K pathways (Figure 6.25).
Figure 6.25: Activation of the PAR-2 receptor by proteases. This diagram demonstrates
activation of PAR-2 at the trypsin cleavage site. PAR-2 cleavage site = SKGRSLIGKV,
tethered ligand activating sequence = SLIGKV. Inactive portion of PAR-2 cleavage site =
SKGR.
Analysis of the cleavage products of PAR-2-FP by mass spectrometry revealed that
Asp f 13 cleaved the PAR-2 receptor at the same site as trypsin (Arg36/Ser37), however
only the inactive fragment of the cleavage site (SKGR) was detected by MALDI-MS, the
activating fragment (SLIGKdD) was not found nor were any smaller cleavage products.
This may have been due to limitations in the experimental procedure. The starting peptide
preparation was not pure and given the complexity of the sample, it is possible that the
SLIGKdD fragment was not present in sufficient quantities for detection over the back-
ground noise by MS. It is also possible that Asp f 13, may have cleaved the PAR-2-FP, then
further degraded the active fragment, SLIGKdD, into smaller peptide fragments (2 amino
acids or less) that were below the limits of detection of the MS method used. Degradation
of the SIGKdD fragment of PAR-2-FP by Asp f 13, might suggest that Asp f 13 cleaves
the PAR-2 receptor but then prevents activation by degrading the active fragment of the
tethered ligand, however, further analysis of PAR-2 cleavage, with a less complex starting
sample would be required to validate this proposal.
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Analysis of the cleavage products of PAR-2-FP incubated with Asp f 5 revealed that
Asp f 5 cleaved PAR-2-FP at two sites Ser37/Leu38 and Leu38/Ile39, generating the active
peptide IGKdD. Studies by Matsuwaki et al. demonstrated that cleavage of the same
fluoropeptide used in this study, with an an aspartic protease from A. alternata, resulted
in the production of the IGKdD peptide fragment [113]. Furthermore they showed that
the novel IGKdD active PAR-2 ligand was a potent activator of PAR-2 capable of causing
the PAR-2 driven secretion of EDN from eosinophils. It is therefore suggested that Asp f
5 can cause the activation of PAR-2 and that this may lead to the release of IL-8, however
this has yet to be demonstrated in airway epithelial cells.
Blocking of the PAR-2 receptor using specific antibodies failed to demonstrate the ac-
tivation of PAR-2 in vitro, despite the results demonstrating Asp f 5 and Asp f 13 cleavage
sites in the PAR-2 receptor. Both Asp f 5 and Asp f 13 were shown to induce the release
of IL-8 from A549 cells in a protease-dependent manner, however experiments in this
study failed to show that this was due to the activation of PAR-2, suggesting that either
the methods used in this study were not sensitive enough or appropriate for the detection
of PAR-2 activation, or that a different protease-dependent mechanism was responsible
for mediating the release of IL-8.
Other studies have successfully demonstrated the inhibition of PAR-2 mediated cy-
tokine secretion with PAR-2 blocking antibodies and it is possible that optimisation of
the amounts of blocking antibody, length of blocking time, protease concentration and
length of treatment time might yield significant results [86, 125]. Studies examining the
activation of protease activated receptors have also used different methods to investigate
the activation of PARs. Studies by Chiu et al., Matsuwaki et al. and Boitano et al., all
measured the release of calcium from epithelial cell monolayers in response to a variety
of fungal proteases, and its inhibition by the addition of PAR receptor peptide antogo-
nists [25, 38, 113]. Studies by Chiu et al. also demonstrated the activation of elements
down stream of the PAR-2 receptor such as activation of the ERK1/2 pathway [38]. In
order to make a more firm conclusion about the role of A. fumigatus protease in PAR-
2 activation, it was felt that other techniques should also be used to confirm the results
demonstrated by blocking studies.
It is also possible that there were other pathways which may have modulated the re-
lease of IL-8 in response to A. fumigatus, that were not investigated in this study. Both
Moretti et al. and Balloy et al. explored the mechanisms causing IL-8 release from PMNs
and airway epithelial cells, respectively, during exposure to both A. fumigatus conidia and
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culture supernatants [13,120]. Both studies described a complex series of interactions be-
tween the pathways associated with PAR-2 and Toll-Like Receptor 4 (TLR-4), including
A. fumigatus driven activation and inhibition of p38 MAPK, ERK1/2, MyD88 and NF-κB.
(Figure 6.26). However, neither study fully described or identified the precise proteases
involved in the activation of these pathways or directly attributed their activation to the
activation of PAR-2 by disrupting PAR-2 receptor activation.
Figure 6.26: Intracellular pathways causing the release of IL-8 from epithelial cells, as
described in experiments by Balloy et al. and Moretti et al. [13, 120].
Moretti et al. demonstrated that exposure of PMNs to A. fumigatus conidia alone,
resulted in increased ERK1/2 and NF-κB activation in a manner that was dependent on
the MyD88/TLR-4 pathway [120]. However they also showed that activation of PAR-2,
by PAR-2 agonists, during exposure of PMNs to A. fumigatus conidia resulted in reduced
ERK1/2 and NF-κB activation in a manner that was dependent on p38 but not MyD88,
suggesting that PAR-2 activation might cause reduced NF-κB activation and therefore
reduced inflammation [120]. This might have suggested that A. fumigatus proteases would
have reduced IL-8 release, however, Moretti et al. also showed that a serine protease from
A. fumigatus was capable of cleaving PAR-2, but that cleavage results in deactivation of
the receptor and loss of sensitivity to the PAR-2 agonist trypsin [120].
Balloy et al. investigated the effects of TLR-4 and PAR-2 activation on IL-8 secre-
tion specifically, and found that activation of the TLR-4 pathway in response to A. fu-
migatus conidia resulted in NF-κB activation but not IL-8 secretion, whilst activation of
phosphatidylinositol 3-kinase, p38 MAPK, and ERK1/2 was required for IL-8 secretion,
pointing towards a PAR-2 dependent mechanism [13]. Balloy et al. also suggest that ac-
tivation of these pathways may also cause the release of IL-8 via transcription factors not
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dependent on NF-κB [13].
Taken with the results of the current study, these results suggest that A. fumigatus
proteases, such as Asp f 13 or Asp f 5, might activate TLR-4 as an allergen, then prevent
the suppression of ERK1/2 activation by inactivation of the PAR-2 receptor, resulting in
a protease-dependent increase in IL-8 via NF-κB dependent and independent pathways
as described by Moretti et al. [120]. It is also possible that Asp f 5 and Asp f 13 might
cause activation of PAR-2 independently of TLR-4 activation, causing the production of
IL-8 via a transcription factor associated with the p38 pathway as as suggested by Balloy
et al. [13]. Results from this study suggest further studies are required to identify the
precise mechanism by which Asp f 5 and Asp f 13 might cause cytokine production via
the activation of PAR-2.
6.5.4 Conclusions
The aim of this chapter was to investiagte the protease-dependent release of IL-8 from
epithelial cells by A. fumigatus culture supernatants containing the serine protease Asp f
13 and by recombinant Asp f 13 via activation of the PAR-2 receptor. From the results
shown in this chapter, it is possible to conclude that both native and recombinant Asp f
5 and Asp f 13, caused damage to epithelial cell monolayers and the release IL-8, which
occurred in a protease activity dependent manner. The results for Asp f 13 were also found
to strongly mimic those for the treatment of cells with pig lung culture supernatants,
which were shown to contain active Asp f 13 as well as other A. fumigatus allergens,
demonstrating that whole A. fumigatus culture supernatants showed a similar effect to
recombinant proteases. Analysis of cleavage of PAR-2 suggested that both Asp f 5 and
Asp f 13 cleaved PAR-2, resulting in active ligands that were capable of activating PAR-2.
However, the results failed to conclusively demonstrate the role of protease activated
receptors in the protease-dependent secretion of IL-8 from epithelial cells. Taken together
with the results of other studies in this area, it is suggested that future work should fo-
cus on investigating PAR dependent calcium release by epithelial cells when treated with
A. fumigatus proteases, as well as the downstream effects of A. fumigatus proteases on
PAR and TLR cross-talk pathways. Additionally, it is suggested that activation of other
proteases activated receptors be investigated as well as the secretion of other cytokines
mediated by PAR activation including IL-6, RANTES, GM-CSF and eotaxin. Further-
more, work on the Asp f 13 homologues, Pen c 13 and Pen ch 13, suggested that Asp f
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13 may also have a role in tight junction disruption, via the cleavage of occludin, which
should also be investigated [38, 167]. Finally, the results shown in this chapter were rel-
evant only to the cell line in which the experiments were performed, and the effects of
these proteases on primary airway epithelial cells from both healthy and asthmatic should
also be investigated.
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Chapter 7
Discussion
Several conclusions can be drawn from the results obtained in this study, which had im-
plications in the regulation and role of secreted proteases in both invasive and allergic A.
fumigatus related diseases.
7.1 The effect of different culture conditions on the se-
cretion of allergen proteases by Aspergillus fumigatus
Investigating the effects of growth substrate on protease secretion by A. fumigatus, re-
vealed that A. fumigatus was able to sense the type of substrate available as a nitrogen
source in its environment, and regulate the type of proteases required to degrade the sub-
strate on the transcriptional level. Furthermore, growth of the AF293 strain of A. fumiga-
tus in casein medium resulted in the secretion of Asp f 5, Asp f 13 and Lap1 with protease
activity dominated by the metalloproteases, whilst growth in pig lung medium resulted
in the secretion of Asp f 5 and Asp f 13 with protease activity dominated by the serine
protease Asp f 13.
These findings have several important implications in the way A. fumigatus protein
extracts are used in both in vitro and in vivo research studies. As A. fumigatus allergens,
and specifically allergen proteases, are considered to be important in mediating inflam-
mation, it is crucial that the precise composition of A. fumigatus allergen preparations is
clearly defined, both in terms of the allergens present and the relative levels of protease
activity from different proteases. Commercially available preparations of A. fumigatus
allergens are poorly defined, and do not contain information on the strain of A. fumigatus
used, the nature of the allergens present (whole cell extract, supernatants, etc.) or the
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levels of protease activity. Furthermore, the allergen preparations used in research stud-
ies whilst often clearly defined by the study, are not standardised between studies with
respect to the A. fumigatus strain and growth conditions used, making comparison of the
results of between studies difficult. For example in the investigation of the effects of A.
fumigatus proteases on airway epithelial cells, Kogan et al. used A. fumigatus grown in
DMEM supplemented with 10% FCS for 3 days [93], whilst Kauffman et al used A. fumi-
gatus grown in 0.2 mol L-1 borate buffer containing collagen (0.2% w/v) and YCB (0.5%)
for 5 days [88]. In both cases protease activity in culture supernatants was characterised
for both class and amount of protease activity however, the protease assay methods used
were different and the proteases and allergens present were not fully identified, making
comparisons difficult.
The expression of different allergens and protease by A. fumigatus under different
growth conditions is also relevant in the clinical diagnosis of fungal allergy. Previous
studies have shown that different preparations of fungal allergens from the same species
of fungi provided by different manufacturers, were found elicit different skin test results in
the same patient [3]. It is suggested that the variations observed may be due to differences
in both the A. fumigatus growth conditions and allergen extract preparation techniques
and suggests that extensive standardisation of fungal extracts used in research and clinical
diagnostics is required. In the current study, growth of A. fumigatus in insoluble casein
and insoluble pig lung media was found to induce protease secretion in a reproducible
manner. However, insoluble casein, whilst readily available from Sigma-Aldrich, was a
poor inducer of active Asp f 13, and insoluble pig lung, whilst a strong inducer of Asp f 5
and Asp f 13, may not be reproducible between labs, due to variation in the type pig lungs
available and their source. Bergmann et al. demonstrated the secretion of protease from
A. fumigatus grown in minimal medium supplemented with 0.1 % peptone and 0.4%
BSA [23]. This medium, is clearly defined, is made from components that are easily
obtainable and readily standardised, and supports the growth of A. fumigatus in protease
gene disruption studies, making it an ideal candidate for the production of standardised
A. fumigatus allergen preparations.
Findings from the present study, also highlighted the need to be able to quantify lev-
els of fungal protein within preparations where other proteins may be present, to ensure
equal loading of fungal protein during both in vitro and in vivo studies. It is suggested
that a ”housekeeping” protein that is equally secreted between all A. fumigatus strains and
growth conditions be used as a measure of total A. fumigatus protein secretion within com-
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plex supernatants. Although ELISA assays are already available for the measurement of
proteins such as β-glucan and galactomannan, these proteins are cell wall associated and
the assays are optimised for the sensitive detection of A. fumigatus in clinical samples. As
an alternative, it is suggested that a protein such as cell wall β-1,3-endoglucanase, which
was detected in supernatants of both A1160pyrg+ and AF293 strains of A. fumigatus, be
used as a measure of both growth and protein secretion.
Results from the current study also demonstrated that protease production by AF293
was tightly regulated and depended on the nitrogen source available in the growth media.
Suppression of protease production when A. fumigatus was grown on a primary nitrogen
source suggested that the overall control of protease production might be linked to the
nitrogen catabolite repression system [23]. However, the differential expression of Asp
f 5, Asp f 13 and Lap1 in casein and pig lung media, suggests another control mecha-
nism by which A. fumigatus might regulate the production of proteases depending on the
type of protein available in its growth environment. It is therefore suggested that future
work in this area should focus on both the overall regulation of protease activity and the
mechanisms regulating secretion of the less well characterised Lap1 protease, with initial
experiments focusing on identifying the transcription factor controlling Lap1 expression.
7.2 The effects of Asp f 5 and Asp f 13 gene disruption in
A. fumigatus
Investigating the effects of disruption of Asp f 5 and Asp f 13 genes in A. fumigatus on the
release of proteases during growth in a variety of culture media, confirmed that growth
in casein resulted in the secretion of Asp f 5, Asp f 13 and Lap1, whilst growth on pig
lung medium resulted in the production of Asp f 5 and Asp f 13. They also demonstrated
that gene disruption of Asp f 5 and Asp f 13 did not result in the secretion of any other
proteases, suggesting that these are important secreted proteases in A. fumigatus.
Investigation of the secretion of proteases by several strains of A. fumigatus showed
that in some strains of A. fumigatus, protease secretion was not suppressed by the pres-
ence of a primary nitrogen source, a finding that disagrees with evidence currently in
the literature [58]. Results from the current study demonstrating strain to strain varia-
tion in the regulation protease secretion suggested that as well as standardising the media
and growth conditions of A. fumigatus in the production of A. fumigatus allergen prepa-
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rations, the strain of A. fumigatus used should be also be standardised. It is suggested
that future work in this area should focus on investigating the secretome and whole pro-
teome of the strains of A. fumigatus described in this study on a variety of standardised
growth media, including BSA/peptone, casein and Vogel’s minimal medium, in order to
be better characterise the production of allergens and specifically allergen proteases by A.
fumigatus. This should support the standardisation of the A. fumigatus allergen extracts
used in both research and clinical diagnosis. This finding is also important in determin-
ing the mechanisms controlling protease secretion in A. fumigatus. Comparison of the
transcriptomes and DNA binding by transcription factors in strains of A. fumigatus that
differently regulate the secretion of proteases on a primary nitrogen source (for example
AF293 vs. CEA10) may provide clues as to the pathways regulating protease secretion
by A. fumigatus.
Findings from the current study investigating the A1160pyrg+ strain of A. fumigatus
demonstrated that Asp f 5 and Asp f 13 were secreted during growth on Vogel’s mini-
mal medium but that secretion was suppressed during growth on casein medium. In the
current study, work focused on the disruption of the allergen proteases Asp f 5 and Asp
f 13. However investigating the effects of the disruption of Lap1, on the transcriptome
and secretome of A. fumigatus, especially in casein medium, might provide clues as to
the mechanism that controlled the suppression of Asp f 5 and Asp f 13 secretion in casein
medium, and the wider mechanisms allowing for the detection of different types of pro-
tein in the environment. Additionally, investigations into Lap1 secretion by the AF293
and A1160pyrg+ strains of A. fumigatus in the current study, only demonstrated Lap1
production during growth on casein medium. However, other studies using a different
strain of A. fumigatus have suggested that Lap1 may be secreted during growth on other
media types such as insoluble collagen [163]. Further investigation of Lap1 secretion by
different strains A. fumigatus may provide further evidence for the detection of different
protein environments by A. fumigatus and the regulation of protease secretion.
Previous studies by Sharon et al., Bergmann et al., and Jaton-Ogay et al., have all
shown that disruption of both individual and clusters of proteases does not reduce pathogenic-
ity in murine models of invasive aspergillosis [23, 81, 155]. However, all of these studies
used strains of A. fumigatus that did not demonstrate dysregulated protease secretion on a
primary nitrogen source, as observed in the AF90, AF210, AF65, AF10, AF294, CEA10
and A1160pyrg+ strains of A. fumigatus in this study. It is suggested that the dysregu-
lation of protease secretion, results in more rapid growth of A. fumigatus in a complex
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nitrogen environment, which provides an advantage during invasion, and therefore in-
creased pathogenicity compared with strains in which protease production is regulated.
It is proposed that future work in this area should focus on the disruption of individ-
ual protease genes or transcription factors controlling protease secretion, in a strain of A.
fumigatus, such as A1160pyrg+, and the virulence and allergenicity of this strain com-
pared to those of unmodified and reconstituted strains. It is also suggested that, a more
comprehensive study into the effects of strain variation in the regulation of protease se-
cretion, may provide a clear association between dysregulation of protease secretion and
increased virulence in vivo as well as reveal differences in populations of A. fumigatus
isolated from the environment and the clinic. Analysis of virulence in a large number of
strains could be carried out using the wax moth model of invasive aspergillosis validated
by Slater et al., whilst analysis of protease activity and growth could be carried out using
the modified microbroth method described by Paisley et al [133, 161]. These methods
both lend themselves to high throughput analysis of A. fumigatus strains.
7.3 The cloning and expression of Asp f 5 and Asp f 13 in
P. pastoris
The cloning and expression of Asp f 5 and Asp f 13 in P. pastoris resulted in recombinant
proteases with proteolytic and immuno-reactive properties similar to those reported for the
native proteases, and also demonstrated that codon optimisation of A. fumigatus cDNA
before cloning into yeast resulted in significantly higher levels of protein expression.
Work from this study focused on the cloning of Asp f and Asp f 13, however, as sug-
gested in the current study and a previous study by Riazanskaia (PhD thesis, unpublished),
Lap1 is thought to be important in mediating the degradation of epithelial cell monolay-
ers and associated tight junction proteins [143]. Future work may involve the cloning and
characterisation of Lap1, including its specific protease activity and IgE binding capabil-
ities, in order to investigate the effects of Lap1 as an allergen protease both in vitro and in
vivo. Future cloning experiments involving Asp f 5, Asp f 13 and Lap1 may also involve
the targeted substitution of amino acids, to disrupt the active site of the proteases, in order
to investigate their effects solely as allergens. Furthermore, cloning of specific regions of
Asp f 5 and Lap1 would allow the investigation of IgE epitope binding sites and a greater
understanding of the molecular features of these proteases that make them allergens, as
279
demonstrated by Banerjee et al. for Asp f 2 [16] and LuPing et al. for Asp f 13 [109].
The availability of recombinant proteins for Asp f 5 and Asp f 13, allows a more
substantial analysis of the specific amino acid sequence of the cleavage sites of these pro-
teases. Enoksson et al., have described a system by which potential cleavage sites of A.
fumigatus proteases might be identified using MALDI-MS [49]. Identification of the spe-
cific protease cleavage sites of Asp f 5 and Asp f 13 may suggest novel host protein targets
for the proteases, such as cytokines, latent growth factors pro-enzymes and receptors. The
availability of recombinant proteins may also enable the production of specific antibodies
against Asp f 5 and Asp f 13, allowing better quantification of Asp f 5 and Asp f 13 in
A. fumigatus culture supernatants. Additionally antibodies specific to Asp f 13 have been
shown to inhibit it’s protease activity in vitro [54]. It is suggested that the inhibition of
allergen proteases using monoclonal antibodies may be used therapeutically in diseases
such as ABPA and SAFS. Future work should therefore focus on the efficacy of antibodies
against allergen proteases in animal models of A. fumigatus mediated allergic disease.
Finally, the production of recombinant allergens may represent a way of producing
more clinically relevant A. fumigatus allergen preparations for the diagnosis of A. fumiga-
tus allergy. Whilst studies by Moutaouakil et al. suggested that individual allergens such
as Asp f 13 might not be useful in the diagnosis of A. fumigatus allergy, a specific mixture
of A. fumigatus allergens may be useful in skin prick testing and eliminate the need for
crude A. fumigatus allergen preparations [122]. Furthermore, the effect of combinations
of different allergens and allergen proteases could be investigated in research studies, both
in vitro and in vivo as previously demonstrated by Goplen et al. [60].
7.4 The effects ofAspergillus fumigatus allergen proteases
on airway epithelial cells
The treatment of airway epithelial cells with proteolytically active A. fumigatus super-
natants and recombinant proteases showed that both Asp f 5 and Asp f 13 were capable of
inducing the release of the pro-inflammatory cytokine, IL-8, from airway epithelial cells.
Further investigation showed that both Asp f 5 and Asp f 13 were capable of activating the
PAR-2 by protease-dependent cleavage, and that both were capable of cleaving PAR-2 at
a site which caused it’s activation.
Blocking of the PAR-2 receptor during treatment with Asp f 5 or Asp f 13 resulted
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in a small but non-significant reduction in the level of IL-8 secretion. It was thought that
optimisation of the concentrations of Asp f 13 and the PAR-2 blocking antibody (SAM-
11) used in this assay, as well as increased samples, may have lead to significant decrease,
as shown in other studies where this technique was used [86, 125]. Other techniques may
also be used to demonstrate the Asp f 5 and Asp f 13 activation of PAR-2. Studies by
Chiu et al., Matsuwaki et al. and Boitano et al., all measured the release of calcium from
epithelial cell monolayers in response to a variety of fungal proteases, and its inhibition
by the addition of PAR receptor peptide antagonists [25, 38, 113]. Studies by Chiu et al.
also demonstrated the activation of elements down-stream of the PAR-2 receptor such as
activation of the ERK1/2 pathway [38]. Both Moretti et al. and Balloy et al. described
a complex series of interactions between the pathways associated with PAR-2 and Toll-
Like Receptor 4 (TLR-4), including A. fumigatus driven activation and inhibition of p38
MAPK, ERK1/2, MyD88 and NF-κB. In order to be more conclusive regarding the role of
A. fumigatus proteases in PAR-2 activation, it was felt that in the future other techniques
should also be used to confirm the results demonstrated by blocking studies. Furthermore,
work in this area should also investigate the pathways through which activated PARs
signal and investigate the role of Asp f 5 and Asp f 13 in possible PAR and TLR cross
over pathways, in a variety of cell types including primary airway epithelial cells, PMNs
and eosinophils.
The activation of PAR-2 by Asp f 5 and Asp f 13 might also be investigated in vivo.
Unlike other sources of allergic material, fungi, including A. fumigatus can colonise
the lung and evidence from Denning and colleagues suggests that ongoing fungal in-
fection occurs in the lungs of asthmatics [45, 46]. Colonisation by A. fumigatus, may
lead to increased exposure of the lungs to allergen proteases causing increased damage
and inflammation. Studies by Porter et al. have shown that colonisation of the mouse
lung by Aspergillus niger causes increased eosinophilic inflammation and airway hyper-
responsiveness that was dependent on aspergillopepsin (an Asp f 10 homolog) and re-
sulted in allergic sensitisation to bystander antigens [140]. Their study also showed low
levels-neutrophil driven inflammation and unpublished results for PAR-2 -/- mice from
the same group, suggested that the PAR-2 receptor was not involved [139,140]. However,
A. niger does not produce homologs of Asp f 5 and Asp f 13, and is suggested that the
effects of aspergillopepsin in A. niger mediated eosinophilic inflammation were due to
damaged caused to the epithelial cell monolayer and increased allergen exposure rather
than cytokine release by PAR-2 activation.
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It is proposed that in a similar model of allergy induced by A. fumigatus colonisation,
production of Asp f 5 and Asp f 13 by A. fumigatus may cause increased neutrophilic in-
flammation via cytokine release resulting from PAR-2 activation and eosinophilic inflam-
mation due to damage of the airway epithelium by A. fumigatus proteases. Unpublished
data from our research group supports this theory, with preliminary data suggesting that
intra-nasal exposure of mice to casein culture supernatants from A. fumigatus in which
Asp f 5 and Asp f 13 genes had been disrupted, resulted in decreased airway hyper-
responsiveness compared with controls. In vivo studies should investigate the effect of
both A. fumigatus strain variation and specific gene disruption in A. fumigatus of Asp f
5 and Asp f 13 in both allergen exposure, and colonisation models of asthma in mice.
Furthermore the effects of PAR gene disruption in mice on disease development should
be investigated in similar studies of allergy induced by both A. fumigatus allergen expo-
sure and colonisation. These studies should demonstrate the relative requirements of PAR
activation and A. fumigatus proteases for the development of eosinophil and neutrophil
driven inflammation in severe asthma with A. fumigatus involvement.
It is also possible that Asp f 5 and Asp f 13 might mediate their effects on airway in-
flammation through other protease dependent pathways. Studies by Knight et al. demon-
strated the transcriptional up-regulation of a variety of genes, including both chemokines
and metalloproteases, during the exposure of airway epithelial cell line to A. fumigatus
condia [59]. The identification of novel targets for A. fumigatus proteases may be inves-
tigated in a similar way by analysing the transcriptomes of a variety of cell types treated
with A. fumigatus proteases. Alternatively pathways already known to be activated by
allergen proteases could be investigated with respect to activation by A. fumigatus pro-
teases. For example several allergen proteases including Der p 1 and Pen c 13 have been
shown to degrade tight junctions, suggesting that A. fumigatus proteases may act in a sim-
ilar manner [167,175]. Der p 1, has also been shown to interact with several immune cell
surface receptors including CD23 and CD25, resulting in increased B and T cell mediated
inflammation [151, 154]. Additionally, Der f 1 has been shown to activate TGF-β by the
cleavage of the LAP, suggesting that allergen proteases might mediate airway wall remod-
elling via the activation of TGF-β [123]. Lastly, a recent study has shown that A. fumiga-
tus serine proteases caused increased secretion of mucus from airway epithelial cells via
the TNF-α-converting enzyme/TGF-α/epidermal growth factor receptor pathway [128].
These studies suggest that there a wide range of potential systems through which A. fu-
migatus proteases might mediate the symptoms of severe asthma. More over, other novel
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targets for A. fumigatus proteases might be discovered by investigating genetic variation
in the individuals effected by A. fumigatus related allergic diseases. For instance current
studies in our research group are investigating novel SNPs in the genomes of SAFS and
ABPA patients in order to identify possible pathways that make these individuals more
susceptible to A. fumigatus related allergic diseases.
7.5 Final conclusions
Allergen proteases from A. fumigatus have been suggested to be involved in the devel-
opment severe asthma through two main mechanisms, degradation of the epithelial cell
monolayer and it associated tight junctions, and the activation of cell surface receptors.
Novel results from the current study show that these effects were likely to be mediated by
Asp f 5 and Asp f 13, with evidence suggesting both Asp f 5 and Asp f 13 are capable of
cleaving the PAR-2 receptor in a manner that induces the release of IL-8. The proposed
effects of PAR-2 mediated cytokine release and epithelial cell monolayer disruption on
the processes of neutrophilic inflammation, eosinophilic inflammation, and airway wall
remodelling in severe asthma are shown in Figure 7.1.
It is suggested that degradation of the epithelial cell monolayer in a protease dependent
manner by Asp f 5 and Asp f 13, leads to increased exposure to environment allergens,
including Asp f 5 and Asp f 13, resulting in an increase in both eosinophilic and mast
cell driven responses, causing more frequent acute asthma exacerbations and increased
epithelial cell damage and remodelling due to damage associated with prolonged inflam-
mation. It is also suggested that the activation of PAR-2 and TLR-4 related pathways by
Asp f 13 results in the production of IL-6, IL-8, MCP-1, GM-CSF and Eotaxin, which
directly increase recruitment of macrophages, eosinophils and neutrophils. Additionally,
it is suggested that IL-6, along with the increased levels of TGB-β and IL-1β in asthmatic
lungs, causes increased stimulation of Th-17 cells. Signalling by activated Th17 cells via
IL-17 and IL-22 is suggested to cause the release of more neutrophil and macrophage
chemoattractants, further increasing neutrophil and macrophage migration to the airway
wall and increasing inflammation and airway damage.
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Figure 7.1: The suggested role of A. fumigatus allergen proteases in neutrophilic and
eosinophilic inflammation in severe asthma. Th2= CD4+ T helper cell 2, Th17= CD 4+ T
helper cell 17, NE= Neutrophil elastase, MMP= Matrix Metalloprotease, ROS= Reactive
oxygen species. Pathway data obtained from [13, 73, 120, 158].
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